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Abstract 
 
 Protein tyrosine nitration (PTN) is a posttranslational modification resulting 
from oxidative/nitrosative stress that has been implicated in a wide variety of 
disease states.  Characterization of PTN is challenging due to several factors 
including its low abundance in a given proteome, preferential site modification, 
multiple target site proximity within unique peptide sequences, and analytical 
method and instrument limitations.  Current analytical techniques are 
insufficiently sensitive to identify endogenous nitration sites without incorporation 
of either nitrotyrosine or target protein enrichment.  However, enrichment 
proficiency can also be inadequate.  Chemical derivatization of the nitro- moiety 
can be incomplete or result in undesirable byproduct formation, while 
immunoaffinity proficiency is contingent upon antibody specificity. 
 To overcome analytical method and enrichment deficiencies, we aimed to 
develop a comprehensive nitroproteome-specific workflow using molecular 
methods combined with mass spectrometry.  Our approach was to systematically 
address all relevant factors contributing to PTN such as primary sequence, 
protein conformation, solvent accessibility, and nitrating agent concentration.  
Our ultimate goal was to increase mass spectrometric sensitivity for PTN 
identification.  All putative nitroprotein/nitropeptide identifications were then 
subjected to rigorous validation by either manual spectrum analyses or peptide 
x 
 
synthesis.  We further developed MS methods for quantitation of nitropeptides 
from complex mixtures with minimal sample processing.  Successful application 
of our nitroproteome-specific mass spectrometric workflow is expected to provide 
powerful tools for comprehensive PTN investigation that will elucidate its role in 
the onset and progression of a variety of disease states as well as facilitate 
discovery of therapeutic targets. 
xi 
 
  
Chapter One: Introduction 
 
Protein-tyrosine nitration overview 
 Posttranslational modifications induced by oxidative or nitrative stress can 
contribute to the pathophysiological events associated with the progression of 
certain diseases (1-8).  Protein tyrosine nitration (PTN) is such a modification 
characterized by covalent addition of a nitro- group (–NO2) to the ortho position 
carbon on the phenolic ring of a protein-bound tyrosine residue (Fig. 1B).  PTN 
alters the physicochemical properties of the modified Tyr residue as well as the 
protein containing it, resulting in aberrant function, turnover rate, protein: protein 
interaction, and cell signaling (3, 9-12). 
 The significance of tyrosine nitration is exemplified by the fact that over 
fifty disease states including Alzheimer’s, Parkinson’s, Amyloid Lateral Sclerosis, 
diabetes, and cancer have been associated with PTN (5, 13, 14).  Nitration found 
above normal endogenous levels is considered a biomarker for tissue damage 
caused by oxidative and/or nitrative stress (6, 15).  However, its potential role as 
a causative factor in human disease and the molecular mechanism by which 
PTN confers toxicity remain largely unknown.   
 PTN has been linked to modulation of enzymatic activity (1-8) as well as 
increased nitroprotein turnover rates (16, 17).  There is also evidence that 
nitration can impact cellular signal transduction through various activities (3, 10, 
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18-20).  The nitro- group (–NO2) itself is considered a signaling molecule in an 
oxygen tension-dependent nitration/denitration cycle (3, 21) or as a modulator of 
kinase-directed tyrosine phosphorylation (3, 10, 18-20). 
 PTN has also been shown to increase with age—indicating a potential role 
in aging and age-related diseases such as cancer (22).  Elevated reactive 
oxygen and nitrogen species (ROS and RNS, respectively) often result from 
inflammatory stress triggers—producing oxidative/nitrative stress conditions.  A 
major outcome of oxidative/nitrative stress is the overproduction of both 
superoxide (O2•¯) and nitric oxide (NO), which can react in a diffusion-limited 
manner (23-25) to form the RNS, peroxynitrite anion (ONOOˉ; Fig. 1a). 
 Although ONOOˉ is generated constitutively as a byproduct of cellular 
respiration, PTN resulting from normal endogenous ONOOˉ generation occurs at 
levels elusive to current detection methods.  However, increased ONOOˉ 
production due to oxidative/nitrative stress initiated by activated macrophage 
response to lipopolysaccharide (LPS) or the presence of other foreign 
substances is considered to be the key contributing factor for PTN under 
physiological conditions (1, 2, 16, 26-28). 
 Since oxidative/nitrative stress-induced PTN levels are likely to be 
significantly higher than normal endogenous levels, induction of these conditions 
is expected to facilitate detection.  Assuming molecular and mass spectrometric 
methods are sufficiently sensitive for PTN detection under these circumstances, 
enrichment strategies such as those required to detect normal endogenous 
nitration (3, 15, 29) are expected to be superfluous. 
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Nitrating agents for in vitro study 
Tetranitromethane 
 Tetranitromethane (TNM) was a popular in vitro tyrosine nitrating agent in 
the late 1960’s and early 1970’s (3, 30-34).  A typical experiment would have 
been the reaction of ≤ 10 mM TNM (33) with protein suspensions at a pH of 8.  
The pH was critical for tyrosyl residue nitration, because at pH ≤ 6, cysteine 
would be preferentially nitrated (32).  Today, TNM use for in vitro PTN study is 
limited since it lacks biological relevance.  Additionally, TNMs reactivity specificity 
is inconsistent at different concentrations (i.e. it frequently modifies other amino 
acid residues such as cysteine, methionine, and tryptophan).  It is also prone to 
side reactions that may result in Tyr-nitrosylation (R—N=O) (3, 35)—perturbing 
qualitative and quantitative analysis. 
Peroxynitrite 
 Peroxynitrite is an oxidized form of NO more commonly used for current in 
vitro protein-bound tyrosine nitration experiments.  It is considered to be the 
major contributor to PTN in biological systems.  Peroxynitrite is formed from the 
reaction between superoxide (O2•ˉ) and NO in a diffusion-limited manner (23-25, 
36) and has a half life of less than one second (2, 3, 17, 37). 
 Superoxide is generated during cellular respiration via the mitochondrial 
electron transport chain (38) and alternate sources such as activated 
polymorphonuclear leukocytes (e.g. macrophages, neutrophils) may contribute to 
O2•ˉ generation via the oxidative burst.  Endogenous NO production is controlled 
by NO synthase (NOS) isoforms, which use molecular oxygen to catalyze the   
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 Figure 1.  Peroxynitrite formation and subsequent tyrosine nitration.  A) 
Nitric oxide and superoxide combine to form the nitrate isomer, peroxynitrite.  B) 
L-tyrosine reacted with peroxynitrite is modified to 3-nitrotyrosine in the presence 
of carbon dioxide or a transition metal. 
 
 
oxidation of L- arginine to citrulline (11, 39).  Expression of inducible NOS 
(iNOS), a high-output form of NOS (40), is elevated in certain cells such as 
activated macrophages. 
 Nitric oxide is an important free radical signaling molecule involved in 
regulation of cell and tissue function (41-44) that has strong affinity for transition 
metal centers and ROS (43).  It also interacts with cytochrome oxidase 
depending on NO and oxygen concentrations to modulate cellular respiration (11, 
39, 45), ATP production (45), and oxygen free-radical production (46).  
Exogenous NO can also be introduced via inhaled drugs of abuse—potentially 
altering NO-mediated signaling and/or increasing ONOOˉ generation and 
subsequent nitration (18). 
Mechanism for peroxynitrite-mediated protein-tyrosine nitration 
 Although several mechanisms have been proposed to describe 
peroxynitrite-mediated PTN occurring either under normal physiological or   
O O+ON O N O O-
O
NH2
OH
OH
Nitric Oxide PeroxynitriteSuperoxide
L-tyrosine
+ O N O O-
Peroxynitrite
O
NH2OH
OH
NO 2
3-nitrotyrosine
• •= = = − −
=
A.
B.
-
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 Figure 2.  Radical pathway for peroxynitrite-mediated Tyr-nitration.  A)  L-
tyrosine in the presence of nitrosoperoxycarbonate radical decomposition 
products results in tyrosyl radical formation (B).  Nitrogen dioxide radical (NO2ˉ) 
reacts with the tyrosyl radical forming the water-stabilized transition state (C) 
before re-aromatization of the phenolic ring to form 3-nitrotyrosine (D).  Adapted 
from Gunaydin & Houk, 2009. 
 
 
inflammatory conditions in the cell (2, 3), it is generally accepted that nitration 
occurs through a radical-driven pathway (2, 3, 47-49) such as the one depicted in 
Figure 2.  The exothermic reaction (19.1 kcal/mol) between intracellular carbon 
dioxide (CO2) and peroxynitrous acid (HNO3) results in formation of a 
nitrosoperoxycarbonate (ONOOCO2) intermediate (16).  Nitrosoperoxycarbonate 
decomposes to form radical products (Fig. 2A) that can ultimately react with the 
tyrosyl radical (Fig 2B).  Water molecule assistance stabilizes the transition state 
depicted in Figure 2C, prior to re-aromatization of the phenolic ring—yielding 3-
nitrotyrosine (3NT) (Fig. 2D).  Decomposition of HNO3 to NO2ˉ and •OH is the 
rate-limiting reaction (16).  Free or bound transition metal ions can also augment 
nitration efficiency through catalysis of radical formation (26). 
Physicochemical consequences of protein-tyrosine nitration 
 Nitration to protein-bound tyrosine shifts the pKa of the phenolic hydroxyl 
group from ~ 10.1 to ~ 7.2—altering side-chain reactivity at physiological pH (50).  
O
NH2
OH
OH
+
ONOOCO 2
-
O
NH2
OH
OH
+
CO .3
- .NO2+
CO.3 HCO3
-
O
NH2OH
O.
.NO2
O
NH2OH
OH
NO2
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3-nitrotyrosine
O
NH2OH
O
NO2
H
H
O H
A. B. 
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Nitration also confers a 35 Å3 bulk addition to Tyr (3, 12) and shifts its 
spectrophotometric absorbance from 276 nm (Tyr) to 427 nm (3NT) at 
physiological pH.  At acidic pH (~ pH 3), 3NT has a characteristic absorbance 
maximum at 356 nm and its hydrophobicity increases—two physical properties 
that become analytically advantageous as described in Chapter Two.  The 
resultant physicochemical changes can impart local or remote conformational 
changes affecting enzymatic activities, protein: protein interactions, turnover 
rates, and cell signaling (3, 10, 12, 27). 
Functional consequences of protein-tyrosine nitration 
Accelerated degradation 
 Although 3NT occurs at a low steady state—affecting fewer than 10E-5 
tyrosine residues (2, 3), nitro- modified proteins are degraded at accelerated 
rates.  This phenomenon can result in functional loss and have downstream 
effects on related pathways.  For example, mitochondrial proteins undergoing in 
vitro generated nitrative stress (incubated with L-Arginine for 30 minutes) were 
degraded much faster than unmodified cognate proteins (26).  The half-lives for 
nitroproteins were measurable in hours as compared to days (Table 1) for the 
unmodified isoforms (26).  Supporting these results, native Tyr-containing protein 
half-lives found in this study were in agreement with degradation rates reported 
by Grisolia in 1981 (51). 
Antioxidant interference 
 Another possible functional consequence resulting from PTN is antioxidant 
interference.  An example of this can be found in interruption of the bond on   
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Table 1.  Nitrated mitochondrial protein half-lives. 
 
Mitochondria incubated with L-Arg for 30 min, then washed, were analyzed by 
tandem 2D gels.  One gel was blotted and stained for nitrotyrosine, while the 
second was trypsin-digested and analyzed by matrix-assisted laser desorption 
ionization time-of-flight (MALDI-TOF).  Isoelectric point and molecular weights 
were also considered for protein identifications.  Adapted from Beckman, 1992 
(26). 
 
 
Cytochrome-c (Cyt-c) heme iron-methionine 80 (Met80) conferred by Tyr74 
nitration (12).  The bond shift was confirmed by circular dichroism (CD) and 
nuclear magnetic resonance (NMR) spectroscopy analyses performed at 
physiological pH (12).  Cyt-c functions as an electron scavenger in the electron 
transport chain (ETC), as well as an apoptosis initiator upon release from the 
mitochondrion (12).  The conformational change conferred by PTN can alter Cyt-
c functionality possibly resulting in heightened oxidative stress or apoptosis 
initiation.  These consequences imply a potential causative role for PTN in 
disease pathology. 
 Another aspect of PTN cytotoxicity through antioxidant impairment is its 
propensity to be self-perpetuating.  For example, enzymes involved in the 
antioxidant response (phase II drug metabolizing enzymes) have been previously 
identified to be PTN-susceptible targets (52).  This result is likely due to the fact 
that phase II enzyme expression increases under oxidative stress conditions.  
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However, nitration can diminish their ROS scavenging and disposition capacities, 
resulting in exacerbated cell damage. 
Altered enzyme activity  
 Enzyme activity can also be modulated by Tyr-nitration.  For example, 
TNM treatment to ATP synthase β-subunit (ATPase-β) induced nitration to two 
residues (Tyr345 and Tyr368), resulting in a 66% activity loss (53).  Although TNM 
conferred nitration to a total of five ATPase- β Tyr residues, an earlier study (54) 
reported finding in vivo nitration to Tyr345 and Tyr368, indicating the physiological 
relevance of the two targets.  To validate these findings, site-directed 
mutagenesis was performed severally at either location (Phe substitutions: 
Y368F and Y345F), which resulted in reversal of ATPase inactivation by 54% 
and 28%, respectively (55). 
Age-related effects 
 Evidence has also been found indicating age-related ATPase activity loss 
related to, but not directly caused by, PTN (55).  Nitration to rat liver 
mitochondrial ATPase-β (Tyr345 and Tyr368) was found to diminish enzymatic 
activity by two-fold in old (80 weeks) rats as compared to young (4 weeks) (55).  
Since ATP binding affinity was invariant between young and old rats, a yet to be 
determined age-related factor appears to be acting concomitantly with PTN 
modification to suppress ATPase activity in aging rats. 
Protein conformational changes 
 The three-dimensional (3D) crystal structure of ATPase-β (Protein Data 
Bank 1MAB) confirms Tyr345 and Tyr368 solvent accessibility—a prerequisite to 
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ONOOˉ-mediated nitration susceptibility under physiological conditions (55).  
Also, the primary sequence surrounding the Tyr345 and Tyr368 satisfies a 
proposed nitration susceptibility consensus sequence (11).  However, tandem 
mass spectrometric (MS/MS) data indicated the less activity-altering Tyr368 to be 
the predominantly-nitrated species.  The increased susceptibility of Tyr368 
appears to be due to its maintaining a lower pKa under standard conditions (7.6 
v. 8.2 for Tyr345).  Interestingly, Tyr345 was found to be the predominantly-nitrated 
species in conditions of constitutively high NO concentrations achieved by L-Arg 
perfusion (55).  Taken together, these results can be interpreted to link 
conformational changes imparted by Tyr345 nitration to oxidative stress-induced 
ATPase activity loss and diminished energy metabolism. 
Altered signal transduction 
 PTN has also been implicated in modulation of intracellular signal 
transduction, especially tyrosine phosphorylation (3, 10, 18-20).  Nitro- 
modification may not only compete with phosphorylation for specific Tyr sites, but 
it may also disrupt normal phosphorylation indirectly through nitration of tyrosine 
kinase (TK)—a previously identified potential peroxynitrite-mediated nitration 
target (9).  Nitrated TK activity is generally associated with reduced 
phosphorylation (9); however, it could potentially result in constitutive TK activity 
and hyper-phosphorylation.  An example of activity gain can be found in insulin 
phosphorylation, which has been demonstrated to show increased activity in the 
presence of low levels of peroxynitrite (3, 19).  The implication is that there exists 
a balance of nitrating agent and nitroprotein that effectively modulate kinase-
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directed signal transduction pathways (3).  This also implies the nitro- group itself 
acts as a signaling molecule in an oxygen tension-dependent nitration/denitration 
cycle (21). 
Impact on human health 
Nitration as a potential causative factor in disease 
 Although PTN is generally thought of as little more than a marker for 
disease (6, 15), it is also suspected of being a causative factor (56).  The 
presence of PTN in over fifty disease states (5, 13) is evidentiary of its having a 
causative role in at least some cases.  PTN has been shown to influence 
essential cell processes such as energy metabolism, ROS disposition, and 
signaling as discussed previously in this chapter.  As analytical methods improve, 
it is expected that a more defined account will develop of PTNs impact in certain 
disease pathologies.  This section will review some of the recent studies 
connecting PTN to specific disease states. 
Proliferation 
 Uncontrolled proliferation has been identified as one of the six major 
hallmarks of tumorigenesis in cancer (57).  PTN has been implicated as having 
mitogenic activity through inhibition of prostaglandin 2 synthase (PGI2 synthase).  
Increased expression of PGI2 synthase works to switch vascular cells from 
proliferating states to differentiation (58).  Thus, highly-proliferating cells are 
expected to express low-levels of PGI2 synthase (58).  PTN can alter PGI2 
synthase activity, mimicking low-level expression and resulting in uncontrolled 
proliferation. 
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 Another study found bovine PGI2 synthase from aortic microsomes to be 
50% nitrated correlating with a 50% reduction in activity upon treatment with 25 
µM ONOOˉ (59).  Thermolysin in-gel digestion of PGI2 synthase-containing SDS-
PAGE bands, followed by mass-spectrometric characterization using nano-flow 
reversed-phase high performance liquid chromatography-Fourier transform ion 
cyclotron resonance (HPLC-FTICR) analysis identified a nitration site at Tyr430.  
The site was validated through synthetic peptide analysis as well as Edman 
microsequencing.  Because nitration was absent on all other proteins prior to 
treatment with 500 µM ONOOˉ (nitration remained specific for PGI2 synthase up 
to 250 µM ONOOˉ), it was postulated that low level endothelial generation of 
ONOOˉ was responsible for PGI2 synthase-specific inhibition. 
 A subsequent study by Spisni et al (2001) determined the localization of 
PGI2 synthase to be near the caveolar membrane (60).  Also localized near the 
caveolae is eNOS, which is regulated by caveolin-1 (61).  This places PGI2 
synthase in proximity to a possible ONOOˉ generation source.  This finding 
supports the assertion that PGI2 is a likely PTN target, considering PGI2 
synthase is likely to be exposed to normal levels of endogenous ONOOˉ 
generation.  It also explains how PGI2 could be a more susceptible nitration 
target than proteins not associated with caveolae. 
 It is also important to note that PGI2 synthase is constitutively expressed 
(58), thus excluding variant expression as a factor in modification susceptibility.  
Taken together, PTN appears to serve at least a regulatory role for PGI2 
synthase activity and that excessive nitration-induced PGI2 synthase inhibition 
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could potentially mimic mitogen activity, resulting in uncontrolled proliferation and 
tumorigenesis. 
Metabolism 
 Since ONOOˉ was thought to be the product of O2•– leakage from the ETC 
and NO from a constitutively-expressed mitochondrial NOS (mNOS), the 
mitochondrion was the focus of many early nitration studies (7, 9, 11, 42, 55, 62-
66).  Thus, the mitochondrion was considered a nitration “hot spot” where 
peroxynitrite generated in the matrix affected proteins involved in energy 
metabolism (11). 
 To better characterize the mitochondrial global nitration profile, Elfering et 
al (2004) acquired whole rat liver mitochondria and sub-fractionated it to evaluate 
3NT sub-mitochondrial localization.  Fractions isolated were the outer membrane, 
inter-membrane space, inner membrane, contact sites, and the matrix (11).  
Whole mitochondria and subfractions were analyzed by Western blot stained for 
3NT (11).  Quantification was performed by calculating the ratio of the 
percentage of nitroprotein content compared to total protein in each fraction.  The 
results correlated to expectations that the major sub-mitochondrial fractions 
containing 3NT would be the matrix (58.3%) and the inner membrane (30.5%). 
 Additionally, sustained NO production was induced via L-arginine 
supplementation to isolated mitochondria and assayed for 3NT generation.  The 
results showed a greater than two-fold nitration increase on ATPase-β—
supporting the claim of the existence of mitochondrial NOS (11) and linking PTN 
to energy metabolism disruption via decline of the functional ATP synthase pool.  
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The nitrated ATPase-β half-life had been reduced to 0.5 hours (11), in contrast to 
the unmodified ATPase-β half-life of 0.59 days (51). 
Neurodegenerative diseases 
 Synucleinopathic lesions in Parkinson’s disease caused by aggregation of 
α-synuclein have been linked to PTN (14).  In this study, anti-nitro-α/β-synuclein 
monoclonal antibodies were raised to ensure specificity for 3NT-containing α-
synuclein.  The efficacy of the novel antibodies were validated by enzyme-linked 
immunosorbent assay (ELIZA) containing nitro-α/β-synuclein, unmodified α/β-
synuclein and other 3NT-containing proteins.  The antibodies raised were 
demonstrated to show better specificity than a commercially-available polyclonal 
anti-3NT antibody used in parallel—an analytical issue that will be discussed 
later in this chapter. 
 The study concluded that overproduction of reactive oxygen/nitrogen 
species and/or impairment of antioxidative responders contributes to the onset 
and progression of neurodegenerative synucleinopathies (14).  Synucleinopathic 
lesion formation correlated with the presence of nitro-α/β-synuclein as 
demonstrated by immunostaining, immunofluorescence, and silver-enhanced 
immunoelectron microscopy (14).  The results of this investigation provided 
further evidence of PTN as a byproduct of oxidative/nitrative stress.  It also 
demonstrated the potential for PTN to be a causative factor in a 
neurodegenerative disease. 
 Another study investigated the effects of site-specific nitration and 
dityrosine bridging of tau protein in Alzheimer’s disease (13).  In vitro 
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peroxynitrite (ONOOˉ) reactions with tau resulted in the formation of SDS-
insoluble aggregates containing 3,3′-dityrosine (3,3′-DT).  These results indicate 
a possible pathophysiological link between nitrative stress and Alzheimer’s 
disease.  However, at present PTN can only be confirmed as a biomarker for the 
disease.  Nitration site-specificity will be discussed in more detail in the following 
section. 
Protein-tyrosine nitration site-specificity 
Evidence for protein-tyrosine nitration site preference 
 Although tyrosine comprises 3.2% of the proteome (3, 67); residue 
abundance does not correlate with nitration susceptibility (4, 7, 68).  Random 
tyrosine nitration has been refuted by both in vivo and in vitro assays (3, 11, 16, 
69).  Fundamental requirements for Tyr nitration susceptibility are solvent 
accessibility and the absence of steric interference to a RNS such as ONOOˉ.  
The slightly hydrophilic character imparted on Tyr imparted by the presence of a 
hydroxyl group on its phenolic ring is partially responsible for its localization to 
aqueous environments (70).  In fact, 85% of Tyr residues are found in solvent-
accessible environments (7, 68).  Thus, PTN site-preference appears to be 
driven by alternative factors since most tyrosines are available for peroxynitrite-
mediated nitration under normal physiological conditions (3). 
Factors influencing site-specific nitration 
 Since nitration can alter major biological processes such as tyrosine 
kinase-regulated signal transduction pathways (3, 10, 18-20), identification of 
modification sites can help predict functional outcomes in the cell.  Although high 
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molecular weight proteins would intuitively be more susceptible to nitration based 
on tyrosine abundance, experimental data show that nitration preference does 
not correlate with the number of available tyrosine residues on an individual 
protein (16).  For example, β-casein (~ 2% tyrosine content), has been shown to 
be more susceptible to nitration than phospholipase A2, which has ~ 8% tyrosine 
content (16).  Also preferential nitration was observed on two of 18 available sites 
on human serum albumin (71).  Thus protein accessibility to a nitrating agent is 
another likely factor in nitration susceptibility. 
Models for nitration susceptibility prediction 
 Although nitration targets specific Tyr residues, there does not appear to 
be a consensus sequence driving susceptibility.  Rather, the microenvironment, 
electrostatic forces, and secondary structure appear to be the major factors 
influencing nitration site-preference (7, 68, 69).  Souza et al. (1999) and 
Ischiropoulos (2003) postulated that Tyr localization near turn-inducing residues 
(i.e. Pro, Gly) and acidic residues (Asp, Glu) favors nitration.  However, the 
propensity for nitration near negatively-charged and hydrophobic residues 
remains dubious based on recent findings (69). 
 Multiple consensus sequences for tyrosine nitration susceptibility have 
also been postulated based on experimental data from in vitro nitration to 
proteins in native conformation (3).  One example is the proposed structural 
motif, [LMVI]X-[DE]-[LMVI]X(2,3)-[FVLI]X (3,5)Y, where X can be substituted for 
any amino acid residue (11).  This model is based in part on the susceptibility of 
ATPase-β Tyr345 (3, 11) (see: Functional Consequences).  This sequence, 
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simplified as L-DL---V-----Y--, is based on alignment (ClustalX) of a sparse 
sample set of ten proteins.  Additionally, there is no indication of a consensus 
residue (or positive substitution) for the site adjacent to Tyr on the carboxy 
terminal side, and gaps of three and five amino acids are found between 
residues.  Although this model may apply to ATPase-β and a small sample of 
other proteins, experimental data is too scarce to support universal applicability.  
Moreover, recent work has demonstrated that adjacent residues to the Tyr site 
can significantly influence nitration susceptibility (69). 
 It should also be noted that consensus sequences are primary sequences 
inferred from proteins reacted with nitrating agents in their native conformations.  
The native state allows susceptibility to be influenced by solvent accessibility and 
three-dimensional structure, conditions that are likely inconsistent throughout a 
given proteome.  In other words, a short primary sequence shared by a scant 
number of proteins cannot reliably predict the localization of that sequence 
among a vast number of alternately structured proteins.  Likewise, it is unintuitive 
to purport primary structure as the major factor driving modification susceptibility 
without having isolated and tested it outside the influence of three-dimensional 
structure.  In Chapter Two, these issues were addressed as they applied to a 
unique case of site-selective PTN. 
Using bioinformatics for nitration site prediction 
 Bioinformatic prediction algorithms are also limited by a native state bias.  
In August 2011, Liu et al (72) published GPS YNO2 (available at 
http://yno2.biocuckoo.org/), a program which claims 76.51% accuracy, 50.09% 
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sensitivity, and 80.18% specificity for nitration site preference.  However, there 
remains limited empirical data to validate the program’s efficacy since site 
preference is calculated based exclusively on sparse empirical data from in vitro 
nitration reactions with proteins in their native states.  Again, prediction is based 
on primary sequence with no experimental data relevant to primary structure 
influences on nitration susceptibility.  In Chapter Two, nitration susceptibilities of 
short sequences containing amino acid substitutions with dissimilar chemical 
properties were isolated and tested.  These data were expected to complement 
existing prediction programs—especially in the case of preferential nitration to 
adjacent tyrosine residues located within a similar microenvironment. 
Limitations to protein-tyrosine nitration characterization 
Dityrosine formation 
 As stated previously, 3NT occurs at extremely low endogenous levels and 
shows preference for specific proteins and sites.  Moreover, a study by Pfeiffer, 
Schmidt, & Mayer asserts that 3NT is not the predominant product of 
peroxynitrite radical reaction evolved from enzymatic production of •NO and O2•ˉ 
(73).  This study demonstrated that in vitro mimicry of endogenous ONOOˉ 
formation using NO generated from (Z)-1-{N-[3-aminopropyl]-N-[4-(3-
aminopropylammonio) butyl]-amino}diazen-1-ium-1,2-diolate] (SPER/NO) and 
O2•ˉ generated from 32.5 µM hypoxanthine/xanthine oxidase was less efficient at 
tyrosine nitration (nitration efficiency = 0.17%) than reaction with 70 µM authentic 
peroxynitrite (nitration efficiency = 4.9%).  Moreover, generation of low steady-
state peroxynitrite was found to result in tyrosyl radical intermediates which were 
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more likely to self-bond forming dityrosine than proceed through to nitro-
modification to tyrosine (73). 
Denitration 
 Another important aspect to consider in the study of PTN with regard to 
detection and quantification is the availability of proteins conferred with the nitro- 
modification for analysis at a given interval.  In addition to protein turnover rates, 
evidence has been found that in vivo 3NT levels continue to diminish in 
conditions of proteolytic inhibition (3, 21, 74, 75)—indicating reversal of the nitro- 
modification.  While the existence of a “denitrase” remains unresolved, current 
data appear to be more indicative of denitration occurring through a chemical 
process (3, 10, 21, 74, 75).  Taken together, the results of these studies indicate 
that some form of denitration, either through a catalytic or chemical process, is 
actively diminishing the pool of nitroproteins concomitantly with increased 
degradation rates under normal proteolytic conditions. 
Misidentification 
 Misidentification of 3NT can adversely affect site prediction algorithms and 
possibly confound our understanding of metabolic pathways modulated by PTN.  
Many studies have relied on MS/MS search algorithms to identify and localize 
site-specific nitration from large-scale experiments.  Often a shotgun proteomic 
approach is taken, where complex mixtures of tryptic peptides from a biological 
sample are analyzed by a single HPLC MS/MS run (76, 77).  Unfortunately, lower 
abundance peptides can be missed due to ion suppression (78, 79) and low-
stringency database search parameters typical for processing such data may   
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Table 2.  Evaluation of published nitropeptides by de novo sequencing.   
 
The above table is a summary of validations of putative nitropeptides (81) using 
the protocol proposed by Stevens et al. (2008).  The first column lists the 
reported nitropeptide sequences, while the third column enumerates the actual 
sequences as determined by manual evaluation of the published spectra to 
determine the likely actual peptide sequences, which were subsequently 
synthesized and analyzed by HPLC-MS/MS.  These data demonstrate the need 
for stringent identification criteria for the reporting of PTN using mass 
spectrometric data (adapted from Stevens et al, 2008). 
 
 
lead to erroneous nitration site localization (80). 
 For example, the Δm for nitration (+45 Da) can be mimicked by chemical 
modifications that occur during sample preparation such as the combined Δm 
imparted by asparagine deamidation to iso-Asp (∆m = +1 Da) and primary amine 
carbamylation (∆ m = +43 Da) (http://www.ionsource.com).  The net 44 Da 
precursor mass increase can confound database search outputs in cases where 
spectra originate from an analysis allowing ≥ 2 m/z isolation width since nitration 
confers a Δm of +45 Da.  This phenomenon resulted in the misidentified sites 
(81) enumerated in Table 2 as evaluated in 2008 by Stevens et al (80).  Although 
high-resolution MS/MS analyses can produce more confident nitration site 
identifications using spectra derived from accurate precursor masses, manual 
Reported nitropeptide sequence*
Charge 
State Actual Peptide Sequence
Charge 
State
Theoretical 
Δ m/z
Approximate theoretical 
resolution (M/ΔM) required to 
resolve ESI-generated ions of 
reported nitropeptides from 
those of actual peptides
EY*RKDLEESIR 2 KVQHELDEAEER 2 0.0000 N/A b
ERYAAWoxMY*TY*SGLFCVTVNPYK 3 DQEGQDVLLFIDNIFR 2 - 0.3800 2,500
Y*EEEIK 1 SIHELEK 1 -0.0840 10,000
SYKY*LLLSMVK 2 NLVHITHGEEK 2 -0.0019 350,000
a oxM, oxidized methionine; *nitration, 
b Not applicable
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evaluation of putative nitropeptide spectra may remain necessary for validation 
(80). 
 To strengthen manual spectral validation, LC-MS/MS analysis of high-
quality synthetic nitropeptides can be performed.  The synthetic cognate peptides 
should elute at the authentic nitropeptides’ characteristic chromatographic 
retention times (RT) and produce identical MS/MS spectra.  With the goal of 
ensuring reliable data reporting for PTN, appropriate guidelines for validation and 
publication of MS data were proposed by Stevens et al (2008) that have been 
adopted by many subsequent studies. 
Molecular methods for protein-tyrosine nitration study 
Electrophoretic separation and immunostaining 
 The current standard for PTN study relies on one or two-dimensional (1D 
or 2D) gel electrophoresis followed by either immunochemical analyses such as 
western blotting or mass spectrometry.  Although gel electrophoresis can yield 
high-resolution protein separation, it is limited to relative quantitation of 3NT with 
little confidence in target protein specificity.  Site-specificity cannot be determined 
by immunochemical detection.  Mass spectrometry can by employed to identify 
potential protein targets from 1D or 2D gels; however, site identification is rare.  
Moreover, redundancy among nitroprotein identifications is scarce among 
various methods (i.e. no single technique appears to be sufficient to identify the 
full complement of nitroproteins from a given protein set). 
 Two examples of inconsistency among nitroprotein identifications can be 
found in PTN studies of aging rat heart (82) and brain (81).  Whole heart and 
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heart mitochondrial lysates were analyzed by 1D gel electrophoresis (1DE) of 
and 2D gel electrophoresis (2DE) of 3NT immunoprecipitates (IP) (82), while 
brain lysates were analyzed by either 1DE, isoelectric focusing (IEF), or 
combined 1DE/IEF (81). 
 Twenty-three nitroproteins were identified from whole heart lysate, and 34 
from heart mitochondria (82).  Of the 57 total nitroproteins identified, 24 were 
unique to 2DE and 29 to IP/1DE (82).  Results from the rat brain analyses were 
even more contrasting as the combination of all three approaches yielded 34 
total identifications, with only three unique to IEF.  The latter results also 
contained misidentified nitropeptides (81), as outlined in Table 2.  Neither study 
was able to confirm specific nitration sites. 
 Immunoblotting in parallel with Coomassie-stained gels can be exploited 
for locating prospective 3NT-containing bands as well as for confirmation of 3NT 
target molecular weights.  Mass spectrometric analysis can be performed on 
digests of cognate bands from the 1D or 2D gels to determine likely PTN targets.  
However, anti-3NT antibody specificity is questionable (3) and site identification 
remains challenging due to insufficient starting material for MS analysis or 
incomplete extractions that can result in limited sequence coverage and 
nitropeptide omissions. 
Immunoaffinity capture and chemical derivatization 
 Although 3NT becomes more abundant under oxidative stress conditions, 
it typically remains below the analytical limit of detection (LOD) for current mass-
spectrometric approaches.  Immunological or chemical derivatization enrichment 
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strategies (3, 15, 29) are often employed to acquire enough material to surpass 
the LOD.  However, enrichments can be problematic due to unreliable antibody 
specificity, excessive sample processing, and generation of unwanted chemical 
artifacts (3).  Also, mass spectrometry is limited by the separation method, 
amount of material, complexity of sample, sample processing, trypsin efficiency, 
extraction efficiency (from gel matrices), solubility and protein mass (3). 
 Perhaps the most widely used chemical approach has been enrichment by 
dithionite reduction of 3NT to aminotyrosine followed by various labeling 
strategies for affinity capture to facilitate detection (3, 83).  However, quantitation 
is difficult due to the potential for aminotyrosine re-oxidation to 3NT and/or 
inconsistent reduction of proteins, especially surface and membrane-bound due 
to the instability of dithionite at room temperature (3, 9, 21, 84). 
 Regardless of the shortcomings inherent to immunoaffinity and chemical 
derivatization, Petre et al, (2012) have recently concluded that enrichment of 
either 3NT-containing proteins or peptides is essential to acquire enough material 
to exceed mass spectrometric LOD (85).  Immunoaffinity continues to be subject 
to the aforementioned issues regarding antibody specificity and reproducibility, 
while chemical enrichment strategies have consistently yielded undesirable side-
reactions and 3NT regeneration, precluding accurate quantitation (3, 62, 86).  
Inspired by the limitations to conventional molecular approaches, our major aim 
was to develop proteomics and mass spectrometry-based methods to improve 
PTN detection sensitivity facilitating accurate quantitation and better 
characterization of PTN with limited sample manipulation. 
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Mass spectrometry-based methods for protein-tyrosine nitration study 
Enzymatic digestion of protein suspensions 
 A common method for protein and PTM identification from complex 
mixtures incorporates the use of a proteolytic enzyme such as trypsin (which 
cleaves at the carboxy termini of Arg and Lys residues, except when followed by 
Pro) prior to analysis.  After preparing the samples in an aqueous solution at 
acidic pH, the peptide mixture complexity is reduced by reversed-phase high-
performance liquid chromatography (HPLC)—a method that separates analytes 
based on their characteristic hydrophobicities (87).  The peptide mixture is then 
delivered to a mass spectrometer for MS/MS analysis to collect peptide and 
peptide fragmentation mass data.  Since protein identifications are dependent 
upon peptide identifications, this is considered a “bottom-up” proteomic approach 
(88, 89). 
Chromatographic separation 
 Reversed phase HPLC is achieved by use of a pump system to deliver an 
aqueous peptide-containing solution to a column containing a stationary-phase 
composed of porous silica beads bound to long alkyl (e.g. C18) chains (87, 90).  
The long alkyl chains create a hydrophobic environment with strong affinity for 
peptides containing one or more hydrophobic residues (87, 90, 91).  The 
peptides are loaded onto the column in aqueous solvent (e.g. 0.1% formic acid in 
water) and are eluted in order of least to greatest hydrophobicity through 
introduction of organic solvent such as methanol or acetonitrile in a linear 
gradient over time (87, 90, 91). 
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Electrospray peptide ionization 
 As peptides elute they are delivered to the mass spectrometer as 
positively-charged ions, due in part to their solution pH of ~3 and an applied 
voltage prior to their release into the atmosphere at the ion source (92-94).  The 
solvated charged ions are forced through a ~ 10 µm orifice where the solution 
forms a “Taylor Cone” (95) followed by a jet stream and a spray plume emission 
(Fig. 3).  Electrostatic repulsion and heat help eject the peptide ions into the gas 
phase (92-94) as they enter the vacuum of the mass spectrometer.  This entire 
process is termed electrospray ionization or ESI (92-94, 96).  Its inventor, John 
Fenn, was awarded the Nobel Prize in Chemistry in 2002 
(http://www.nobelprize.org). 
Ion movement and mass analysis 
 Peptide ions enter the mass spectrometer by means of a vacuum interface 
and a low electrical potential in a heated capillary (ion transfer tube).  As they 
move toward the analyzer, the ions are focused by multipole optics in an 
oscillating electrical field (97).  The vacuum increases as electrical potential 
continues to decrease pulling the ions forward until they reach an ion trap—a 
quadrupole that has alternating RF frequency and the ability to trap the ions by 
quickly ramping up the electrical potential at two small quadrupoles on either 
end—trapping the ions in an oscillating spiral pattern controlled by direct current 
(DC) and RF (98-100).  The trapped ions are scanned out of the trap by 
increasing RF voltage that resonates with all ions with mass-to-charge ratios 
(m/z) within the mass range of the instrument (98).  
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 Figure 3.  Electrospray ionization.  Nano-flow emitters are typically constructed 
of 20 µm ID polyimide fused-silica tapered by pulling under flame or laser to ~ 10 
µm ID.  High voltage is applied to the analyte/solvent solution prior to 
atmospheric emission.  The voltage causes a change in solvent tension that 
forms a solvent cone (Taylor Cone).  The solvent propels forward as a jet, then 
atomizes into a plume of solvent spray containing analyte ions.  The solvent is 
heat-evaporated from the analyte ions, which enter the gas phase at the interface 
between atmospheric pressure and the vacuum of the mass spectrometer at the 
heated capillary.  
 
 
 In full-scan mode on a linear ion trap MS, ions of all m/z are ejected 
sequentially to the detection system—conversion dynodes whose signals are 
amplified by electron multipliers (99).  The calibration of the instrument is such 
that each ion ejected at a given frequency is of a particular m/z, while the 
intensity of the peak transmitted by the detector is proportional to the number of 
ions present.  Thus, the resulting mass spectrum (MS) is a graphical 
representation of all the ions present and their relative intensities during a single 
scan. 
Data-dependent tandem mass spectrometry 
 The ion trap also functions as a collision cell to induce fragmentation of 
peptide ions to produce a spectrum of daughter ions (98, 101).  The trap can 
isolate a particular mass by scanning all other m/z out as in full-scan, while 
omitting the resonance frequency for the desired mass.  This isolation is done 
Taylor Cone
Emitter Tip (Fused Silica)
Jet
Plume
+ 2 kV
Electrical Lead
~ 
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 µ
m
25 
 
until the cell is filled with a preset number of ions (e.g. 3 × 104) of the selected 
m/z or for a specified time (e.g. 100 ms).  Mass selection is typically within a 
range of ± 1 Da to account for mass error.  The selected ions are then kinetically 
fragmented by collision with an inert gas such as helium or argon (101-103).  
Peptides most commonly break at their amide (peptide) bonds (101) in a process 
known as collision-induced dissociation (CID) (101-103).  The fragment ions that 
retain a positive charge are ejected to the detectors as they lose stability in the 
trap (98) because they are no longer isobaric with the precursor m/z.  The signal 
received by the detectors is amplified by electron multipliers where the electrical 
signal intensities are proportional to the abundance of the ions initially striking the 
conversion dynode surface.  The resulting peaks represent the full spectrum of 
positively-charged fragment ion masses for each peptide (102, 104). 
 A typical tryptic peptide carries a charge of +2 imparted by protonation of 
the amino terminus and the terminal basic residue—either Arg or Lys.  Peptide 
ions fragment in one location during CID, on average.  One of the fragment ions 
typically carries the positive charge, with the fragmentation spectrum containing 
mainly two types of fragment ions, b-type and y-type ions (101).  B-type fragment 
ions are those containing the amino acid residues from the amino terminus to the 
broken peptide bond, where y-type are those containing the residues to the C-
terminus of the broken peptide bond (101).  This entire process is known as 
tandem MS, or MS/MS (101-103) and is outlined in Figure 4. 
 Data-dependent scanning can be used as a “shotgun” (105) approach for 
identifying the majority of a proteome from a complex peptide solution based on 
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progressively lower full scan MS intensities.  Data-dependent method parameters 
are set by the analyst for optimal output based on the requirements of the 
experiment.  A typical instrument method will have a scanning cycle beginning 
with a full survey scan, followed by isolation of the (e.g. top ten) most intense 
ions from the mass spectrum (i.e. precursor ions).  This process continues for the 
top ions from each subsequent full scan; however, previously-selected precursor 
masses are commonly placed on an exclusion list after one-to-several 
appearances in the top-10 for a set period of time related to chromatographic 
peak width.  Thermo Scientific terms this function “Dynamic Exclusion”, which 
allows for lower-abundance ions to be isolated and fragmented—significantly 
augmenting the identification potential of the overall experiment. 
Bioinformatic peptide, protein, and posttranslational modification 
identification 
 Precursor ion m/z combined with MS/MS spectra are used to identify the 
peptides present in a bottom-up experiment, and likewise the proteins of origin.  
Each spectrum can be analyzed manually to determine the peptide sequence by 
calculating the Δm between each pair of sequential fragment ion peaks, which is 
equal to the amino acid residue mass.  This approach is referred to as de novo 
sequencing (106).  However, data from a typical HPLC-MS/MS analysis often 
consists of thousands of spectra, with many containing alternate ion types (a, c•, 
x, z•), dehydration losses, ammonia losses and other gas phase fragmentations 
or rearrangements (101) that contribute to the complexity of sequence 
determination. 
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 Thus, database search programs such as Mascot (107) are employed to 
determine peptide sequences by searching annotated databases containing 
comprehensive mass lists such as the UniProt knowledge base (UniProtKB, 
http://www.uniprot.org/).  Search parameters include the expected constant 
modification from trypsin digestion preparation (carbamidomethyl-C) and a few 
possible variable modifications (e.g. Met oxidation, nitro-Tyr), as well as any of 
the aforementioned chemical changes that occur in gas-phase in the mass 
spectrometer. 
 Mascot identifications are often subjected to a more stringent validation 
process such as the Scaffold platform (108), which compares theoretical spectra 
including expected fragment ion intensities to the acquired spectra from the 
MS/MS analysis.  Scaffold then scores the probabilities of all identifications using 
the Peptide Prophet (109) and Protein Prophet (110) algorithms based on 
spectrum comparison to theoretical and percentage of identified product ions for 
each precursor m/z.  Scaffold PTM can also be a useful resource for site 
validation by providing a probability-based score for site-specific modifications 
using the Ascore (111) algorithm. 
High-resolution mass spectrometry 
 A high-resolution hybrid linear ion trap/ FT mass analyzer (Orbitrap) can 
be exploited to determine precursor masses with resolving power of up to 150, 
000 (112).  However, resolution settings for a typical protein identification 
experiment range from 30,000 to 100,000 at 400 m/z to accelerate scan times.  
The Orbitrap analyzes mass by their specific ion frequencies as they revolve   
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Figure 4.  Data-dependent acquisition with high-resolution precursor 
scanning.  In (1), a tryptic peptide (PEPTIDEK) is introduced to the mass 
spectrometer via ESI at the ion source among all ions eluting at a particular time 
point.  Assuming it is one of the top-ten most abundant ions in the full-scan mass 
spectrum resulting from high resolution/accurate mass (HR/AM) analysis in the 
Orbitrap, PEPTIDEK (2) is isolated in the collision cell (linear ion trap mass 
analyzer) and fragmented by CID in helium gas.  The fragment (b- and y-type) 
ions are scanned out of the ion trap and are amplified by dual conversion dynode 
electron multipliers (detector) resulting in the spectrum to the right.  The 
spectrum shown for PEPTIDEK is an example of a typical Scaffold annotation. 
 
 
around a central electrode and oscillate harmonically back and forth in the trap 
(112).  The outer shell is an electrode-detector that records an image of all the 
m/z oscillation frequencies (112).  The frequency (ωz) of the axial oscillations can 
be used to determine all the masses present in the trap because they are 
dependent exclusively upon the m/z and the field curvature (k) as indicated by 
the relationship 𝜔𝑧 = � 𝑘𝑚/𝑧  (112).  Fourier transformation (113) is then applied to 
determine the mass spectrum for a full scan and select the most abundant ions 
for MS/MS fragmentation in the linear ion trap or the high-energy collision-
induced dissociation (HCD) cell, which is unique to an Orbitrap.  HCD product 
ions are directed into an Orbitrap analyzer for high-resolution daughter ion 
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spectra.  The high-resolution precursor masses, combined with their MS/MS 
spectra, furnish the analyst with high confidence peptide identifications and 
posttranslational modification site identification. 
 Orbitrap analysis can also facilitate relative quantification of low mass 
reporter ions such as those used in iTRAQ (Life Technologies, Grand Island, NY, 
USA) post-digestion chemical labeling by taking advantage of HCD 
fragmentation and the extended m/z range of an Orbitrap mass analyzer.  An 
Orbitrap also allows for identification of low mass immonium ions resulting from 
internal peptide fragmentation, such as the characteristic 181.06 Da 3NT 
diagnostic ion, in cases where the precursor mass is greater than three times the 
product ion mass—a limitation that applies to linear ion trap detection.  
Multiple Reaction Monitoring mass spectrometry 
 An extremely powerful tool for quantification of analytes of known m/z and 
chromatographic retention time (RT) is the Triple-Stage Quadrupole MS (TSQ 
Ultra, Thermo, USA).  A major advantage of a TSQ is its ability to determine 
absolute quantitation of specific analytes from complex mixtures.  Exploiting this 
feature, however, requires extensive knowledge of the target analyte and pure 
samples for calibration and internal standard incorporation. 
 Multiple Reaction Monitoring (MRM) MS is a method that can be 
developed for a specific analyte on a TSQ.  In method development mode, the 
analyte of choice is delivered by direct infusion—facilitating optimization of ion 
optic parameters that are specific to the analyte.  This process improves 
detection sensitivity as well.  Often the analyte is introduced via a “T” connector   
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Figure 5.  Multiple Reaction Monitoring mass spectrometry.  A triple-stage 
quadrupole (Q1-Q3) mass spectrometer can be used to quantify analyte “X” from 
a complex mixture.  In Q1, X is selected with all other m/z scanned-out.  X is 
fragmented in the collision cell (Q2), allowing all product ions to pass to Q3.  In 
this example, Q3 selects for the x-specific product ions, y and z, by scanning-out 
all other m/z.  This is indicative of method optimization having been performed 
prior to analysis to determine X-specific product ions of most intense signal 
strength.  The AUC for Xy, z is normalized to the AUC of an internal standard 
and is quantified using an external calibration curve constructed from linear 
regression of the resultant AUCs from serial dilution of known amounts of X. 
 
 
into the HPLC solvent composition at the anticipated flow rate to optimize source 
parameters such as ESI voltage as well as sheath and auxiliary gas pressures.
 After precursor mass optimization, a user-designated number of product 
(fragment, daughter) ions are detected after collision energy (CE) ramping in the 
collision cell.  The collision cell in a Thermo TSQ Ultra is filled with argon, which 
imparts fragmentation proportional to CE, unlike helium (typical collision gas in a 
linear ion trap), which has a finite CE fragmentation limit.  Product ions are 
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recorded hierarchically by their respective signal intensities.  Once the spectrum 
of product ions is determined by CE ramping, CE is optimized individually for a 
pre-determined number of MRM transitions (product ions).  These data are 
subsequently entered into the method for each analyte.  Method optimization is 
performed for all relevant analytes for a given experiment including an internal 
standard (IS).  For absolute quantitation, an IS must be present at equimolar 
concentration in each analytical sample.  Although specifics pertinent to each 
experiment will dictate the appropriate processing step for IS spike-in, it is 
suggested that it is introduced at the earliest step possible to ensure consistency 
among replicates. 
 After MRM transition optimization is complete for all analytes of interest as 
well as the IS, the HPLC-MRM instrument method can be established.  MRM 
exploits the benefits of a TSQ in the following manners for sensitive and specific 
analysis of the analytes of interest.  First, each analyte’s precursor ion is isolated 
as it passes through quadrupole 1 (Q1).  Next each precursor is fragmented 
individually in the collision cell (Q2).  Precursor-specific product ions (transitions) 
are then selected by Q3 (Fig. 5)—becoming the only ions allowed to reach the 
detector.  The output from the detector is in the form of a peak composed of 
transition signal intensities throughout the elution time of each analyte.  The AUC 
of the peak is relevant to the amount of analyte in each sample. 
 Another method parameter for increased sensitivity is the segment 
function.  Data point acquisition can be improved for analyte peaks that can be 
resolved chromatographically.  For example, if analyte A has a RT of 3.5 min, 
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analyte B has a RT of 5 min, and analyte C’s RT is 8 min; three distinct analytical 
segments can be designated where only the analyte expected to elute at each 
time point and the IS are scanned for (i.e. A: 0-4 min, B: 4-6 min, and C: 6-10 
min).  Segment analysis provides for more data points across a given peak for 
more accurate quantitation. 
Consolidated mass spectrometric method workflow 
 The approach of choice for nitroprotein identification and site quantitation 
is a consolidation of all of the aforementioned methods.  First a nitration site is 
identified from data-dependent HPLC-MS/MS analysis on an Orbitrap.  After 
informatics and manual spectral quality validations, it is preferred that the 
representative peptide prospect meet specific criteria prior to isotope-labeled 
synthesis of each permutation.  A MRM peptide prospect must be unique to the 
protein of interest and be detectable in both modified and unmodified 
permutations.  It should lack missed cleavages (unless it is consistently missed) 
and it should be free of variably modified residues (e.g. by oxidation) such as 
Cys, His, and Met. 
 AQUA (Thermo Scientific, USA) or similar high-quality, high-purity isotope-
labeled peptides are then synthesized, representing all permutations of the 
variably modified peptide as well as an IS.  The synthetic peptides are then 
analyzed by HPLC-MS/MS on the Orbitrap to validate RT and spectral 
characteristics.  Finally, MRM optimizations are performed by the previously 
described method on the TSQ for each AQUA peptide.  A calibration curve is 
generated for each target modification including the IS for normalization.    
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 Figure 6.  MS workflow for the identification and quantitation of PTN.  In this 
example, in vitro peroxynitrite reactions were performed on a protein standard (BSA) to 
develop and test the method.  Reacted protein was digested with trypsin and analyzed 
by HPLC-MS/MS in a LTQ Orbitrap XL.  A peptide prospect meeting the MRM 
development criteria was identified by both Scaffold PTM and manual analysis.  AQUA 
peptides were synthesized and MRM transition parameters were optimized.  The strong 
signal to noise ratio depicted by the peak shown at the quantitative processing step is 
typical for this type of experiment as the specificity of MRM allows detection only when 
CID of the precursor ion results in the designated product ions within a particular time-
frame.  Quantitation is made by averaging the areas under the curve (AUC) for all 
analytical replicates of each sample, normalized to the AUCs of the IS for each replicate. 
 
 
Absolute quantitative analysis can then be performed on in vitro treatments or 
biological samples. 
 The IS used for a calibration curve can either be diluted to a median 
concentration (e.g. 2.5 orders of magnitude above its LOD) for use as the solvent 
for serial dilution of the AQUA peptides, or it may be uniformly spiked-in to each 
sample prior to analysis.  The IS should be introduced into the biological samples 
by spike-in as early as possible, typically before the desalt step to ensure 
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consistency among sample recoveries.  Quantitation of each target analyte is 
performed by averaging the normalized AUCs for all analytical replicates and 
calculating the mass using the linear regression of the calibration standard.  
Figure 6 represents the entire combined workflow as it was performed using 
peroxynitrite-treated BSA standard in Chapter Two. 
Summary of approaches and project aims 
 The following chapters summarize the development, optimization, and 
application of novel proteomic and mass-spectrometric approaches for improved 
PTN characterization.  Chapter Two describes the development of the combined 
mass-spectrometric workflow described above as well its application to a PTN 
target identified form a peroxynitrite-treated protein standard.  Chapter Two also 
determines the nitration susceptibility of Tyr based exclusively on primary 
structure influence.  Chapter Three describes the application of global and 
targeted approaches for the identification of PTN originating from biological 
systems.  Finally, Chapter Four describes the development of an alternative 
mass-spectrometric approach to improve sensitivity for PTN identification using a 
novel stable isotope labeling technique with low mass fragment ion screening 
and relative quantitation.  The consolidation of these analytical methods are 
expected to improve the sensitivity and selectivity for PTN with the ultimate 
objective of providing tools that promote better characterization of PTN’s role in 
the onset and progression of human disease.  Improved PTN site prediction is 
also expected by taking primary structure as well as tertiary conformation into 
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consideration.  Identification of specific protein targets and sites is expected to 
benefit targeted therapeutics. 
References cited 
1. Pfeiffer S, Leopold E, Hemmens B, Schmidt K, Werner ER, Mayer B. 
Interference of carboxy-PTIO with nitric oxide- and peroxynitrite-mediated 
reactions. Free Radical Biology and Medicine. 1997;22(5):787-94. 
2. Pfeiffer S, Schmidt K, Mayer B. Dityrosine formation outcompetes tyrosine 
nitration at low steady-state concentrations of peroxynitrite. Journal of Biological 
Chemistry. 2000 March 3;275(9):6346-52. 
3. Abello N, Kerstjens HAM, Postma DS, Bischoff R. Protein tyrosine nitration: 
Selectivity, physicochemical and biological consequences, denitration, and 
proteomics methods for the identification of tyrosine-nitrated proteins. Journal of 
Proteome Research. 2009 07/06;8(7):3222-38. 
4. Ischiropoulos H. Biological tyrosine nitration: A pathophysiological function of 
nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998 
Aug;356(1):1-11. 
5. Neumann H, Hazen JL, Weinstein J, Mehl RA, Chin JW. Genetically encoding 
protein oxidative damage. J Am Chem Soc. 2008 03/01;130(12):4028-33. 
6. Pfeiffer S, Lass A, Schmidt K, Mayer B. Protein tyrosine nitration in cytokine-
activated murine macrophages. Journal of Biological Chemistry. 2001 September 
07;276(36):34051-8. 
7. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine 
nitration. Biochem Biophys Res Commun. 2003 JUN 6;305(3):776-83. 
8. Batthyany C, Souza JM, Duran R, Cassina A, Cervenansky C, Radi R. Time 
course and site(s) of cytochrome c tyrosine nitration by peroxynitrite. 
Biochemistry. 2005 06/01;44(22):8038-46. 
9. Aulak KS, Koeck T, Crabb JW, Stuehr DJ. Dynamics of protein nitration in 
cells and mitochondria. American Journal of Physiology - Heart and Circulatory 
Physiology. 2004 January 01;286(1):H30-8. 
10. Koeck T, Fu X, Hazen SL, Crabb JW, Stuehr DJ, Aulak KS. Rapid and 
selective oxygen-regulated protein tyrosine denitration and nitration in 
mitochondria. Journal of Biological Chemistry. 2004 June 25;279(26):27257-62. 
36 
 
11. Elfering SL, Haynes VL, Traaseth NJ, Ettl A, Giulivi C. Aspects, mechanism, 
and biological relevance of mitochondrial protein nitration sustained by 
mitochondrial nitric oxide synthase. American Journal of Physiology - Heart and 
Circulatory Physiology. 2004 January 01;286(1):H22-9. 
12. Abriata LA, Cassina A, Tórtora V, Marín M, Souza JM, Castro L, et al. 
Nitration of solvent-exposed tyrosine 74 on cytochrome c triggers heme iron-
methionine 80 bond disruption: Nuclear magnetic resonance and optical 
spectroscopy studies. Journal of Biological Chemistry. 2009 January 
02;284(1):17-26. 
13. Reynolds MR, Berry RW, Binder LI. Nitration in neurodegeneration:  
Deciphering the “Hows” “nYs”. Biochemistry (N Y ). 2007 06/01; 
2012/12;46(25):7325-36. 
14. Giasson BI, Duda JE, Murray IVJ, Chen Q, Souza JM, Hurtig HI, et al. 
Oxidative damage linked to neurodegeneration by selective α-synuclein nitration 
in synucleinopathy lesions. Science. 2000 November 3, 2000;290(5493):985-9. 
15. Herce-Pagliai C, Kotecha S, Shuker DEG. Analytical methods for 3-
nitrotyrosine as a marker of exposure to reactive nitrogen species: A review. 
Nitric Oxide. 1998 10;2(5):324-36. 
16. Gunaydin H, Houk KN. Mechanisms of peroxynitrite-mediated nitration of 
tyrosine. Chem Res Toxicol. 2009 05/18;22(5):894-8. 
17. Jiao K, Mandapati S, Skipper PL, Tannenbaum SR, Wishnok JS. Site-
selective nitration of tyrosine in human serum albumin by peroxynitrite. Anal 
Biochem. 2001 6/1;293(1):43-52. 
18. Kielbasa W, Fung H. Nitrite inhalation in rats elevates tissue NOSIII 
expression and alters tyrosine nitration and phosphorylation. Biochem Biophys 
Res Commun. 2000 Aug 28;275(2):335-42. 
19. Monteiro HP. Signal transduction by protein tyrosine nitration: Competition or 
cooperation with tyrosine phosphorylation-dependent signaling events? Free 
Radical Biology and Medicine. 2002 9/15;33(6):765-73. 
20. Luo C, Durgin BG, Watanabe N, Lam E. Defining the functional network of 
epigenetic regulators in arabidopsis thaliana. Mol Plant. 2009 /7/1;2(4):661-74. 
21. Kuo W, Kanadia RN, Shanbhag VP, Toro R. Denitration of peroxynitrite-
treated proteins by ‘protein nitratases’ from rat brain and heart. Molecular and 
Cellular Biochemistry. 1999;201(1):11-6. 
37 
 
22. Ferrer-Sueta G, Radi R. Chemical biology of peroxynitrite: Kinetics, diffusion, 
and radicals. ACS Chemical Biology. 2009 03/20;4(3):161-77. 
23. Muijsers RBR, Folkerts G, Henricks PAJ, Sadeghi-Hashjin G, Nijkamp FP. 
Peroxynitrite: A two-faced metabolite of nitric oxide. Life Sci. 1997 
4/18;60(21):1833-45. 
24. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent 
hydroxyl radical production by peroxynitrite: Implications for endothelial injury 
from nitric oxide and superoxide. Proceedings of the National Academy of 
Sciences. 1990 February 01;87(4):1620-4. 
25. Kirsch M, de Groot H. Formation of peroxynitrite from reaction of nitroxyl 
anion with molecular oxygen. J Biol Chem. 2002 April 19, 2002;277(16):13379-
88. 
26. Beckman JS, Ischiropoulos H, Zhu L, van der Woerd M, Smith C, Chen J, et 
al. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by 
peroxynitrite. Arch Biochem Biophys. 1992 11/1;298(2):438-45. 
27. Elfering SL, Haynes VL, Traaseth NJ, Ettl A, Giulivi C. Aspects, mechanism, 
and biological relevance of mitochondrial protein nitration sustained by 
mitochondrial nitric oxide synthase. American Journal of Physiology - Heart and 
Circulatory Physiology. 2004 January 01;286(1):H22-9. 
28. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad 
Sci U S A. 2004 Mar 23;101(12):4003-8. 
29. Duncan MW. A review of approaches to the analysis of 3-nitrotyrosine. Amino 
Acids. 2003 12/01;25(3):351-61. 
30. Riordan JF, Sokolovsky M, Vallee BL. Tetranitromethane. A reagent for the 
nitration of tyrosine and tyrosyl residues of Proteins1. J Am Chem Soc. 1966 
09/01; 2013/01;88(17):4104-5. 
31. Riordan JF, Sokolovsky M, Vallee BL. Environmentally sensitive tyrosyl 
residues. nitration with tetranitromethane*. Biochemistry (N Y ). 1967 01/01; 
2013/01;6(1):358-61. 
32. Sokolovsky M, Riordan JF, Vallee BL. Tetranitromethane. A reagent for the 
nitration of tyrosyl residues in proteins*. Biochemistry (N Y ). 1966 11/01; 
2013/01;5(11):3582-9. 
33. Sokolovsky M, Riordan JF. On the use of tetranitromethane as a nitration 
reagent for tyrosyl residues. FEBS Lett. 1970 /8/17/;9(4):239-41. 
38 
 
34. Cuatrecasas P, Fuchs S, Anfinsen CB. The tyrosyl residues at the active site 
of staphylococcal nuclease: Modifications by tetranitromethane. J Biol Chem. 
1968 September 25, 1968;243(18):4787-98. 
35. Lee SJ, Lee JR, Kim YH, Park YS, Park SI, Park HS, et al. Investigation of 
tyrosine nitration and nitrosylation of angiotensin II and bovine serum albumin 
with electrospray ionization mass spectrometry. Rapid Communications in Mass 
Spectrometry. 2007;21(17):2797-804. 
36. Goldstein S, Merenyi G. The chemistry of peroxynitrite: Implications for 
biological activity. Globins and Other Nitric Oxide-Reactive Proteins, Pt a. 
2008;436:49-61. 
37. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. 
Chem Res Toxicol. 1996 01/01;9(5):836-44. 
38. Salvemini D, Doyle TM, Cuzzocrea S. Superoxide, peroxynitrite and 
oxidative/nitrative stress in inflammation. Biochem Soc Trans. 2006;34:965-70. 
39. Giulivi C, Poderoso JJ, Boveris A. Production of nitric oxide by mitochondria. 
Journal of Biological Chemistry. 1998 May 01;273(18):11038-43. 
40. Xie Q, Nathan C. The high-output nitric oxide pathway: Role and regulation. J 
Leukoc Biol. 1994 11/01;56(5):576-82. 
41. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, 
and pharmacology. Pharmacological Reviews. 1991 June 01;43(2):109-42. 
42. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and 
disease. Physiological Reviews. January 2007 January 2007;87(1):315-424. 
43. Hill BG, Dranka BP, Bailey SM, Lancaster JR, Darley-Usmar VM. What part 
of NO don't you understand? some answers to the cardinal questions in nitric 
oxide biology. Journal of Biological Chemistry. 2010 June 25;285(26):19699-704. 
44. Beckman J, Koppenol W. Nitric oxide, superoxide, and peroxynitrite: The 
good, the bad, and the ugly. American Journal of Physiology-Cell Physiology. 
1996 NOV;271(5):C1424-37. 
45. Giulivi C. Functional implications of nitric oxide produced by mitochondria in 
mitochondrial metabolism. Biochem J. 1998 Jun 15, 1998;332(3):673-9. 
46. Sarkela TM, Berthiaume J, Elfering S, Gybina AA, Giulivi C. The modulation 
of oxygen radical production by nitric oxide in mitochondria. Journal of Biological 
Chemistry. 2001 March 09;276(10):6945-9. 
39 
 
47. Bartesaghi S, Ferrer-Sueta G, Peluffo G, Valez V, Zhang H, Kalyanaraman 
B, et al. Protein tyrosine nitration in hydrophilic and hydrophobic environments. 
Amino Acids. 2007 05/01;32(4):501-15. 
48. Schöneich C, Sharov VS. Mass spectrometry of protein modifications by 
reactive oxygen and nitrogen species. Free Radical Biology and Medicine. 2006 
11/15;41(10):1507-20. 
49. Ghesquière B, Colaert N, Helsens K, Dejager L, Vanhaute C, Verleysen K, et 
al. In vitro and in vivo protein-bound tyrosine nitration characterized by diagonal 
chromatography. Molecular & Cellular Proteomics. 2009 December 
01;8(12):2642-52. 
50. Guingab-Cagmat JD, Stevens SM, Ratliff MV, Zhang Z, Gold MS, Anagli J, et 
al. Identification of tyrosine nitration in UCH-L1 and GAPDH. Electrophoresis. 
2011;32(13):1692-705. 
51. Grisolia S, Timoneda J, Hernandezyago J, Soler J, Dearriaga M. Intracellular 
degradation of mitochondrial-enzymes. Acta Biol Med Ger. 1981;40(10-1):1407-
18. 
52. Talalay P. Chemoprotection against cancer by induction of phase 2 enzymes. 
Biofactors. 2000 10;12(1-4):5. 
53. Haynes V, Traaseth NJ, Elfering S, Fujisawa Y, Giulivi C. Nitration of specific 
tyrosines in FoF1 ATP synthase and activity loss in aging. American Journal of 
Physiology - Endocrinology And Metabolism. 2010 May 01;298(5):E978-87. 
54. Haynes V, Traaseth NJ, Elfering S, Fujisawa Y, Giulivi C. Nitration of specific 
tyrosines in FoF1 ATP synthase and activity loss in aging. American Journal of 
Physiology - Endocrinology And Metabolism. 2010 May 01;298(5):E978-87. 
55. Fujisawa Y, Kato K, Giulivi C. Nitration of tyrosine residues 368 and 345 in 
the beta-subunit elicits F0F1-ATPase activity loss. Biochem J. 2009 Oct 
15;423:219-31. 
56. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and 
peroxynitrite. Nature. 1993 08/12;364(6438):584-. 
57. Gold L. The role for transforming growth factor-beta (TGF-beta) in human 
cancer. Crit Rev Oncog. 1999;10(4):303-60. 
58. Spisni E, Bartolini G, Orlandi M, Belletti B, Santi S, Tomasi V. Prostacyclin 
(PGI2) synthase is a constitutively expressed enzyme in human endothelial cells. 
Exp Cell Res. 1995 /8;219(2):507-13. 
40 
 
59. Schmidt P, Youhnovski N, Daiber A, Balan A, Arsic M, Bachschmid M, et al. 
Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry 
as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem. 2003 
April 11, 2003;278(15):12813-9. 
60. Spisni E, Griffoni C, Santi S, Riccio M, Marulli R, Bartolini G, et al. 
Colocalization prostacyclin (PGI2) Synthase–Caveolin-1 in endothelial cells and 
new roles for PGI2 in angiogenesis. Exp Cell Res. 2001 5/15;266(1):31-43. 
61. Feng Y, Venema VJ, Venema RC, Tsai N, Caldwell RB. VEGF induces 
nuclear translocation of flk-1/KDR, endothelial nitric oxide synthase, and 
caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun. 1999 
/3/5/;256(1):192-7. 
62. Yeo W, Lee S, Lee J, Kim K. Nitrosative protein tyrosine modifications: 
Biochemistry and functional significance. BMB Reports. 2008;41(3):194-203. 
63. Zhang Q, Qian W, Knyushko TV, Clauss TRW, Purvine SO, Moore RJ, et al. 
A method for selective enrichment and analysis of nitrotyrosine-containing 
peptides in complex proteome samples. Journal of Proteome Research. 2007 
06/01;6(6):2257-68. 
64. Heijnen HFG, van Donselaar E, Slot JW, Fries DM, Blachard-Fillion B, 
Hodara R, et al. Subcellular localization of tyrosine-nitrated proteins is dictated by 
reactive oxygen species generating enzymes and by proximity to nitric oxide 
synthase. Free Radical Biology and Medicine. 2006 6/1;40(11):1903-13. 
65. Liu B, Tewari AK, Zhang L, Green-Church KB, Zweier JL, Chen Y, et al. 
Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: 
Mitochondria as the major target. Biochimica et Biophysica Acta (BBA) - Proteins 
& Proteomics. 2009 3;1794(3):476-85. 
66. Cassina P, Cassina A, Pehar M, Castellanos R, Gandelman M, de Leon A, et 
al. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor 
neuron degeneration: Prevention by mitochondrial-targeted antioxidants. J 
Neurosci. 2008 Apr 16;28(16):4115-22. 
67. Clementi C, Carloni P, Maritan A. Protein design is a key factor for subunit–
subunit association. Proceedings of the National Academy of Sciences. 1999 
August 17;96(17):9616-21. 
68. Souza JM, Daikhin E, Yudkoff M, Raman CS, Ischiropoulos H. Factors 
determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys. 
1999 11/15;371(2):169-78. 
41 
 
69. Seeley KW, Stevens Jr. SM. Investigation of local primary structure effects on 
peroxynitrite-mediated tyrosine nitration using targeted mass spectrometry. 
Journal of Proteomics. 2012 3/16;75(6):1691-700. 
70. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character 
of a protein. J Mol Biol. 1982 5/5;157(1):105-32. 
71. Elfering SL, Haynes VL, Traaseth NJ, Ettl A, Giulivi C. Aspects, mechanism, 
and biological relevance of mitochondrial protein nitration sustained by 
mitochondrial nitric oxide synthase. American Journal of Physiology - Heart and 
Circulatory Physiology. 2004 January 01;286(1):H22-9. 
72. Liu Z, Cao J, Ma Q, Gao X, Ren J. GPS-YNO2: Computational prediction of 
tyrosine nitration sites in proteins. Molecular bioSystems. 2011;7(4):1197-204. 
73. Pfeiffer S, Schmidt K, Mayer B. Tyrosine nitration is negligible at low 
peroxynitrite steady-state levels. Free Radical Biology and Medicine. 
1999;27(Supplement 1):S84-. 
74. Smallwood HS, Lourette NM, Boschek CB, Bigelow DJ, Smith RD, PaÅ¡a-
ToliÄ‡ L, et al. Identification of a denitrase activity against calmodulin in activated 
macrophages using high-field liquid chromatography-FTICR mass spectrometry. 
Biochemistry (NY). 2007 09/01; 2012/12;46(37):10498-505. 
75. Kamisaki Y, Wada K, Bian K, Balabanli B, Davis K, Martin E, et al. An activity 
in rat tissues that modifies nitrotyrosine-containing proteins. Proc Natl Acad Sci U 
S A. 1998 Sep 29;95(20):11584-9. 
76. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, et al. Direct 
analysis of protein complexes using mass spectrometry. Nat Biotech. 1999 
print;17(7):676-82. 
77. Washburn MP, Wolters D, Yates JR. Large-scale analysis of the yeast 
proteome by multidimensional protein identification technology. Nat Biotech. 
2001 print;19(3):242-7. 
78. Annesley TM. Ion suppression in mass spectrometry. Clin Chem. 2003 
Jul;49(7):1041-4. 
79. Taylor PJ. Matrix effects: The achilles heel of quantitative high-performance 
liquid chromatography electrospray tandem mass spectrometry. Clin Biochem. 
2005 4;38(4):328-34. 
80. Stevens SM, Prokai-Tatrai K, Prokai L. Factors that contribute to the 
misidentification of tyrosine nitration by shotgun proteomics. Molecular & Cellular 
Proteomics. December 2008 December 2008;7(12):2442-51. 
42 
 
81. Hong SJ, Gokulrangan G, Schöneich C. Proteomic analysis of age 
dependent nitration of rat cardiac proteins by solution isoelectric focusing 
coupled to nanoHPLC tandem mass spectrometry. Exp Gerontol. 2007 
7;42(7):639-51. 
82. Kanski J, Hong SJ, Schöneich C. Proteomic analysis of protein nitration in 
aging skeletal muscle and identification of nitrotyrosine-containing sequences in 
vivo by nanoelectrospray ionization tandem mass spectrometry. Journal of 
Biological Chemistry. 2005 June 24;280(25):24261-6. 
83. Prokai Tatrai K, Guo J, Prokai L. Selective chemoprecipitation and 
subsequent release of tagged species for the analysis of nitropeptides by liquid 
chromatography-tandem mass spectrometry. Molecular cellular proteomics. 
2011;10(8). 
84. Chen C, Chen J, Rawale S, Varadharaj S, Kaumaya PPT, Zweier JL, et al. 
Protein tyrosine nitration of the flavin subunit is associated with oxidative 
modification of mitochondrial complex II in the post-ischemic myocardium. 
Journal of Biological Chemistry. 2008 October 10;283(41):27991-8003. 
85. Petre BA, Ulrich M, Stumbaum M, Bernevic B, Moise A, Doring G, et al. 
When is mass spectrometry combined with affinity approaches essential? A case 
study of tyrosine nitration in proteins. J Am Soc Mass Spectrom. 2012 
Nov;23(11):1831-40. 
86. Guo J, Prokai-Tatrai K, Prokai L. Relative quantitation of protein nitration by 
liquid chromatography–mass spectrometry using isotope-coded dimethyl labeling 
and chemoprecipitation. Journal of Chromatography A. 2012 4/6;1232(0):266-75. 
87. Karger BL, Gant JR, Martkopf A, Weiner PH. Hydrophobic effects in 
reversed-phase liquid chromatography. Journal of Chromatography A. 1976 
11/17;128(1):65-78. 
88. Bogdanov B, Smith RD. Proteomics by FTICR mass spectrometry: Top down 
and bottom up. Mass Spectrom Rev. 2005 03/01;24(2):168-200. 
89. Kelleher NL, Lin HY, Valaskovic GA, Aaserud DJ, Fridriksson EK, McLafferty 
FW. Top down versus bottom up protein characterization by tandem high-
resolution mass spectrometry. J Am Chem Soc. 1999 02/01; 
2013/04;121(4):806-12. 
90. Stone KL, Elliott JI, Peterson G, McMurray W, Williams KR. 21] reversed-
phase high-performance liquid chromatography for fractionation of enzymatic 
digests and chemical cleavage products of proteins. In: James A. McCloskey, 
editor. Methods in Enzymology. Academic Press; 1990. p. 389-412. 
43 
 
91. Vailaya A, Horvath C. Retention in reversed-phase chromatography: Partition 
or adsorption? Journal of Chromatography A. 1998 12/31;829(1):1-27. 
92. Wilm M. Principles of electrospray ionization. Molecular & Cellular 
Proteomics. 2011 05/19. 
93. McLuckey SA, Stephenson JL. Ion/ion chemistry of high-mass multiply 
charged ions. Mass Spectrom Rev. 1998 01/01;17(6):369-407. 
94. Ogorzalek Loo RR, Udseth HR, Smith RD. A new approach for the study of 
gas-phase ion-ion reactions using electrospray ionization. J Am Soc Mass 
Spectrom. 1992 10;3(7):695-705. 
95. Taylor G. Disintegration of water drops in an electric field. Proceedings of the 
Royal Society of London Series A, Mathematical and Physical Sciences. 1964 
07/28;280(1382):383-97. 
96. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray 
ionization for mass spectrometry of large biomolecules. Science. 1989 
10/06;246(4926):64-71. 
97. Stafford Jr. GC, Kelley PE, Syka JEP, Reynolds WE, Todd JFJ. Recent 
improvements in and analytical applications of advanced ion trap technology. 
International Journal of Mass Spectrometry and Ion Processes. 1984 
/9/7/;60(1):85-98. 
98. Louris JN, Cooks RG, Syka JEP, Kelley PE, Stafford GC, Todd JFJ. 
Instrumentation, applications, and energy deposition in quadrupole ion-trap 
tandem mass spectrometry. Anal Chem. 1987 07/01; 2013/03;59(13):1677-85. 
99. Douglas DJ, Frank AJ, Mao D. Linear ion traps in mass spectrometry. Mass 
Spectrom Rev. 2005 Jan-Feb;24(1):1-29. 
100. March RE. Quadrupole ion trap mass spectrometry: A view at the turn of the 
century. International Journal of Mass Spectrometry; Volume 200: The state of 
the field as we move into a new millenium. 2000 12/25;200(1):285-312. 
101. Tabb DL, Smith LL, Breci LA, Wysocki VH, Lin D, Yates JR. Statistical 
characterization of ion trap tandem mass spectra from doubly charged tryptic 
peptides. Anal Chem. 2003 03/01; 2013/03;75(5):1155-63. 
102. Papayannopoulos IA. The interpretation of collision-induced dissociation 
tandem mass spectra of peptides. Mass Spectrom Rev. 1995 01/01;14(1):49-73. 
 
44 
 
103. Alexander AJ, Boyd RK. Experimental investigations of factors controlling 
the collision induced dissociation spectra of peptide ions in a tandem hybrid 
mass spectrometer. I. leucine enkephalin. International Journal of Mass 
Spectrometry and Ion Processes. 1989 /6/22/;90(3):211-40. 
104. de Hoffmann E, Stroob V. Mass spectrometry: Principles and applications. 
Third ed. Somerset, NJ: Wiley & Sons; 2007. 
105. Wu CC, MacCoss MJ. Shotgun proteomics: Tools for the analysis of 
complex biological systems. Curr Opin Mol Ther. 2002 Jun;4(3):242-50. 
106. Taylor JA, Johnson RS. Sequence database searches via de novo peptide 
sequencing by tandem mass spectrometry. Rapid Commun Mass Spectrom. 
1997 06/15;11(9):1067-75. 
107. Perkins DN, Pappin DJC, Creasy DM, Cottrell JS. Probability-based protein 
identification by searching sequence databases using mass spectrometry data. 
Electrophoresis. 1999 12/01;20(18):3551-67. 
108. Searle BC. Scaffold: A bioinformatic tool for validating MS/MS-based 
proteomic studies. Proteomics. 2010 03/01;10(6):1265-9. 
109. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model 
to estimate the accuracy of peptide identifications made by MS/MS and database 
search. Anal Chem. 2002 10/01;74(20):5383-92. 
110. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for 
identifying proteins by tandem mass spectrometry. Anal Chem. 2003 
09/01;75(17):4646-58. 
111. Beausoleil SA, Villen J, Gerber SA, Rush J, Gygi SP. A probability-based 
approach for high-throughput protein phosphorylation analysis and site 
localization. Nat Biotech. 2006 print;24(10):1285-92. 
112. Makarov A. Electrostatic axially harmonic orbital trapping: A high-
performance technique of mass analysis. Anal Chem. 2000 03/01; 
2013/02;72(6):1156-62. 
113. Fourier JBJ. Théorie analytique de la chaleur. Paris: Chez Firmin Didot, 
père et fils; 1822. 
  
45 
 
  
Chapter Two: Investigation of local primary structure effects on 
peroxynitrite-mediated tyrosine nitration using targeted mass spectrometry 
 
Introduction 
Overview 
 Endogenous nitration remains difficult to characterize with conventional 
biochemical strategies.  Immunochemical methods are limited to relative 
quantitation, are suspect in terms of antibody specificity, and are not informative 
in terms of protein identification or site localization.  HPLC and gas 
chromatography (GC)-MS approaches typically require chemical derivatization 
and enrichment prior to analysis (1-3), negatively affecting reproducibility due to 
multiple sample preparation steps.  Quantitation is also compromised due to 
incomplete reactions and chemical byproduct formation (1, 4).  Moreover, 
published works annotating putative nitration sites have often neglected to follow 
appropriate guidelines for mass spectrometric data reporting (5), diminishing 
confidence in site identifications and purported nitration susceptibility factors.  
This chapter describes an approach designed to increase PTN detection 
sensitivity and site-specific quantitation via a consolidated mass spectrometric 
workflow (Chapter One, Fig. 6).  The workflow combines high resolution MS 
screening with multiple reaction monitoring (MRM).  MRM analyses effectively 
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quantified PTN site-preference on a unique BSA peptide as well as nitration 
susceptibility influenced exclusively by local primary structure. 
Nitration site preference 
 HPLC-MS/MS analysis on an Orbitrap identified a unique nitropeptide 
(DAFLGSFLYEY(nitro)SR) resulting from peroxynitrite reactions with bovine serum 
albumin (BSA).  Preferential nitration to Tyr11 was evident—a phenomenon that 
merited further exploration considering the proximity of Tyr9.  MRM prospecting 
was performed by manual spectral and Scaffold PTM analyses to validate the 
site and site-preference probability (100% based on the Ascore algorithm). 
Secondary structure influence on nitration susceptibility 
 Since DAFLGSFLYEY(nitro)SR met our previously-described prototype 
peptide selection parameters, three synthetic stable isotope-labeled (AQUA, 
Thermo Scientific, USA) peptides (DAFLGSFLYEYSR[13C,15N], DAFLGSFLYEY[3-
nitro]SR[13C,15N], and DAFLGSFLY[3-nitro]EYSR[13C,15N]) were synthesized 
representing three of the possible four nitration-states (doubly-nitrated could not 
be synthesized).  Since retention times and spectral characteristics of 
DAFLGSFLYEYSR and DAFLGSFLYEY(nitro)SR were consistent with previous 
analyses, MRM transitions were optimized for all three permutations—allowing 
for quantitative analysis of variant nitration. 
 To test the influence of secondary structure on site preference, isotope 
label-free DAFLGSFLYEYSR (USF Department of Chemistry) was synthesized.  
MRM analysis of the products of ONOOˉ reaction with the synthetic peptide 
allowed for relative quantitation of nitration site preference due to MRM outputs 
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and chromatographic resolution of the two permutations (Chapter Two, Fig. 3A).  
The results of free nitro-DAFLGSFLYEYSR analysis indicated significant Tyr11 
site preference, albeit to a lesser degree than native state BSA.  In light of these 
results, we hypothesized that local primary structure influences selective nitration 
to specific Tyr residues in cases where more than one residue occupies a similar 
structural location and chemical environment. 
Primary structure influence on nitration susceptibility 
 A novel method devised in 2001 successfully eliminated secondary 
structure to ascertain peptide local primary structure influence on deamidation 
rates of glutaminyl and asparaginyl residues (6).  The approach incorporated 
synthesis of a complete library of the 800 possible adjacent residue combinations 
using the 20 ordinary amino acids with glycine termini, resulting in pentapeptides 
devoid of secondary conformation influence on deamidation (6). 
 The pentapeptides were analyzed via direct loop ESI injections into a 
Thermoquest (San Jose, CA, USA) LCQ ion-trap mass spectrometer.  
Enhanced-resolution (zoom) scans of the expected precursor masses were 
performed for eighteen injections of each sample (representing one time-point 
between 4 and 102 days).  The percentage of deamidated peptide was 
determined by comparison of the contribution of each isotopic peak as compared 
to the naturally-occurring isotope ratios (Note: deamidation results in a Δm of +1 
Da). 
 In this study, a modified method using a truncated pentapeptide library 
based on the adjacent residues to both tyrosines in DAFLGSFLYEYSR was used 
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to gain direct insight into local primary structure influence on Tyr nitration 
susceptibility.  This approach was expected to elucidate the chemical properties 
influencing peroxynitrite-mediated nitration site-specificity and yield powerful data 
to enhance site prediction algorithm accuracy. 
Results 
 The results for Chapter Two are contained in a previously published work 
(7) and can be found in Appendices A-D.  The article has been reproduced with 
express consent of the publisher (see Appendix E). 
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Chapter Three: Application of global-scale and targeted approaches for the 
identification of protein-tyrosine nitration in biological systems 
 
Introduction 
Overview 
 As discussed previously in Chapters One and Two, nitration occurs near 
O2•¯ generation centers such as the mitochondrial matrix (Fig. 7), peroxisomes of 
liver cells, and near sites of injury (1, 2).  Peroxynitrite’s reactivity is diffusion-
limited (3, 4) defined by its short half life of less than one second (5, 6).  Thus, 
the early focus of this study was PTN in liver mitochondria.  Another area of 
interest was the brain, where activation of the resident immune cells, microglia, 
contributes to oxidative/nitrative stress.  A hallmark of classical microglia 
activation is increased expression of iNOS—which, in conjunction with ROS 
produced in the oxidative burst, is thought to promote peroxynitrite generation 
and subsequent PTN.  Both of these systems served as biological models of 
nitrative stress allowing us to apply the workflow developed in Chapter Two. 
 To characterize a potential causative role for PTN in disease, baseline 
nitration must be determined under normal conditions.  Then, global changes to 
tyrosine nitration profiles can be assayed upon introduction of oxidative/nitrative 
stress triggers.  Nitration target protein identifications can elucidate the specific 
pathways affected by oxidative/nitrative stress-induced PTN.  Finally, to fully   
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Figure 7.  Tyrosine nitration in the mitochondrial matrix.  Energy metabolism 
normally results in some electron “leakage” from the electron transport chain.  
Partial reduction of oxygen can lead to O2•- formation.  Most superoxide is 
reduced to H2O2 by SOD and subsequently converted to water and molecular 
oxygen by catalase.  However, under oxidative stress conditions, iNOS 
upregulation results in increased NO, which reacts with O2•- to form the highly-
reactive ONOOˉ anion.  Peroxynitrite reacts with CO2 originating from the citric 
acid cycle to form nitrosoperoxycarbonate, which facilitates nitration by the 
radical pathway outlined in Figure 2. 
 
 
ascertain the functional consequences of PTN, specific nitration sites must be 
both identified and quantified from biological systems in normal conditions and 
while undergoing oxidative/nitrative stress.  Our approach was to 
comprehensively investigate PTN in liver mitochondria and activated microglia to 
elucidate the proteins and pathways involved in the onset and progression of 
oxidative/nitrative stress-induced disease states. 
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Protein-tyrosine nitration in the liver 
Ethanol-induced oxidative/nitrative stress 
 It is well-established that oxidative stress induced by chronic alcohol 
(ethanol) abuse is a major contributor to liver damage (7-16).  Both chronic and 
acute ethanol exposures increase reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) in hepatocytes (7, 8, 11, 12, 14).  Hepatotoxicity from 
oxygen and nitrogen radical formation can occur through either a direct pathway 
involving ethanol metabolism in the liver (12-15) or through an indirect pathway 
initiated by endotoxin-induced activation of Kupffer cells—the resident 
macrophages of the liver (8, 9, 16, 17). 
Direct route for ethanol-induced hepatotoxicity 
 Direct ethanol-induced hepatotoxicity may result from impaired 
mitochondrial function (8, 10, 12, 14) or over-production of acetaldehyde by 
either alcohol dehydrogenase or cytochrome P450 2E1 (CYP2E1) (8, 11, 13, 15).  
ROS and RNS generated from these pathways can induce the release of tumor 
necrosis factor alpha (TNF-α) (8, 14, 15) or cytochrome c (7, 14, 18, 19) resulting 
in hepatocyte injury or apoptosis (Fig 8). 
Indirect route for ethanol-induced hepatotoxicity 
 Indirect hepatotoxicity from ethanol exposure involves exorbitant release 
of the endotoxin, lipopolysaccharide (LPS), from resident gut flora (7-9, 14, 16). 
Ethanol increases the permeability of the gastrointestinal tract promoting direct 
passage of LPS produced by gram-negative bacteria to the liver (8, 9, 16).  
Kupffer cells residing in the liver are activated by LPS through CD14, a surface   
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 Figure 8.  Indirect ethanol-induced hepatotoxicity.  Ethanol perforates the GI 
tract resulting in LPS release into the blood stream and direct contact with the 
liver.  Kupffer cells activated by LPS interaction with CD14 produce NFκB, which 
induces TNF-α, iNOS, and superoxide production.  TNF-α and O2•ˉ are released 
in response to the presence of endotoxin resulting in hepatocyte injury.  Inducible 
NOS upregulation can promote ONOOˉ formation and additional injury through 
PTN. 
 
 
receptor that has toll-like receptor 4 (TLR-4) co-receptor activity (8, 9, 20).  
Kupffer activation results in inflammatory cytokine (e.g. TNF-α) and O2•ˉ release 
(7-9, 14), as well as NO via iNOS upregulation (8, 21).  These factors represent 
ideal conditions for ONOOˉ formation than can result in PTN—further contributing 
to tissue damage. 
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Protein-tyrosine nitration resulting from oxidative/nitrative stress 
 Although PTN is seen as a biological marker for ethanol-induced oxidative 
stress (8, 9, 17), a causative role in ethanol-induced hepatic injury has yet to be 
established.  We hypothesized that oxidative/nitrative stress induced by ethanol 
increases ONOOˉ levels and PTN in mitochondria, resulting in hepatotoxicity 
through either attenuated energy metabolism or diminished ROS scavenging by 
enzymes with antioxidant activity (e.g. superoxide dismutase II).  However, 
elucidation of changes to the mitochondrial nitroproteome under 
oxidative/nitrative stress would first necessitate establishment of a PTN baseline 
occurring under normal conditions.  Our approach was to develop an analytical 
workflow sensitive enough to detect and quantify nitration in liver mitochondria, 
with the long-term goal of PTN quantitation between liver mitochondria from 
either normal or ethanol-treated experimental groups.  Alcohol’s direct (8, 10, 12, 
14) or indirect (7-9, 14, 17) roles in hepatotoxicity have common elements with 
those involved in neurotoxicity, which are outlined in more detail in the following 
section. 
Protein-tyrosine nitration in the brain 
Overview 
 In the brain, oxidative stress from inflammatory triggers such as alcohol 
and LPS promotes iNOS expression (22).  Increased NO is generated 
concomitantly with increased ROS, including O2•−, resulting in ONOOˉ formation 
and cytotoxicity.  These properties may define the role of iNOS in host immunity 
(23), enabling its participation in anti-microbial and anti-tumor activities as part of 
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the macrophage oxidative burst.  However, as in Kupffer activity, they are also 
damaging to the host (23).  Although injury caused by acute stress is typically 
temporary, chronic insult by inflammatory triggers may result in protracted 
damage and complications.  Thus, characterization of the pathways affected by 
oxidative/nitrative stress-induced PTN is expected to provide insight into the 
long-term consequences of ethanol abuse such as neuroinflammation. 
 Since nitration is implicated in multiple neurological disease states (24-
26), our aim was to determine PTN’s role in oxidative/nitrative stress pathologies 
in the brain.  Specifically, the effects of LPS and ethanol-induced oxidative stress 
in neuron-like cells (B35 neuroblastoma; ATCC CRL2754) and highly 
aggressively proliferating immortal (HAPI) microglia (27), the resident 
macrophages in the brain and spinal cord (27-30) were investigated.  PTN 
resulting from oxidative/nitrative stress was assayed after both direct and indirect 
microglial activation (30).  Preliminary data from this study have established B35 
and HAPI cell lines as a relevant in vitro model system to study oxidative/nitrative 
stress-induced nitration in the brain (30). 
Microglia 
 Microglia are a special type of tissue-localized macrophage that comprise 
10% of cells in the central nervous system (28).  Microglial progenitor lineage is 
divergent from bone marrow-derived macrophages in that their development is 
independent of the transcription factor Myb (31).  The disparate developmental 
regulation between the two cell lines is thought to result in distinct populations of 
functionally variant immune cells (28, 32, 33). 
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Microglial activation (general) 
 Microglia are normally inhibited by neurons through contact-dependent 
receptor-ligand interactions as well as through neuronal secretions such as 
fractalkine (28, 34).  Likewise, attenuation of these signals can be activating (28).   
Neuronal activation of microglia can also occur through secretion of α-synuclein 
(35) and NFκB (36).  Classical activation can also be stimulated through direct 
interaction with exogenous molecules such as LPS (20).  Classical activation is 
characterized by the release of free radicals and inflammatory cytokines in 
response to the presence of exogenous triggers or neuronal injury (29, 37, 38). 
 We aimed to exploit these activation pathways to test our hypothesis that 
activated microglia exhibit increased PTN and that it plays a role in a previously-
described non-classical microglial activation phenotype induced by alcohol (39, 
40).  Our approach was to induce activation directly through exogenous 
microglial stimulation by LPS and indirectly through secretions from neurons 
exposed to ethanol.  The resulting microglial proteome and sub-proteome was 
analyzed by anti-3NT western blotting and mass spectrometric methods 
described in Chapters One and Two such as data-dependent and site-targeted 
HPLC-MS/MS, with the ultimate goal of quantifying site-specific nitration of 
neurotoxicologically-relevant targets. 
Direct microglial activation 
 LPS is a TLR4 ligand that has been shown to activate the microglia-
mediated inflammatory process (20, 28, 41).  LPS-induced microglial activation 
results in upregulation of iNOS, which is thought to have ROS scavenging activity 
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in oxidative stress conditions (42).  Inducible NOS expression occurs 
concomitantly with the pro-apoptotic release of caspase-3/7 (28, 41, 43) 
downstream of TLR4 as seen in a Parkinson’s disease model (28, 44) and has 
recently been implicated as a component of LPS-induced inflammatory response 
in microglia (30). 
 LPS activation also stimulates increased superoxide (O2•ˉ) production via 
nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase (45, 46), 
potentially exacerbating ONOOˉ formation.  Evidence supporting LPS-induced 
ONOOˉ increase has been previously demonstrated in rat neuron-glia cultures 
(47) and primary microglial cells harvested from Fisher 344 rat pup brains (41, 
45). 
Indirect microglial activation 
 As in the case of LPS-induced inflammatory response, free radical 
formation upon ethanol exposure has been linked to NADPH oxidase (17).  
Additionally, recent experiments have shown increased iNOS expression in 
microglia exposed to conditioned media from neuronal cells (B35) treated with 50 
mM ethanol for 24 hours (30).  Taken together, these results demonstrate 
indirect microglial activation in response to neuronal signaling under ethanol-
induced oxidative stress and the potential for ONOOˉ-mediated PTN. 
Rationale for PTN study in microglia 
 Since ROS combined with increased NO production constitute a 
microenvironment conducive to peroxynitrite formation, we hypothesized that 
microglia would exhibit a concomitant increase in PTN upon activation by 
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neuronal secreted factors induced by ethanol exposure.  Our aim was to confirm 
a global PTN increase in HAPI microglia exposed to B35-conditioned-media, 
unique nitroprotein target identification, and nitration site identification and 
quantitation to better characterize PTN’s role in microglia-mediated 
neurodegenerative pathologies. 
Materials and Methods 
All reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless 
otherwise specified. 
Rat liver mitochondria isolation 
 Rat liver mitochondria (RLM) were isolated using the following protocol 
from Abcam (formerly Mitosciences, Cambridge, MA, USA) unless otherwise 
specified.  Fresh or recently thawed rat liver stored in PBS was washed twice in 
mitochondrial isolation buffer, divided into ~ 0.5 g sections, and minced with a 
scalpel on a glass slide on ice.  Cell membranes were disrupted by 20-30 strokes 
with pestle A in a pre-chilled Dounce glass homogenizer, followed by 20-30 
strokes with pestle B.  Samples were centrifuged at 1,000 × g for 10 min at 4 °C 
to remove whole cells and nuclei.  The supernatant was collected into a clean 
tube and spun at 12,000 × g for 15 min at 4 °C to pelletize mitochondria.  The 
supernatant was aspirated and the pellet resuspended and washed twice by 
pipette in isolation buffer containing Halt Protease and Phosphatase Inhibitor 
Cocktail (PI; Thermo Scientific, USA) followed by centrifugation at 12,000 × g for 
15 min at 4 °C.  Washed pellets were resuspended in isolation buffer with PI in 
1.5 mL tubes, sonicated on ice at 20% AMPL for 18 s by six 3 s pulses with 
59 
 
intermittent 3 s pauses to disrupt membranes and mitochondrial deoxyribonucleic 
acid (mtDNA).  Lysates were centrifuged at 16,000 × g for 20 min at 4 °C to 
clarify and supernatants transferred to clean tubes.  Protein concentrations were 
assayed by the Pierce 660 nm 96-well plate method previously described.   
Rat mitochondria nitroprotein enrichments 
 Mitochondria from Sprague-Dawley (SD) rat liver (Harlan Laboratories, 
Indianapolis, IN, USA or Bioreclamation, LLC, Jericho, NY, USA) were obtained 
using a Mitosciences (Eugene, OR, USA) isolation kit for tissue.  Briefly, 
mitochondria were isolated from ~ 0.4 g of tissue by homogenization in a 2.0 mL 
Dounce glass homogenizer with pestles followed by differential centrifugation.  
The mitochondrial fractions were sonicated with 6 pulses for 3 seconds (s) with 3 
s pauses between at 20% amplitude (AMPL) to disrupt membranes and nucleic 
acids.  Lysates were clarified by centrifugation at 16,000 × g for 20 min, followed 
by transfer of supernatant to fresh microcentrifuge tubes. 
 Mitochondrial lysates were assayed for protein concentration with Pierce 
660 reagent (Thermo Scientific, USA) on a Powerwave XS2 microplate reader 
(Biotek Instruments, Inc., Bath, UK) followed by dilution to 1 mg × mL-1 in 1 mL 
aliquots.  Anti-NT immunoprecipitation (IP) was performed on the lysates by 
addition of 50 µg anti-nitrotyrosine immunosorbent agarose (Cayman Chemical, 
Ann Arbor, MI, USA) to each aliquot.  Immunoprecipitation was conducted on a 
rocking platform set to medium speed at 4 °C for 24 h.  Immunoprecipitates were 
then washed thrice in ice-cold PBS, with the final wash aspirated to leave a pellet 
of 3NT-containing proteins.  Proteins were eluted at 95 °C in 50 µL of 1 × 
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reducing Laemmli Buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 5% β-
mercaptoethanol, 2% SDS, 0.01% bromophenol blue) and loaded onto an SDS-
PAGE gel for protein separation.  After electrophoresis, the gel was stained with 
Coomassie brilliant blue to determine the relative molecular weights of 
precipitated proteins containing 3NT. 
 The IP-enriched 1D gel lane was divided into five equal fractions (Fig. 
11), digested with trypsin, and analyzed by HPLC-MS/MS with data-dependent 
acquisition on a hybrid linear quadrupole ion trap-Fourier transform (FT) orbital 
ion trap mass spectrometer (LTQ Orbitrap XL, Thermo Scientific, USA) equipped 
with XCalibur (version 2.0.7) data acquisition software to identify enriched 
proteins.  Raw data was searched against the UniProt rat database with the 
Mascot (version 2.2) search engine.  Scaffold (version 3.00.08, Proteome 
Software Inc., Portland, OR) was used to validate MS/MS based peptide and 
protein identifications. 
Peroxynitrite reactions with rat liver mitochondrial lysate 
 In vitro Tyr-nitration was performed on RLM lysate (3 mg) isolated from 
4.7 g of adolescent SD rat liver.  The lysate was buffer-exchanged into PBS, 
assayed for protein content, and aliquotted into five volumes at 1 mg × mL-1.  
Samples were reacted with 1 mM peroxynitrite for 1 h at room temperature and 
quenched by addition of formic acid to five percent.  IP was performed as 
described previously using 3NT affinity sorbent with overnight incubation at 4 °C.  
Nitrotyrosine-containing proteins bound to agarose beads were washed and 
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eluted in 1 × reducing Laemmli Buffer prior to loading on SDS-PAGE gel (Fig. 
13). 
 The gel was stained with Coomassie brilliant blue and band regions 
indicated by numbers 1-4 were excised and pooled in a single tube.  A standard 
in-gel trypsin digest was performed as described below, followed by peptide 
extraction and analysis by HPLC-MS/MS on a LTQ Orbitrap XL (Orbitrap) mass 
spectrometer.  The European Bioinformatics Institute’s (EBI) universal protein 
resource database (UniProt) rat database was searched with Mascot (version 
2.2), followed by peptide and protein validation using the Scaffold platform 
(version 3.00.08). 
In-solution trypsin digestion 
 In solution digests were performed by the following method on all samples 
unless otherwise indicated.  Proteins (various concentrations) were suspended in 
100 µL of 6 M urea (Acros Organics, NJ, USA) and 50 mM ammonium 
bicarbonate (ABC).  Disulfide bonds were reduced by addition of dithiothreitol 
(DTT) in 50 mM ABC to a final concentration of 10 mM and incubated for 1 h at 
room temperature (RT).  Sulfhydryl groups were blocked by alkylation reaction 
with iodoacetamide in 25 mM ABC at a final concentration of 40 mM at RT for 1 h 
in the dark.  The alkylation reaction was quenched via DTT addition to 40 mM.  A 
sufficient volume of 50 mM ABC to bring urea to less than 1 M was then added, 
followed by addition of L-1-tosylamido-2-phenylethyl chloromethyl ketone 
(TPCK)-treated trypsin (Applied Biosystems, Foster City, CA, USA) at a ratio of 
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1:50 trypsin: protein.  Digestion proceeded overnight (16 – 20 h) at 37 °C with 
addition to 2.5 % formic acid to inhibit trypsin. 
 Desalting of peptide solutions was performed on MacroSpin 300 Å C18 
solid-phase extraction (SPE) spin columns (The Nest Group, Inc., Southborough, 
MA, USA) followed by “speed-vac” centrifugal vacuum concentration at 50 °C 
(Labconco, Kansas City, MO, USA).  Lyophilized peptides were resuspended in 
0.1 % formic acid and sonicated for 10 min to ensure solubility prior to HPLC-
MS/MS analyses. 
In-gel trypsin digestion 
 In gel tryptic digests were performed as follows, unless otherwise noted.  
Coomassie-dyed SDS-PAGE gels were washed twice in deionized, 0.2 µM-
filtered (nanopure) water for a minimum of ten minutes.  Bands of interest were 
excised by razor blade with minimal unstained gel on their boundaries.  Excised 
bands were carefully minced to a size that would not be drawn into a 200 µL 
micropipette tip allowing increased solution access to protein.  SDS removal was 
performed by a minimum of three 10-minute cycles on a vortex in a 50:50 
acetonitrile (ACN): water solution, followed by dehydration in 100% ACN for 
approximately 5 min.  Gels were rehydrated in 100 mM ABC prior to washing in 
50:50 ACN: 50 mM ABC under agitation for 15 min.  After removal of wash 
buffer, gels were dried by speed-vac at 50 °C, then rehydrated in 45 mM DTT 
and incubated at 50- 55 °C for 30 min to reduce disulfide bonds.  DTT buffer was 
removed and replaced with 100 mM iodoacetamide and alkylated in the dark for 
30 min at RT.  After removal of iodoacetamide-containing buffer, gels were 
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washed thrice in 50:50 ACN: 50 mM ABC under agitation for 15 min—ensuring 
no bromophenol blue remained before continuing.  Gels were then completely 
lyophilized by speed-vac and chilled on ice before covering with the equivalent of 
two gel volumes with 10 ng × µL-1 trypsin and allowed to incubate on ice for 30-
45 min (until gel was completely rehydrated).  The samples were then incubated 
overnight (ON) at 37 °C, followed by removal of solution to a clean tube and two 
200 µL washes in 50:50 ACN: water in 0.1% formic acid with wash solution 
transferred to tube containing original supernatant.  Peptide-containing solutions 
were speed-vac lyophilized, then suspended in 0.1% formic acid.  Digests were 
placed in a water bath with ultrasonics for < 10 min, centrifuged at 15K × g (to 
pelletize any residual polyacrylamide) and transferred to autosampler vials in 
preparation for HPLC-MS/MS. 
Nuclear extractions from tissue culture 
 Nuclear extractions from tissue cultures were performed as follows, unless 
otherwise noted.  The Thermo Scientific NE-PER Nuclear and Cytoplasmic 
Extraction Reagents (part #78835) were used per the manufacturer’s protocol 
with experimental specifics as noted herein.  Tissue cultures were harvested at 
near confluence from 75 cm2 culture flasks with trypsin-EDTA (per ATCC 
recommendations for cell line).  After harvest, 10 mL DMEM was added, followed 
by centrifugation at 500 × g (4 °C).  DMEM was aspirated from the cell pellets, 
which were quickly resuspended in ice cold Dulbecco’s phosphate-buffered 
saline (DPBS).  Approximately 7 × 106 cells/flask were transferred to 1.5 mL 
microcentrifuge tubes and sedimented by centrifugation at 500 × g (4 °C) for 5 
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min.  On ice, DPBS was removed and cytoplasmic extraction was performed 
using the appropriate ratio of CER I: CER II: NER—following the sequence of 
vortex-mixing and reagent addition prescribed by the manufacturer.  The nuclear 
extraction was also performed per the manufacturer’s instructions, followed by a 
modified version of a previously described sulfuric acid histone extraction (48), 
protein assay, and SDS-PAGE analysis. 
Acid extraction of histones 
 The nuclear protein extract as described above was acid-extracted for 
histone isolation by a modified version of a previously published method (48).  
Sulfuric acid (H2SO4, 0.4N) was added slowly to a 5:1 H2SO4: nuclear protein 
suspension ratio on ice.  The suspension was pipette-mixed and incubated for 30 
min on ice with vigorous vortex-mixing every 10 min.  The mixture was 
centrifuged at 2000 × g for 5 min at 4 °C and the supernatant was removed to a 
fresh microcentrifuge tube.  The above was repeated once, adding the 
supernatant to that acquired previously.  The histone solution was then 
concentrated to ~ 50 µL by centrifuge under vacuum at 50 °C.  Protein 
concentrations were assayed by Pierce 660 nm on 96-well plate.  Twenty µg of 
each was loaded onto an 18% SDS-PAGE gel and run at 150 V for 45 min, 
followed by 120 V for 45 min.  Western transfer to a polyvinylidene fluoride 
(PVDF) membrane was performed at 40 V for 100 min at 4 °C.  The blot was 
stained for 3NT-containing proteins and developed as described below.  
Additionally, 10 µg of each histone extraction was loaded onto a second gel (4-
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20% gradient) for Coomassie detection and in-gel digestion for HPLC-MS/MS 
validation of histone enrichment (Fig. 26). 
Western detection of nitroproteins 
 Western transfers followed this general protocol with electrophoresis 
voltages and times based on resolution requirements for proteins of varying 
mass ranges.  SDS-PAGE gels were transferred in the BioRad (Hercules, CA) 
Mini Protean gel system by application of 40 V for 90 min (plus 10 min for each 
additional gel) with ice pack in buffer to keep it close to 4 °C for the entirety of the 
transfer.  The resulting blot was then rinsed in tris-buffered saline with 0.1% 
tween-20 (TBST) for five minutes on a rocking platform.  Blocking was performed 
by incubation of the blot for ≥ 30 min in 5% non-fat dry milk suspended in TBST 
(blotto) at either RT for 45 min or 4 °C for extended times.  The blot was rinsed 
briefly in TBST, followed by addition of anti-3NT mouse monoclonal IgG clone 
1A6 (EMD Millipore, Billerica, MA, USA) at a ratio of 1:1000 in blotto and 
incubated ON at 4 °C.  The blot was washed thrice for 10 min in TBST before 
incubation in goat anti-mouse IgG horseradish peroxidase (HRP)—conjugate 
(EMD Millipore, Billerica, MA, USA) for ≥ 1.5 h at RT.  The blot was then washed 
thrice for 10 min in TBST, followed by development with SuperSignal West Pico 
Chemiluminescent substrate (Thermo Scientific, USA) or equivalent for 1 min 
followed by x-ray film development. 
Western blot stripping and re-probing 
 The following protocol was followed for western stripping and re-probing 
experiments, unless otherwise specified.  Previously developed blots were 
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incubated in a sealed plastic container with 25 mL stripping buffer (2% SDS, 62.5 
mM Tris pH 6.8, 100 mM BME) at 50 °C in a water bath with manual agitation 
every 10 min.  After 30 min, the buffer was removed and the blot was rinsed 
three times for five minutes each in nanopure water.  The wash was then 
repeated with tris-buffered saline with TBST.  Blocking was performed by 
incubation on a rocking platform for ≥ 30 min in blotto.  Typically, primary 
antibody staining was then performed for glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) with a 1:3000 dilution of mouse monoclonal anti-
GAPDH clone 6C5 (EMD Millipore, Billerica, MA, USA) in blotto ON at 4 °C.  
Three 10 min washes in TBST were followed by secondary staining with goat 
anti-rabbit HRP conjugate for ≥ 1.5 hours.  Three additional 10 min washes were 
performed prior to chemiluminescent substrate addition and x-ray film 
development. 
Nitrotyrosine immunoprecipitation 
 The following protocol applies to 3NT IPs, unless otherwise specified.  
Tissue culture lysates were suspended in 1 mL PBS at a concentration of 1 mg × 
mL-1.  Fifty µL of 3NT affinity sorbent was added to each sample using a clipped 
20 - 200 µL pipette tip (to increase inside diameter).  Tubes were inverted several 
times and incubated on a rocking platform for 24 - 72 h at 4 °C.  IPs were 
centrifuged at 2,000 × g for 5 min at 4 °C and the supernatant was discarded and 
replaced with ice-cold PBS.  The agarose-bound protein mixture was mixed by 
pipette, and centrifuged at 2,000 × g for 5 min at 4 °C.  The previous step was 
repeated twice.  Finally, the supernatant was removed and replaced with 2× 
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reducing Laemmli Buffer and boiled at 100 °C for 5 minutes for immediate SDS-
PAGE analysis or stored at −80 °C.  For samples being prepared for direct 
trypsin digest via the filter-aided sample preparation (FASP) method (49), a 
modified 2× reducing Laemmli Buffer was prepared omitting glycerol and 
bromophenol blue. 
In vitro peroxynitrite reactions 
 Peroxynitrite reactions on protein preparations were performed as 
described herein with exceptions noted.  One milligram aliquots of RLM were 
buffer-exchanged to 100 µl PBS using Amicon Ultra 0.5 mL Ultracel 10K 
Membrane filters (EMD Millipore, Billerica, MA, USA) prior to ONOOˉ reaction.  
Peroxynitrite was quickly added at RT (in appropriate volumes for various final 
concentrations) to each sample and immediately mixed by rapid vortex.  After 
reaction, the pH was tested by litmus strip to ensure neutrality.  Samples above 
pH 7.4 were adjusted by slow addition of concentrated formic acid.  Reactions 
were then allowed to incubate at either RT or 37 °C for 1 h.  Reactions were 
quenched by addition of formic acid to 1-5% to achieve a pH of ~ 3.0. 
HAPI cell lipopolysaccharide treatment 
 Lipopolysaccharide treatments adhered to the following general protocol 
with modifications noted.  HAPI cultures were brought to ~ 80% confluence in 
Dulbecco’s Modified Eagle’s Medium (DMEM) with 5% fetal bovine serum (FBS) 
and PSG (10,000 units Penicillin g/mL, 10,000 microgram Streptomycin/mL, 200 
mM L-Glutamine) at 37 °C in 5% CO2.  Various amounts of LPS were pre-diluted 
in serum-free or 1% FBS-containing DMEM with PSG.  Treatments were 
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 Figure 9.  HAPI-LPS SILAC culture schema.  A) HAPI cultures were grown in 
either heavy or light SILAC media to a minimum of six doublings for ≥ 97% label 
incorporation.  B) Diagram of a theoretical doubly-charged isotope peak pair for a 
SILAC-labeled, Lys-terminated peptide with a 2:1 ratio of light to heavy—
indicating two-fold down-regulation of the protein in the treatment group.  Note: 
ion intensity for the majority of peak pairs is expected to be 1:1. 
 
 
performed by removing media, washing thrice with pre-warmed DPBS (37 °C), 
and applying fresh LPS-containing or LPS-free media for controls. 
HAPI cell stable isotope labeling 
 HAPI microglia were prepared for Stable Isotope Labeling in Cell Culture 
(SILAC) using a modified version of a previously-described method (29, 50).  
Briefly, cultures were grown to at least six doublings in dialysis-depleted medium 
supplemented with either “heavy” (13C6 and 15N4 Arg, 13C6 Lys) or “light” 
(unlabeled Arg and Lys) ensuring complete (≥ 97%) label incorporation following 
the scheme described in Figure 9A.  Label incorporation had previously been 
validated  for HAPI cell cultures (29). 
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 Figure 10.  SILAC workflow for HAPI-LPS 3NT IP.  Isotope-labeled and 
unlabeled cultures are harvested after 12 and 24 hours.  Cells are lysed in IP-
ready buffer with non-ionic detergent (nonidet 40 substitute), sonicated, and 
clarified by high-speed centrifugation.  Equal amounts of protein from control and 
treatment groups are pooled prior to anti-nitrotyrosine IP.  IPs are separated by 
SDS-PAGE and Coomassie dyed for strong nitroprotein band detection.  Bands 
are excised, trypsin digested and analyzed by HPLC-MS/MS on LTQ-Orbitrap.  
The large data set is then analyzed using MaxQuant for relative quant of PTN 
based on IP recovery. 
 
 
 SILAC labeling as described above imparts a change in mass (Δm) of +10 
Da on Arg-terminated peptides and +6 Da on Lys-terminated tryptic peptides—
resulting in peak pairs separated by 10.0, 5.00, and 3.33 Da for Arg and 6.00, 
3.00, and 2.00 Da for Lys, representing 1+, 2+, and 3+ ions, respectively.  The 
majority of peak pairs will be separated by a Δm equal to +3 and +5 (Fig. 9B), 
since most tryptic peptides will carry a 2+ charge at acidic pH from protonation of 
the amino terminus and the single basic residue at the carboxy terminus. 
 Quantitation of SILAC is determined by the MS peak intensities acquired 
from peptide pairs (50).  The peak intensity ratio is proportional to the relative 
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abundance of the representative protein from either the control or treatment 
groups (50).  Assuming equal protein is mixed prior to HPLC-MS/MS analysis, 
the expected ratio for the majority of peak pairs will be 1:1, with variances 
expected in a subproteomic population affected by treatment.  Peak pairs found 
to have significant intensity variation are indicative of divergent protein 
expression (50) or, in the case of PTN or other posttranslational modifications, 
variant modification.  Although these data can be analyzed manually, it would be 
a daunting task considering the myriad data acquired from any reasonably 
complex mixture.  Fortunately, SILAC data can be analyzed using the MaxQuant 
program (Max Planck Institute of Biochemistry, Martinsreid, Germany) available 
for free download from http://maxquant.org/downloads.htm. 
 Heavy-labeled Treatment mixtures (LPS—10 ng × mL-1) were prepared in 
the heavy media containing 1% serum immediately before applying to the 
designated culture flasks.  Control medium was prepared with the light amino 
acids in 1% FBS and was free of LPS.  All cells were harvested after either 12 or 
24 h, lysed in non-denaturing lysis buffer (20 mM Tris HCl pH 8, 137 mM NaCl, 
1% Nonidet P-40 (NP-40), 2 mM EDTA) in preparation for 3NT 
immunoprecipitation (IP) as described above.  Samples for SDS-PAGE analysis 
were denatured by addition of 6× LB and boiled for 3-4 minutes prior to gel 
loading. 
 Lysates were mixed at a 1:1 ratio based on protein content and loaded 
directly on 8 - 16% SDS-PAGE gels or were aliquotted in suspension to 1 mg × 
mL-1 prior to ON IP with 3NT affinity sorbent (Cayman).  In each case, duplicate 
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gels were electrophoresed simultaneously allowing for western analysis in 
parallel with gel excision for HPLC-MS/MS analysis.  The HAPI LPS treatment 
SILAC workflow is outlined in Figure 10. 
B35 cell ethanol exposure 
 A modified method (30) was performed for the culture and ethanol 
treatment of B35 neuroblastoma cells.  Briefly, B35 cells were grown to near 
confluence in DMEM supplemented with 10% FBS and 1% PSG at 37 °C with 
5% CO2.  Cultures were rinsed thrice by gentle addition of pre-warmed serum-
free DMEM followed by careful aspiration by vacuum-assisted Pasteur pipette.  
Ethanol-containing (50 mM) or ethanol-free 1% FBS or serum-free DMEM were 
added and cultures were incubated at 37 °C in 5% CO2 for 24 h. 
 At the end of the treatment interval, cultures were viewed using inverted 
light microscopy to ensure that no detachment had occurred before proceeding.  
The media was transferred to 15 or 50 mL conical tubes by serological pipette 
without disturbing the cell monolayer.  Aspirated media was centrifuged at 250 × 
g for 10 min at RT to pelletize any cells from suspension.  The media was 
immediately added to prepared HAPI cultures avoiding the pellet as described 
below. 
HAPI cell exposure to B35-conditioned media 
 To facilitate HAPI exposure to B35 media from ethanol treatments as 
described above, HAPI cultures were grown to ~ 80% confluence (as previously 
described) in synchronicity with the completion of the 24 h B35 ethanol 
treatments described above.  At that time, HAPI cultures were washed thrice in 
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pre-warmed DPBS, prior to immersion in the B35-conditioned media.  
Conditioned-media treated HAPI cultures were allowed to incubate for 24 h at 37 
°C and 5% CO2 prior to aspiration of media and harvesting as described 
previously. 
Liquid chromatographic-mass-spectrometric analyses 
Rat liver mitochondria and nitrotyrosine immunoprecipitation 
 Peptides from RLM extracts were suspended in 0.1% formic acid.  Five 
microliter injections were separated by reversed-phase HPLC on an Eksigent 
NanoLC 2D Ultra system (Dublin, CA, USA) or LC Packings Ultimate system 
(Thermo Fisher Scientific, USA) equipped with nano-flow outlet.  Peptides were 
loaded onto a New Objective (Woburn, MA, USA) capillary trap 100 μm i.d. × 2 
cm C18 column packed with 5 µm silica beads with 300 Å pore widths (ProteoPep 
II) for desalt prior to elution to a ProteoPep II 75 μm i.d. × 10 cm C18 analytical 
column.  Mobile phase A (0.1% formic acid in water) and mobile phase B (0.1% 
formic acid in acetonitrile) were delivered by linear gradient of 2% - 40% B over 
60 min at a flow rate of 250 or 300 nL × min-1, for Eksigent or LC Packings, 
respectively. 
 Eluates were delivered by electrospray ionization (ESI) at 2 - 2.5 kV and 
analyzed by MS/MS on a LTQ Orbitrap XL mass analyzer equipped with 
XCalibur (version 2.0.7) data acquisition software.  Full-scan mass resolving 
power was set to 60,000 (at m/z 400).  Data-dependent MS/MS scans were set 
to acquire the top five most intense ions in the LTQ linear ion trap with dynamic 
exclusion durations of 180 s after one repeat. 
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HAPI-lipopolysaccharide stable isotope labeling 
 Gel extracts were suspended in 0.1% formic acid and centrifuged for 10 
min at 10,000 × g to pelletize any insoluble carry-over (e.g. polyacrylamide).  
Samples were then carefully transferred to auto-sampler vials without disturbing 
the pellet.  Peptides were loaded onto trap and analytical columns as described 
previously using a Dionex Ultimate 3000 (Thermo Fisher Scientific, USA) and 
delivered to the MS over a linear gradient of 2% to 40% B at a flow-rate of 300 nL 
× min-1 for 90 min. 
Data-dependent MS/MS of ESI-delivered peptides was performed on an 
Orbitrap mass analyzer equipped with XCalibur (version 2.0.7) data acquisition 
software.  Full-scan mass resolving power at 400 m/z was set to 60,000.  Full MS 
was followed by data-dependent MS/MS of the top five most intense ions in the 
LTQ linear ion trap with dynamic exclusion set for one repeat and 180 s duration. 
HAPI nitrotyrosine and histone H4 immunoprecipitation 
 Peptides from HAPI microglia whole cell lysates, 3NT IPs, and histone H4 
IPs were analyzed by HPLC-MS/MS on a Finnigan LTQ (Thermo Scientific, USA) 
with delivery from a LC Packings Ultimate at 300 nL × min-1.  Samples were 
loaded onto a 150 μm i.d.×2.5 cm C18 capillary trap column with ProteoPep II 
packing material (New Objective, Woburn, MA, USA) for desalt, followed by 
linear gradient elution from the aforementioned 10 cm analytical column by 2% - 
40% B solvent over 90 minutes. 
 Full MS scans were performed at normal resolution with a target of 4 × 104 
ions with 2 microscans and a 50 ms maximum injection time.  Tandem MS scans 
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selected the top-ten most intense ions with a target of 5 × 103 and dynamic 
exclusion for 180 s with one repeat. 
Database searches and validation of peptide/protein identifications 
Rat liver mitochondria and nitrotyrosine immunoprecipitations 
 Raw MS/MS data were searched against the UniProt rat database (74140 
entries) using Mascot (version 2.2).  An additional subset search was performed 
using X! Tandem (version 2007.01.01.1).  Parent ion mass tolerance was set to 
5.0 ppm and fragment ion tolerance was set to 0.50 Da.  Carbamidomethylation 
of cysteine was specified as a fixed modification while oxidation of methionine, N-
terminal acetylation, and tyrosine nitration were all specified as variable 
modifications.  Trypsin was specified as the proteolytic enzyme.  Scaffold 
(version 3.4.9) was used to validate MS/MS-based peptide and protein 
identifications.  Peptides were accepted if the probability was > 95.0% as 
specified by the Peptide Prophet algorithm (51) and protein identifications were 
accepted at probabilities > 99.9% as specified by the Protein Prophet algorithm 
(52). 
HAPI-lipopolysaccharide stable isotope labeling 
 Tandem mass spectra were searched against the SwissProt database 
(selected for Rattus, 7750 entries) using both Mascot (version Mascot) and 
Sequest (Thermo Fisher Scientific, San Jose, CA, USA; version SRF v. 3).  
Trypsin was specified as the proteolytic enzyme.  Parent ion mass tolerances 
were 1.1 Da for Mascot and 1.2 Da for Sequest and product ion mass tolerances 
were 0.80 Da and 1.00 Da, respectively.  Additionally, SILAC labels for Lys (13C6) 
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and Arg (13C6 and 15N4), Met oxidation, nitro- oxidation of Tyr, and iodoacetamide 
derivative of cysteine were specified as variable modifications in both Mascot and 
Sequest.  
 Scaffold (version 3.4.9) was used to validate MS/MS-based peptide and 
protein identifications. Peptide identifications greater than 95.0% probability were 
accepted (51) and proteins that contained at least one identified peptide with 
probability greater than 99.0% were accepted (52).  Those proteins that could not 
be differentiated based on MS/MS analysis due to homologous peptides were 
parsimoniously-grouped. 
HAPI nitrotyrosine and histone H4 immunoprecipitations 
 Tandem mass spectra were analyzed using Mascot (version 2.2.06) and 
X! Tandem (version Cyclone-2010.12.01.1).  Mascot and X! Tandem searches 
were against the Rat UniProt database including reverse and random sequences 
(74140 entries) assuming trypsin as the digestion enzyme.  Mascot and X! 
Tandem were searched with parent ion mass tolerance of 2.5 Da and fragment 
ion mass tolerance of 0.80 Da.  Cys-alkylation (iodoacetamide derivatization) 
was specified as a fixed modification, and Met-oxidation and nitro- modification to 
Tyr were specified as variable modifications in both searches. 
 Scaffold validation parameters were set to greater than 95% probability for 
peptide identifications (51) and 99% probability for protein identifications (52) with 
a minimum of one identified peptide.  Undifferentiated proteins containing similar 
peptides were grouped for principle of parsimony.  
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Results and Discussion 
Nitroprotein identifications from rat liver mitochondria 
Nitroprotein immunoprecipitations 
 Since 3NT occurs at endogenous levels that currently fall below the LOD 
for mass spectrometry, enrichment is often necessary prior to HPLC-MS/MS 
analysis (1, 53-55).  This is especially true for nitroprotein target and site 
identifications, which cannot be ascertained by alternate methods such as 1D 
and 2D gel electrophoresis.  The approach taken in this study was to enrich 
nitroproteins in non-denaturing conditions by 3NT-specific immunoprecipitation 
(IP) prior to mass spectrometric analysis. 
 Initial experiments were conducted on mitochondrial lysates from frozen 
adolescent male SD rat livers fed with a normal diet.  Briefly, RLM were isolated 
by glass homogenization and sonicated to disrupt membranes and fragment 
nucleic acids before clarification by centrifuge at 16,000 × g.  Enrichment of 3NT-
containing mitochondrial proteins in preparation for electrophoretic separation 
was performed by overnight IP at 4 ºC using 3NT affinity sorbent agarose 
(Cayman).  Bound proteins were pelletized and washed thrice in ice-cold PBS 
prior to re-suspension in 1 × reducing Laemmli Buffer. 
 SDS-PAGE analysis of the 3NT enriched RLM fraction revealed 
numerous distinct bands that were expected to contain a majority of nitroproteins. 
Four regions containing either one or two bands in close proximity were selected 
for HPLC-MS/MS analysis (Fig. 11).  Coomassie-dyed bands showing a 
significant intensity increase as compared to their cognate control bands were of   
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 Figure 11.  IP of the rat liver mitochondrial nitroproteome.  Twenty µg of rat 
liver mitochondrial lysate (-NT enrich) and 3NT–containing (+NT enrich) 
immunoprecipitate (unknown quantity) were analyzed by SDS-PAGE to identify 
putative nitroprotein-containing bands. The enrichment lane was divided into four 
fractions that were excised and trypsin digested.  Peptides were extracted and 
analyzed by HPLC-MS/MS to determine putative nitration targets for possible 
protein-targeted enrichment and/or nitration site-specific targeted mass 
spectrometric method development. 
 
 
particular interest (i.e. bands 1 and 4, Fig. 11), since they were expected to 
contain nitroproteins. 
 Figure 11 shows putative endogenous PTN targets identified from specific 
gel regions.  The most abundant proteins identified included: carbamoyl 
phosphate synthetase-1 (CPS-1), catalase, pyruvate carboxylase, aldehyde 
dehydrogenase; ATP synthase (ATPase) α- and β- subunits, glutamate 
dehydrogenase, glutathione S-transferase (GST) isoforms, Cytochrome-c 
oxidase, and manganese superoxide dismutase (Mn-SOD). 
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 As expected, putative nitration targets found in mitochondria are key 
contributors to energy metabolism (56, 57), ethanol metabolism (58-60), ROS 
disposition (57, 61, 62), the urea cycle (63), gluconeogenesis (64), and 
lipogenesis (65).  Specific targets such as ATPase-β, CPS-1, and glutamate 
dehydrogenase exhibited increased degradation rates in previous studies (66, 
67) and nitration increase to myosin isoforms has been implicated to be a 
consequence of aging (68).  Moreover, PTN found in mitochondria under normal 
conditions supports the potential for a regulatory role in metabolism discussed in 
Chapter One.  Although the presence of PTN could not be confirmed through site 
identifications, the majority of proteins enriched by 3NT IP are presumed to 
contain nitrotyrosine.  Thus, the PTN targets identified by database searches can 
provide insight into the metabolic pathways affected by nitration.  Also, a targeted 
MS method can be employed to increase sensitivity for putative nitration sites on 
specific proteins as discussed later in this chapter. 
Parallel SDS-PAGE and Western analysis of nitroproteins  
 A second attempt at endogenous nitration site identification was made 
using fresh adult male SD rat liver mitochondria.  Mitochondrial isolation was 
followed by 3NT IP as described previously.  In this attempt, two gels were run in 
parallel, one for in-gel digestion for HPLC-MS/MS analysis and the second 
designated for western blotting (Fig. 12) to select gel bands for excision based on 
the presence of a 3NT signal.  Western blot detection correlated with the 
strongest Coomassie bands as indicated by the arrows shown in Figure 12A&B.  
MS analysis of digests from the eight bands indicated in Figure 12B resulted in  
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Figure 12.  Western and 1D gel for ID of nitroproteins from RLM.  A) Western 
blot of 3NT (nY) IPs from rat liver mitochondrial lysates.  B). A SDS-PAGE gel 
run in parallel with the western analysis was coomassie dyed for detection and 
excision of bands at molecular masses where nitration was evident (indicated by 
arrows).  Gels (8-16% polyacrylamide) were run at 120V for 45+ min (until dye 
front reached bottom of gel) to cover the entire mitochondrial proteome and 
maximize resolution. 
 
 
similar identifications to those found previously (Fig. 11); however, PTN site 
identification remained elusive. 
Nitropeptide target prospecting 
Rationale 
 The absence of an identified endogenous nitration site from RLM analyses 
supplied motivation for alternative approaches to 3NT site identification.  Since 
ONOOˉ is a physiologically-relevant nitrating agent, in vitro peroxynitrite 
reactions were performed to identify prospective nitration sites for targeted 
MS/MS instrument method establishment.  Authentic ONOOˉ was reacted with 
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rat liver mitochondrial lysates in PBS (pH 7.4) at RT, maintaining proteins in their 
native states for solvent-accessible Tyr residue targeting.  Our expectation was 
that selective nitration would occur at much higher frequency than in vivo—
augmenting detection of the most susceptible peroxynitrite-mediated nitration 
target sites. 
 This approach also had a provision for increased starting material to 
exceed LOD for mass-spectrometric analysis.  Multiple lanes on a gel can be 
pooled prior to HPLC-MS/MS analysis.  Upon identification of specific nitration 
sites, a more sensitive targeted MS/MS method can be implemented to improve 
sensitivity for those sites.  This is accomplished by selecting each nitropeptide 
precursor mass as a target for CID fragmentation during each round of MS/MS 
scans, a technique similar to that described in Chapter Two. 
Protein tyrosine nitration target and site analysis from peroxynitrite reactions 
 Immunoprecipitates of in vitro peroxynitrite reaction products from RLM 
lysates from were separated by SDS-PAGE and Coomassie-stained to determine 
bands of highest protein concentration.  Five bands from gel regions of equal 
mass labeled 1 – 4 (Fig. 13) were excised and pooled to increase analytical 
sample load.  Those bands were trypsin digested and analyzed by HPLC-MS/MS 
to identify putative PTN sites for targeted MS method development.  
 Database search of the gel region number three (Fig. 13) identified a 
nitration site at Tyr8 on the peptide AIAELGIYPAVDPLSTSR, a unique ATP 
synthase β-subunit (ATPase-β) peptide.  Manual evaluation of the nitration site 
was performed by evaluation of precursor mass accuracy (Δm −1.0 ppm) and   
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 Figure 13.  SDS-PAGE analysis of in vitro peroxynitrite reactions.  
Immunoprecipitates from RLM reacted with 1 mM peroxynitrite were run on an 8 
– 16% SDS-PAGE gel at 150 V for 49 min.  Bands at each of the four numbered 
rows were excised, pooled, trypsin digested, extracted and analyzed via HPLC-
MS/MS.  Upon database search and spectral validation, a nitration site on 
ATPase-β was identified from region #3 (~60 kDa).  A targeted mass 
spectrometric method was built based on this ID to increase sensitivity for the 
ATPase-β nitropeptide. 
 
 
comparison to the unmodified peptide spectrum for product ion intensities as 
seen in Figure 14A.  Sequence coverage for protein identification was 41% (Fig. 
14B) and AIAELGIYPAVDPLSTSR was identified in both unmodified (6 spectra) 
and nitro-modified (1 spectrum) permutations. 
Targeted tandem mass spectrometry for improved sensitivity 
 The ATPase-β nitration site identification from in vitro ONOOˉ reactions 
furnished us with a nitropeptide target for mass spectrometric method   
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Figure 14.  Nitration-susceptible site identification on ATPase-β.  A) Scaffold 
annotated MS/MS spectrum comparison between unmodified 
AIAELGIYPAVDPLSTSR (top) and 3NT-containing AIAELGIY(nitro)PAVDPLSTSR 
shows consistent fragment ion intensities for y and b series ions.  B) ATPase-β 
Protein sequence showing 41% coverage (yellow highlights) from tryptic digest 
with the nitropeptide circled in red.  All fixed and/or variably modified residues 
appear highlighted in green. 
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development to increase sensitivity for the site from a biological sample.  A 
targeted MS/MS method was built to scan for the precursor masses specific to 
both AIAELGIYPAVDPLSTSR (994.50) and AIAELGIY(nitro)PAVDPLSTSR 
(1017.0).  Targeted MS/MS increases sensitivity for a specific analyte by 
circumventing data-dependent MS/MS parameters.  This results in isolation of 
the targeted m/z during each scan cycle (every four seconds on average).  
Targeted methods such as this can result in sensitivity increases of greater than 
two orders of magnitude based on results from previous analyses using a similar 
method (data not shown). 
ATP Synthase β-subunit Tyr-345 nitration inhibits enzyme activity 
 The ATPase-β nitration site identified on Tyr345 had been previously 
reported to diminish ATP synthase activity as a result of in vitro TNM reaction 
(69).  The study induced Tyr345 nitration in recombinant rat ATP synthase (69), 
then assayed ATP synthase activity between reacted and unreacted protein.  
Site-directed mutation confirmed nitro-Tyr345 had the most significant impact on 
ATPase activity.  
 To validate the AIAELGY(nitro)PAVDPLDSISR spectrum (Fig. 15b), it was 
compared to the published spectrum resulting from TNM treatment (Fig. 15a) of 
validated recombinant ATPase-β (69).  Confidence in both nitro-site identifications 
was supported by the precursor ion mass accuracies as well as fragment ion 
peak and spectral intensity identities.  Moreover, demonstration of Tyr345 nitration 
susceptibility with peroxynitrite as the nitrating agent supports our hypothesis that 
it is a target of a physiologically-relevant nitrating agent.  
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 Figure 15.  Tandem mass spectrum of an ATPase-β nitropeptide.  a) MS/MS 
spectrum of the tryptic peptide AIAELGY(nitro)PAVDPLDSISR  from  TNM 
treatment at a molar ratio of 25 TNM to ATPase-β (69).  b) An unknown ATPase-
β concentration to in rat liver mitochondrial lysate was reacted with 200 µM 
ONOOˉ. 
 
 
Three-dimensional model of ATP synthase with nitro-Tyr345 mutation 
 ATPase-β Tyr345 is proximal to, but not directly, in the nucleotide binding 
pocket of the enzyme as seen in Figure 16.  Fujisawa, et al (2009) built a 
computational 3D model of ATPase F1 using the PyMOL Molecular Graphics 
System (Version 1.5.0.4 Schrödinger, LLC).  The model was constructed from 
bovine ATPase-β (PDB reference 1BMF) because it represented all three 
conformational states (tight, loose, and empty).  Mutation of Tyr345 to nitro-Tyr345 
simulated a hypothetical conformational change conferred by 3NT to the 
structure of the catalytic site of ATPase-β (69).  Although computational modeling   
y11+1 y12+1
y3b4 y4 b5
b6 b7
y7
b8
y8
b9y9b10
y10
b11
y11
b12
y12
y13
y14
b15 y15
b16
b17 b18
A I A E L G I Y+45 P A V D P L D S T S R
R S T S D L P D V A P Y+45 I G L E A I A
m/z
R
el
at
iv
e 
In
te
ns
ity
0%
50%
100%
0 500 1000 1500 2000
2,032.01 AMU, +2 H (Parent Error: -1.0 ppm)
a.
b.
85 
 
  
Figure 16.  Three-dimensional model of the ATP binding site on ATPase-β.  
A Cn3D (70) model of rat liver F1 region of ATPase was constructed from the 
protein data bank (PDB http://www.rcsb.org/pdb) code 1mab crystal structure.  
All residues displayed are from ATPase-β, including AIAELGIYPAVDPLSTSR.  
Tyr345 (side chain in gold circle) is localized near the ATP binding pocket residues 
(shown in red dashed circle).  Tyr345 nitration can result in a remote 
conformational change to the binding pocket--disrupting ATP binding (71). 
 
 
can be inaccurate in predicting 3D structure under physiological conditions, the 
model does provide a plausible explanation for the observed ATPase activity 
impairment conferred by Tyr345 nitration (69). 
Application of a targeted tandem mass spectrometric method 
 Because nitration site identification was absent from 3NT IP of 
mitochondrial fractions, in vitro ONOOˉ reactions were performed to identify 
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putative nitration sites that could be targeted during MS/MS acquisition.  After 
successfully identifying a nitration site on ATPase-β from those experiments, a 
AIAELGY(nitro)PAVDPLDSISR-specific targeted method was built.  The targeted 
scans were incorporated into a data-dependent method, reducing the ten data-
dependent scans to eight—preserving a functional scan time. 
 IP was performed in triplicate on 1 mg × mL-1 RLM aliquots—allowing for 
one analytical replicate for each SDS-PAGE gel excision.  Samples were 
analyzed by HPLC-MS/MS acquisition on an Orbitrap using the targeted method 
including the m/z of both the unmodified and nitropeptide identified from ATPase-
β (994.5 and 1017, respectively).  Upon database search, proteins correlating to 
those previously found (Fig. 11 & 12), including ATPase-β, were identified.  
Surprisingly, the analysis did not identify either of the ATPase-β target peptides. 
SDS-PAGE band pooling 
 Because the initial application of the targeted MS/MS method was 
unsuccessful in identifying the ATPase-β nitropeptide, two separate experiments 
designed to “bulk-up” material for increased MS sample load were performed.  In 
the first, six bands from a standard 4 – 20% mini-gel (Precise Tris-Glycine Gels, 
10 x 8cm, Thermo Scientific, USA) containing RLM 3NT-IP from 50 µl of affinity 
sorbent each were pooled post-digestion prior to MS/MS analysis (Fig. 17A). 
 The alternative method was designed to pool 3NT IP eluates prior to gel 
electrophoresis.  Immunoaffinity sorbent from five 1 mg × mL-1 IPs was combined 
and washed using positive pressure from a 12 mL Monoject Plastic Syringe with 
Luer tip (BD, Franklin Lakes, NJ, USA) through a Pierce fritted 0.8 mL centrifuge   
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 Figure 17.  Pooled 3NT IP gel digests.  To increase analytical sample load from 
3NT immunoprecipitates, A) mini-gels were loaded and analyzed with SDS-
PAGE in sextuplicate to allow for pooling of enrichment bands while B) slab-gel 
pooling was done at the IP step and loaded in a single lane.  Bands in the range 
of 56 kDa were extracted, trypsin-digested, and peptides were analyzed with a 
combination ATPase-β peptide targeted and data-dependent MS/MS method. 
 
 
column into 50 mL conical tubes.  Elution was performed by syringe flushing with 
250 µL of 1 × Laemmli Buffer.  A 1 mm, 10% polyacrylamide slab gel was poured 
and fitted with a comb for high-capacity well formation.  A single lane was loaded 
with the eluate described above, four lanes were loaded with control lysate 
(unreacted RLM) and an additional four lanes were loaded with the flow-through 
from anti-3NT IP.  Nitrotyrosine-IP, control lysate, and IP flow-through bands 
were excised at the approximate region containing 50-60 kDa proteins (Fig 17B).  
The control and flow-through bands were pooled as a single sample for analysis.  
Gel bands were trypsin digested and analyzed using the combined targeted/data-
dependent method described above. 
 MS analysis of both the minigel and slab gel excisions identified ATPase-β 
as the top hit.  One spectrum representing the targeted nitropeptide was   
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Figure 18.  ATPase-β nitropeptide identification minigel v. slab gel.  A) 
ATPase-β sequence coverage was 41% (yellow highlighting) from a mini gel 
containing pooled IP from ~ 0.5 mg rat liver mitochondrial lysate using 50 µL of 
3NT affinity sorbent (Cayman).  The analysis yielded identifications of five 
unmodified and one nitro- modified spectrum for AIAELGIYPAVDPLDSTSR 
using the MS/MS targeted method.  B) Sequence coverage was 45% for the slab 
gel containing 3NT IP from ~ 2.5 mg rat liver mitochondrial lysate using 300 µL of 
3NT affinity sorbent.  Analysis identified eleven unmodified and four nitro- 
modified AIAELGIYPAVDPLDSTSR spectra from targeted scans on an Orbitrap.  
Green highlighting indicates Met oxidation and Tyr oxidation to nitro-Tyr.  
 
 
identified from the pooled mini-gel digests and four spectra were identified from 
the pre-electrophoresis pooled single lane of the slab gel. 
 To summarize, the pre-pooling of IP yielded a 4-fold increase in 
nitropeptide AIAELGIY(nitro)PAVDPLDSTSR identification from 17 % less starting 
material and an equal amount of 3NT affinity immunosorbent.  Sequence 
coverage (Fig. 18) was also improved by 8.8 %, demonstrating the use of a slab 
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gel for increased sample loading in a single lane as a viable technique to 
incorporate into a method for enhanced PTN sensitivity. 
 It remains unclear whether or not the targeted MS/MS method influenced 
improved nitropeptide identification as an exclusively data-dependent analysis 
was not performed during this experiment.  Typically, acquisition using multiple 
methods yields complementary data, thus the combination of targeted and data-
dependent was the approach selected for this particular analysis.  Application of 
a combined targeted/data-dependent MS method increases sensitivity for 
specific targets, while providing for discovery of unknown low-level targets. 
Ethanol-induced nitration in human primary hepatocytes 
 Because PTN site investigation using mitochondria isolations was 
unsuccessful in identification of an endogenous site, assay of nitration in whole 
liver cell lysate was selected to improve site identification probability.  Our pilot 
experiment was performed using metabolism-qualified primary human 
hepatocytes (Life Technologies, Grand Island, NY, USA) to evaluate 3NT 
formation as a result of acute ethanol exposure. 
 A significant increase in PTN was apparent in human primary hepatocytes 
(Fig. 19A) after twenty-four hour exposure to 50 mM ethanol (blood alcohol level 
equivalent of 250 mg × dL-1).  The increased 3NT Western blot signal was 
detected at molecular weights below 26 kDa, which was thought to possibly 
indicate histone nitration.  The overall basicity of histones increase their 
likelihood to become PTN targets as demonstrated by the increased nitration 
seen in pentapeptides with high positive charge in Chapter Two.  
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Figure 19.  Ethanol-induced human hepatocyte nitration.  A) Anti-3NT 
Western blot showing increased nitration with a strong signal in the range below 
26 kDa.  B) Full mass spectrum of in-gel digestion of the < 26 kDa excised band 
(circled in A).  C) Accurate mass profile for the Tyr41-containing histone H3 
peptide. D) Reconstruction of a putative nitropeptide containing nitro-Tyr41. 
 
 
 The region below 26 kDa was excised, trypsin-digested, and analyzed 
via HPLC-MS/MS to identify protein contents and PTN sites.  A histone H3 
peptide, YRPGTVALR, was identified by Mascot search of the UniProt human 
database.  Using the accurate mass of the peptide, a profile was found at RT 
13.63 min with a peak area of 142 × 106 (Fig. 19C).  A putative nitropeptide 
chromatographic peak was reconstructed for Y(nitro)RPGTVALR using its accurate 
mass and one transition.  The peak appeared at RT 16.09 min with an area of 
170 × 103 (Fig. 19D).  Preliminary data from this experiment provided the 
foundation for the investigation of ethanol-induced PTN in microglia discussed in 
the following section.  
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Nitration induced by activated microglia 
Rationale 
 As mentioned earlier in this chapter, microglial activation can be induced 
directly through interaction with an exogenous CD-14 substrate (20) or indirectly 
through neuronal signaling (28).  Because NO and O2•ˉ overproduction are 
characteristic of microglial activation, we aimed to identify peroxynitrite-mediated 
nitration targets to characterize PTN resulting from microglial activation by both 
direct and indirect induction. 
Direct microglial activation induced by endotoxin 
 HAPI microglia exposure to 30 ng × mL-1 LPS for 12 h had previously 
been shown to significantly increase iNOS expression (30).  Considering iNOS is 
a high output NO generator (22) and microglia are macrophages capable of 
oxidative burst and chemokine production (29, 37), formation of the reactive 
nitrogen species (RNS), peroxynitrite is likely to occur upon activation.  Thus, 
HAPI culture was considered to represent a good model to evaluate nitrative 
stress in the brain. 
 To determine the global affect of endotoxin exposure on the 
nitroproteome, HAPI cultures were grown to 80% confluence and treated with 50 
ng × mL-1 LPS for 12 h.  Soluble protein fractions from cell lysates were prepared 
for Western analysis.  The resulting blot of whole-cell lysate (Fig. 20) was stained 
to compare untreated and LPS-induced global nitration profiles.  Although the 
overall pattern of nitroproteins detected did not show apparent variation, a 
general trend of increased nitration appeared in the treatment group (Fig. 20).  
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Figure 20.  LPS-treated HAPI lysate anti-3NT Western blot.  Lysates from 
HAPI cultures treated with 50 ng × mL-1 LPS for 12 h were run on a 4 - 20% 
SDS-PAGE, transferred to a PVDF membrane and stained with mouse 
monoclonal 1A6 anti-3NT (Millipore).  Rabbit anti-mouse HRP conjugate 
(Millipore) was used to detect bands containing nitroproteins.  Overall nitration 
patterns appear similar; however, a global increase in nitration was clearly 
evident after LPS-induced activation.  GAPDH loading-control western was 
performed after stripping and re-probing the blot shown. 
 
 
These data were convincing in support of our hypothesis that increased nitration 
occurs concomitantly with iNOS upregulation upon direct stimulus for microglial 
activation.  
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SILAC analysis of HAPI cell direct activation 
 Since a distinct nitration increase was observed in the LPS treatment 
group of an abundant nitroproteome seen in Figure 20, a SILAC experiment was 
performed as described in methods in this chapter to identify PTN targets and 
quantify variant nitration between normal and LPS activation nitroproteomes.  
LPS treatments (10 ng × mL-1) were performed in triplicate for 12 or 24 hours.  
The 12 hour exposure was intended to replicate the conditions described for 
Figure 20 (with the exception of a lower dose of LPS); while the 24 hour 
exposure was intended to elucidate the nitration profile resulting from protracted 
exposure to inflammatory stimulus. 
 Cells were immunoprecipitated in 3NT affinity sorbent prior to anti-3NT 
western blotting (Fig. 21).  Excised bands containing immunoprecipitates from 
equal light and heavy protein starting content were in-gel trypsin digested using 
the protocol described in methods, followed by high-resolution HPLC-MS/MS 
analysis on a LTQ-Orbitrap at the H. Lee Moffitt Cancer Center & Research 
Institute Proteomics Core Facility. 
 Data from Orbitrap analysis was submitted to the MaxQuant program to 
identify PTN targets and quantify over- and under-represented protein groups.  A 
Mascot search with Scaffold validation was also conducted to confirm protein 
identifications.  Scaffold label-free spectrum counting could not be used for PTN 
quantitation since equal amounts of protein were combined prior to 3NT IP. 
 MaxQuant analysis was inconclusive due to low spectral data yields from 
the in-gel digests.  However, Scaffold analysis of the gel band labeled “F”   
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Figure 21.  Parallel SDS-PAGE/ Coomassie and Western development of 12 
and 24 h HAPI LPS SILAC treatments.  A) Band regions A – F were identified 
by western detection to contain 3NT.  B) Cognate bands A – F were excised from 
SDS-PAGE for in-gel digest followed by high-resolution HPLC-MS/MS on a LTQ-
Orbitrap at the Moffitt Cancer Center Proteomics Core Facility. 
 
 
resulted in identification of histone isoforms (Fig. 21B).  The band labeled “F” 
originated from the MW region below 26 kDa and had been selected based on 
western detection of 3NT (Fig. 21A).  Coomassie detection also showed 
significant protein content in the mass range below 26 kDa, which is indicative of 
abundant PTN considering the low MW of proteins migrating to that region. 
 Previous Western analysis of LPS treated HAPI total lysate had also 
detected PTN in the region below 26 kDa, with a clear nitration increase seen in 
the treatment group (Fig. 20)—indicating histones may not only be potential 
nitration targets, but also targets of increased nitration upon microglial activation.  
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Figure 22.  Scaffold histone IDs from 3NT IP of HAPI LPS SILAC gel digests.  
A) Spectral counts for histone peptides from 3NT-IP enrichment are shown 
circled in blue.  Identifications were filtered using 95% peptide confidence and 
99% protein confidences (51, 52).  B) Sequence coverage for histone H4 
highlighting isotope-labeled Arg and Lys (green).  Since no filter was applied, 
data shown is all-inclusive for heavy and light-labeled peptides. 
 
 
 Scaffold analysis of gel region F identified peptides representing histones 
H2A and H4 (Fig. 22B).  This is interesting considering histone H2A is ~15 kDa 
and histone H4 is ~11 kDa and gel region F was excised in the range of 26 kDa.  
Also, histone H4 was detected at the highest abundance with thirteen unique 
peptides.  Five unique histone H2A peptides were identified.  Histone H4 
sequence coverage was 34% using the stringent Scaffold criteria described in 
methods (Fig. 22B). 
 Confidence in histone H4 identification was supported by spectral 
probabilities above 95% using the Peptide Prophet algorithm (51), and 99% 
protein probability from Protein Prophet (52) validation.  Considering the limited 
number of protein identifications from the gel extraction (162 total IDs with keratin 
isoforms comprising 10%), histone H4 was considered a strong potential PTN   
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Figure 23.  Shotgun analysis of LPS treated HAPI microglia 3NT IP.  Histone 
peptides identified with probabilities ≥ 80% from HAPI cultures treated with 30 ng 
× mL-1 LPS for 24 h were 9:3 in favor of the treatment samples (T1-T3, blue box).  
These data combined with similar enrichment for histones H2A and H4 from 
SILAC analysis of HAPI treated with 10 ng × mL-1 LPS provided the rationale for 
histone-focused experiments to evaluate global and site-specific nitration to 
histone proteins as a potential modulator of gene expression under 
oxidative/nitrative stress conditions. 
 
 
target warranting further investigation.  Additionally, histone modifications can 
result in aberrant transcription through altered chromatin remodeling.  An 
example of this was found in a study of murine Mutatect (ATCC CRL-2800) 
tumors where two nitration sites on histone H4 (Tyr72 and Tyr95) were identified 
(72). 
 Histones in general represent strong PTN candidates based on the 
electrostatic influence on nitration susceptibility described in Chapter Two.  The 
abundance of basic residues on histones (see Table 3) can create a 
predominantly positively-charged microenvironment that possibly attracts ONOOˉ 
and/or stabilizes a peroxynitrite-mediated nitration reaction intermediate.  
Experimental focus on histone nitration is discussed later in this chapter and 
Chapter Five based on these results. 
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HAPI lipopolysaccharide whole cell lysate immunoprecipitates 
 Since gel digests are limited by the amount of protein loaded per well as 
well as incomplete digestion and extraction, digests of 3NT IP eluates from whole 
cell lysates were selected for analysis by HPLC-MS/MS.  This approach was 
expected to increase analytical sample load and provide at least complementary 
data to those acquired during the SILAC experiment.  A potential pitfall to this 
one-dimensional “shotgun” (73-75) approach is the possibility of ion 
suppression—a phenomenon that occurs in complex mixtures where co-eluting 
analytes and contaminants can result in poor ion transmission from the source to 
the vacuum interface of a mass spectrometer (76).  The omission of 
electrophoretic separation also negates the ability to support identifications 
based on known relative molecular masses of the fractions being analyzed. 
 HAPI microglia were grown to 80% confluence and treated with 30 ng × 
mL-1 LPS for 24 h.  IP was performed on the lysate from triplicate controls and 
treatments in 3NT affinity sorbent and eluted in a modified Laemmli Buffer (sans 
glycerol and bromophenol blue).  The eluates were trypsin digested using the 
filter aided sample preparation (FASP) method (49), a recent advance in size-
exclusion based buffer exchange that is detergent compatible and facilitates 
proteolytic digestion in a single apparatus.  FASP significantly improves peptide 
recovery compared to solid phase detergent removal systems.  Desalted 
samples were analyzed in the Finnigan LTQ (Thermo Scientific, USA) for relative 
quantitation using the spectral counting method (75). 
  
98 
 
 Figure 24.  Anti-3NT Western of histone H4 IP from LPS-treated HAPI 
lysates.  Apparent nitrotyrosine was detected in the histone H4 IP lanes (C1-3, 
T1-3).  HPLC-MS/MS analyses of bands near 55 kDa and 20 kDa excised from a 
SDS-PAGE gel run in parallel did not identify histone H4.  HeLa lysate (lane 1) 
was included as a positive control for histone H4 and negative control for 3NT.  
HeLa lysate was also negative for histone H4 detection after stripping and re-
probing the blot with anti-histone H4.  Nitrotyrosine-containing BSA (nBSA) was 
used as the positive control for 3NT. 
 
 
 Although spectral counts were below thresholds for significance, histone 
spectral counts indicated 3NT enrichment similar to that of the SILAC experiment 
(Fig. 22a).  Additionally, histone identifications originated predominantly from the 
LPS treatment group—indicative of endotoxin-induced upregulation of iNOS 
linked to concomitant increase in Tyr nitration. 
 Two unique peptides representing histone H4 showed > 95% spectrum 
identification probability as well as 99% protein group confidence.  Histone 
identifications from this experiment, those from SILAC analysis of LPS-treated 
HAPI, and a previously reported histone H4 nitration site-identification (72) 
kDa
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provided the foundation for histone-focused experiments.  Our aim was to 
evaluate global and site-specific histone nitration considering PTN to be a 
potential modulator of gene expression under oxidative/nitrative stress 
conditions. 
Histone H4 targeted enrichment  
 To validate the SILAC gel extract and direct eluate data from 3NT IP 
analyses, which indicated increased histone nitration upon LPS-induced 
inflammatory stimulus, anti-histone H4 antibody was used for protein-specific IP 
to enhance recovery of a putative PTN target.  However, results from several 
attempts at histone H4 enrichment with subsequent anti-3NT Western analyses 
were inconclusive.  Nitrotyrosine Western detections were dubious as clear 
protein bands could not be resolved and thus were not quantifiable.  Also, the 
3NT-containing bands that were detected appeared closer to 20 kDa and 50 kDa 
as seen in Figure 24—too high to be histone H4. 
 Moreover, histone H4 was not identified from HPLC-MS/MS analyses of 
tryptic gel digests of cognate bands excised from Coomassie-stained gels run in 
parallel with the 3NT westerns (data not shown).  After stripping, histone H4 re-
probing of the blots resulted in almost identical results to 3NT staining as seen in 
Figure 24, further confounding analyses. 
Indirect microglial activation by ethanol-induced neuronal signaling 
 As mentioned in the introduction to this chapter, factors secreted by 
neurons inhibit microglia under normal conditions (28, 34).  To determine the 
effect of alcohol on neuronal regulation of microglial activation, HAPI cultures   
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Figure 25.  Ethanol-induced neuronal secretions increase nitration in 
microglia.  A) Anti-iNOS Western analysis of HAPI microglia lysates treated with 
B35 neuron-conditioned media from 24 h exposure to four ethanol 
concentrations.  B) Anti-3NT western blot of the ~ 60 kDa band from HAPI lysate 
treated with B35-conditioned media from 24 h exposure to 50 mM ethanol.  
*Normalized intensity is the mean of two experimental results; **Normalized 
intensity is the mean of triplicate results (p < 0.025, paired t-test). 
 
 
were exposed to media conditioned by B35 neurons treated with 10, 50, and 200 
mM ethanol for 24 h (30).  Anti-iNOS western blot analysis of the HAPI lysates 
detected a single band located close to the expected iNOS migration (~ 131 
kDa).  Densitometry analysis (ImageJ) calculated the greatest iNOS expression 
increase to be 80% (Fig. 25A) in the 50 mM treatment group (30).  These data 
supported our hypothesis that ethanol exposure alters neuronal secretions, 
resulting in classical activation of microglia (39, 40). 
C-1 C-2 C-3 T-1 T-2 T-3
GAPDH
A. 
B. 
iNOS
β-actin
60 kDa
Intensity*
Intensity** 1.0 1.7
1.0 1.81.2 1.6
Ethanol (mM) 0 5010 200
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 Thus, a concomitant nitration increase in microglia activated by ethanol-
induced neuronal secretion was expected to be seen.  To test this, the above 
experiment using 50 mM ethanol exposure was repeated and analyzed the 
resulting lysates by 3NT western blot (Fig. 25B).  Interestingly, a single band 
near ~ 60 kDa was detected—a clear departure from the LPS- induced nitration 
profile seen in Figure 20.  ImageJ densitometry analysis revealed a 70% 
increase in nitration on the 60 kDa band (Fig 25b) correlating to the 80% iNOS 
increase found previously (30) and supporting our assertion that ethanol-induced 
neuronal secretion induces nitration increase in indirectly-activated microglia. 
HAPI cell indirect activation 
 LPS-induced microglial activation resulted in increased nitration to core 
histones, specifically histone H4.  To increase sensitivity for histone nitration 
detection after indirect activation, the histone fraction from HAPI culture exposed 
to conditioned media from ethanol-treated B35 cells were enriched.  Additionally, 
a histone nitropeptide-targeted method was developed to increase mass 
spectrometric sensitivity. 
 Tryptic peptides containing Tyr from the four core histones were 
ascertained by manual sequence analysis.  Arg, Lys and Pro residues were 
highlighted to indicate potential cleavage sites.  Plus two-charged nitropeptide 
ion precursor masses were determined by adding 45 Da for nitro- addition and 1 
Da for H+ to their calculated molecular masses from the Expasy pI/Mw computer 
(77, 78), then dividing by two.  Precursors with m/z between 300 and 1800 were 
included in the targeted method.  Since eleven targets were required for this   
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Table 3.  Rat histone sequences for nitropeptide targeted method 
development. 
 
Rat Histone sequences for nitropeptide targeted method development  
>gi|66730355|Ref|NP_001019453.1| histone H2a [Rattus norvegicus] 
MSGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLYKGNYSERVGASAPVY
LAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGRVTIAQGG
VLPNIQAVLLPKKTESHHKSKGK 
Theoretical pI/Mw: 10.74 / 14188.51  
>gi|204603|gb|AAA74755.1| histone H2B [Rattus norvegicus] 
MPEVSAKGTTISKKGFKKAVTKTQKKEGRKRKRCREESYSIYIYKVLKQVHPD
TGISSKAMSIMNSFVTDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELA
KHAVSEGTKAVTKYTSSK 
Theoretical pI/Mw: 10.19 / 14225.51  
>gi|313319|emb|CAA52035.1| histone H3 [Rattus norvegicus] 
MARTKQTARKSTGGKAPRKQLATKAARKSAPSTGGVKKPHRYRPGTVALREI
RRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSAAIGALQEASEAYLVGLFED
TNLCAIHAKRVTIMPKDIQLARRIRGERA 
Theoretical pI/Mw: 11.27 / 15327.91  
>gi|204601|gb|AAA60735.1| histone H4 [Rattus norvegicus] 
MSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYE
ETRGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG 
Theoretical pI/Mw: 11.36 / 11367.34  
 
Manual analysis of trypsin cleavages among the core histone sequences was 
performed to determine nitropeptide precursor masses for targeted method 
development.  Tyr-containing tryptic peptides representing possible nitropeptide 
MS/MS targets are highlighted in green (or blue to distinguish adjacent peptides).  
Basic residues are shown in bold for each of the four core histones.  Below each 
sequence are the theoretical isoelectric points and molecular weights for each—
calculated using the Expasy pI/MW computer (77, 78). 
 
 
analysis, data-dependent scans were limited to the top-3 most intense ions to 
preserve a functional scan interval. 
 Because nitroprotein targets were determined manually, it was possible 
that the analytical ions would differ (e.g. missed cleavage).  Thus, a second 
analysis of each isolate using top-ten data-dependent acquisition was performed 
for complementarity.  The four core histone amino acid sequences are shown in 
Table 3 with basic residues shown in bold.  
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Figure 26. Histone extract analysis using SDS-PAGE & targeted HPLC-
MS/MS.  A 4-20% gradient SDS-PAGE gel was run for 50 min at 120V to resolve 
the four histone isoforms.  Five bands each were excised from control and 
treatment lanes at locations near our target MWs (H3-15 kDa, H2B-14 kDa, H2A-
14 kDa, and H4- 11 kDa as well as possible core histone complexes-34 kDa).  
Gel bands were trypsin digested and analyzed by data-dependent MS/MS to 
include all possible modification states and targeted MS/MS for 3NT-containing 
peptides.  Doubly-charged nitropeptide precursor masses were calculated 
manually using the pI/MW calculator at http://web.expasy.org/compute_pi/ with 
addition of +45 Da for nitro- addition and +1 Da for protonation.  HPLC-MS/MS 
analyses were used to identify band contents and determine variable 
modification between control and ethanol-treated B35 media-condition HAPI after 
24 h exposure.  The band seen near 26 kDa, expected to contain the linker 
histone, H1, was not analyzed. 
 
 
 Since a modified method for histone extraction based on Siuti and 
Kelleher (48) had been previously performed successfully in our laboratory using 
AML12 (ATCC CRL-2254) lysates (mouse hepatocytes expressing human TGF-
α), it was applied to histone extractions from HAPI microglia.  The method 
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exploits the chemistry of histones, which are readily precipitated from nuclear 
fractions due to their inherent basicity (see Table 3). 
 Nuclear isolates were acquired by centrifugation in isolation buffer 
followed by acid extraction of histones on ice.  Because acid extraction requires 
addition of sulfuric acid to five times the nuclear suspension volume, our 
expectation was that the histone concentrations would be too low for analysis.  
To correct this, the extracts (900 µL) were speed-vac concentrated to ~ 50 µL.  
The resulting protein concentrations of the histone concentrates were ~ 0.7 mg × 
mL-1, sufficient for SDS-PAGE and Western analysis. 
 Histone extracts were analyzed by SDS-PAGE on a 4-20% gradient gel.  
To verify histone enrichment, the gel was Coomassie stained.  Three distinct 
bands were detected in the MW region below 20 kDa, likely representing histone 
isoforms.  Five bands circled in Figure 26, including histone isoforms and 
possibly the core complex were excised and in-gel digested. 
 The gel digests were analyzed by both a histone nitropeptide-targeted/ 
top-3 and a top-10 data-dependent HPLC-MS/MS acquisition on a LTQ.  Mascot 
search of the UniProt mouse database with Scaffold validation confirmed 
successful histone enrichment (Fig. 27) and a possible nitration site on a histone 
H3 peptide (KPHRY(nitro)RPGTVALR) was identified (Fig 28) in both the control 
and treatment (one spectrum for each).  Although the nitropeptide identified had 
one missed cleavage at the Arg adjacent to the nitration site, comparison of the 
nitropeptide and unmodified spectra where the sequences were identical showed 
identity for product ion masses and peak intensities.  Histone H3 Tyr41 had also   
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 Figure 27.  Histone enrichment validation.  Scaffold analysis results validated 
histone enrichment from HAPI microglia incubated for 24 h in B35 neuron-
conditioned media from 50 mM ethanol exposure for 24 h.  Nuclear proteins were 
isolated using the NE-PER Nuclear and Cytoplasmic Extraction Reagents 
(Thermo Scientific, USA).  Histones were acid extracted using a modified version 
of the method described by Siuti and Kelleher (2010).  Histone proteins 
represented 12% of protein IDs with a 1.3 % peptide false discovery rate (FDR) 
and a 1.5 % protein FDR.  Targeted analysis increased total spectral count for 
Histone H4 by > 10-fold due to an unmodified peptide that is isobaric with one of 
the nitropeptide targets. 
 
 
been identified in a preliminary experiment using human primary hepatocytes 
(Fig. 19) and is a known phosphorylation site involved in chromatin remodeling 
(79).  Synthetic KPHRY(nitro)RPGTVALR can be synthesized and analyzed to 
validate the identification as described in Chapter Two. 
Nitrotyrosine localizes to the nucleus 
 To validate our hypothesis that histones are subject to PTN in the nucleus 
the HAPI LPS treatments were repeated, since LPS induces a stronger nitrative 
stress response as demonstrated by Figure 20.  The cells were grown to ~ 70% 
confluence and fixed with 4% paraformaldehyde.  DNA was stained with 4',6-
diamidino-2-phenylindole (DAPI), followed by immunostaining with anti- 3NT   
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 Figure 28.  Histone H3 nitration site identification.  A putative nitration site on 
histone H3 Tyr41 was identified by targeted MS as seen highlighted in (A).  Total 
sequence coverage for histone H3 improved from 26% for non-targeted 
treatment to 37% for the targeted method.  The nitropeptide spectra (B & D) 
originated from a triply-charged precursor with one missed cleavage.  The 
Scaffold peptide probability was 65% with a Mascot score of 30.4.  The 
unmodified spectrum (C) originated from a doubly-charged precursor with no 
missed cleavages.  The Scaffold peptide probability was 95% and the Mascot 
score was 36.2.   
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Figure 29.  3NT localization in HAPI nuclei.  HAPI cells were immunostained 
for 3NT (green) and histone H3 (red) in either untreated (A) or treated with 50 ng 
× mL-1 LPS (B) for 12 h.  DAPI (blue) was used to stain for DNA.  Nitrotyrosine 
immunoreactivity was detected throughout the cytoplasm and appears to be 
within the nucleus.  Histone H3 was also detected within the nucleus; however, 
confocal microscopy will be necessary to validate the co-localization of histone 
H3 and 3NT. 
 
 
and histone H3 fluorescent antibody conjugates.  Nitrotyrosine was expected to 
be present throughout the cell and histone H3 and 3NT were expected to 
colocalize with DNA inside the nucleus. 
 In the fluorescence microscope images seen in Figure 29, 
immunoreactivity from both nitrotyrosine and histone H3 was observed in the 
nucleus.  This result remains inconclusive as to colocalization with histones, 
which will require high-resolution confocal microscopy.  Also, future experiments 
should include staining for iNOS with the expectation that it will also localize to 
the nucleus, supporting the assertion that ONOOˉ can be generated within the 
compartment. 
  
A. B.
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Chapter 4:  Novel mass spectrometric methods for PTN site detection and 
quantification 
 
Introduction 
Protein-tyrosine nitration site identification 
 A major obstacle to mass spectrometric PTN identification is the sensitivity 
required to identify specific nitration sites from a proteome-wide analysis, 
considering detection of a single representative unmodified peptide is often 
sufficient to establish reliable protein identification.  Since 3NT occurs at 
abundances ~ five orders of magnitude lower than L-Tyr, integration of one of the 
enrichment techniques described in Chapter Three is justifiable.  Nevertheless, if 
sensitivity can be enhanced sufficiently to overcome current MS detection limits, 
nitration site identification from complex biological samples may become 
possible, averting the pitfalls associated with chemical modification and 
immunological enrichment. 
 PTN site identification can facilitate more informed interpretations of the 
modification’s contributions to the functional losses it is most often associated 
with.  In Chapters Two and Three, the increased sensitivity potential of targeted 
MS/MS was demonstrated.  This chapter describes the continuing process to 
further improve mass spectrometric methods for PTN investigation by exploiting 
physicochemical properties specific to protein-bound 3NT. 
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The nitrotyrosine immonium ion as a diagnostic marker 
 Nitrotyrosine’s unique spectrophotometric and chromatographic properties 
can be advantageous when nitration is abundant (e.g. UV detection in-line with 
MS) or when the analyte of interest is known (e.g. targeted MS method).  On the 
other hand, when PTN targets are not known or are at low levels, another 
characteristic of protein-bound 3NT can be exploited—its unique CID-derived 
immonium fragment ion. 
 Immonium ions are diagnostic fragments specific to each of the twenty 
common amino acid residues (Table 4) that can be produced by conventional 
CID, pulsed-Q collision-induced dissociation (PQD), higher energy collision 
induced dissociation (HCD), and source fragmentation.  They are internal 
fragment ions formed by a double backbone cleavage characteristic of both y- 
and a-type ions resulting in the general structure [H2N=CH-R]+ (1, 2).  However, 
most immonium ions appear with low frequency and those that do appear with 
stronger signal may not be consistently present (1).  Since the immonium ion 
intensity for Tyr is listed among those considered strong (see Table 4) and 3NT 
is expected to produce immonium ions of similar intensity, the 3NT immonium ion 
was evaluated as a diagnostic tool for PTN identification and quantitation. 
 The 3NT immonium ion had previously been established as a diagnostic 
marker for nitroprotein identification from ONOOˉ reactions with purified protein 
(3).  In this study, the presence of a 3NT immonium ion peak upon peptide 
fragmentation was used exclusively as confirmation for nitropeptide 
identifications (3).  However, spectral quality for confirmations was less than 
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ideal, including low signal-to-noise ratios (S/N) and lacking annotations for 
multitudinous prominent peaks.  Considering the analytes originated from in vitro 
reactions with purified protein, this study’s results emphasize the challenging 
nature of PTN site identification. 
 Another experimental method exploited 3NT immonium ion detection as a 
trigger for precursor ion scanning on a triple-quadrupole time of flight (QTOF) 
mass spectrometer (4).  The method acquired sequence information from 
precursor ions that produced 3NT immonium ions upon fragmentation (4).  
Angiotensin II and BSA standards were reacted with TNM to produce 
nitropeptides for 3NT immonium ion-based MS method development (4).  Again, 
the resultant nitropeptide spectra generated by a 50-fold molar excess of TNM 
had low S/N and included many unidentified peaks.  These results further 
demonstrate the difficulty of nitro-site identification from complex mixtures.  
Nevertheless, the results of these early investigations reinforce the potential 
applicability of the 3NT-specific immonium ion for PTN study. 
Mass spectrometric method development for immonium ion analysis 
 A limitation to immonium ion detection in linear ion traps is the one-third 
rule governing MS/MS product ions (5, 6).  The one-third rule refers to a low 
mass cut-off inherent to CID in a linear ion trap where product ion masses below 
28% of the isolated precursor mass lose stability.  The one-third rule narrows 
detection of the 3NT immonium ions using conventional CID to precursors below 
approximately m/z 650. 
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 A potential solution to the one-third cut-off is the use of PQD activation.  
PQD induces fragmentation on a precursor at an elevated Q-value (high RF 
amplitude) by a short high resonance excitation pulse with a delay at high 
amplitude to allow for kinetic fragmentation (7).  Then the RF amplitude is rapidly 
pulsed-down to lower Q, retaining the low mass fragment ions in the trap before 
scanning them to the detector (7).  PQD, however, can require exhaustive 
collision energy (CE) optimizations before delivering quality spectra (7), and the 
unconventional resultant spectra can confound conventional search algorithms. 
 To overcome the deficiencies characteristic of CID and PQD, analysis 
using both activation types can furnish complementary data (e.g. sequence 
information from CID and immonium ion peaks from PQD of the same precursor).  
Mascot database searching can be useful for protein and nitration site 
identification from the large data sets acquired by these analyses.  However, 
manual reconstruction of XICs containing 3NT immonium ions will likely be 
necessary to identify sequences from PQD-derived spectra and low-abundance 
targets co-eluting with peptides of isobaric mass.  Fortunately, the modest 
number of nitropeptides expected within a given proteome supports the 
practicability of manual data mining for nitration sites. 
Quantitative mass spectrometric methods using stable isotope coding 
 Many current quantitative proteomic methods use either metabolic (8) or 
chemical (9, 10) stable isotope label incorporation to code differential protein 
sets.  These approaches facilitate quantitation either through comparison of 
relative MS intensities of peptide ion pairs (8) or through discrete low mass “tags” 
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resulting from CID of peptides containing isobaric labels (9, 10).  High-resolution, 
accurate-mass (HR/AM) analyzers are generally considered essential for these 
applications; however, encouraging results produced by the application of novel 
strategies using linear ion trap (7, 11) and triple-quadrupole (3) mass analyzers 
warrant further consideration for comparably-equipped laboratories. 
Stable isotope labeling by metabolic incorporation 
 Approaches using metabolic incorporation of stable isotopes such as 
SILAC (8) are valuable for eliminating downstream sampling errors by combining 
protein sets immediately following cell lysis (8, 11).  Protein ratios are determined 
by MS signal intensities of differentially-labeled peptide peaks, and MS/MS 
spectra are employed for protein identifications (11).  However, quantitation using 
MS peaks is complicated by varying levels of background noise and susceptibility 
to background signals is amplified for low-abundance or modified peptides such 
as nitropeptides (11).  Linear quadrupole ion trap analysis can also amplify the 
background effects due to lower precursor mass accuracy.  However, ion trap 
sensitivity can be enhanced by increasing the target ion number for CID or PQD 
activation. 
 Recently, a novel SILAC adaptation specific to the immonium ions of Leu, 
Ile, and Val generated by CID was successfully evaluated on an ion trap mass 
analyzer.  Labeling was performed using media depleted for Leu, Ile, and Val and 
replacing the amino acids with one of two heavy isotope labeled sets.  One set of 
amino acids contained a single 13C label on each residue, while the alternate set 
contained a single 15N label. 
120 
 
 MS analysis yielded isobaric peptide precursor ions; however, CID spectra 
produced immonium ions pairs separated by 1 Da.  The differential masses of 
immonium ion pairs were the result of the double-backbone cleavage specific to 
immonium ion production.  The 15N-containing peptides retained the +1 Da labels, 
while the 13C labels were lost during CID (12).  Additionally, sequence and 
quantitative data were both acquired using MS/MS spectra from a single 
analytical run.  Since quantitation was based on MS/MS spectra, the magnitude 
of background noise was reduced as compared to MS precursor peak 
quantitation (12).  Although this technique can be useful for relative quantitation 
of protein expression from Leu, Ile and/or Val containing peptides, it can be 
problematic as tryptic peptides can contain various combinations of coded 
residues.  Moreover, quantitation can be complicated by the fact that Leu and Ile 
produce a strong immonium ion signal, while Val does not (1, 2). 
Stable isotope labeling by chemical incorporation 
 Post-digestion chemical labeling methods (9, 10) can be both convenient 
and relatively inexpensive for bottom-up protein and posttranslational 
modification quantification.  In these schemes, isobaric tags are applied to free 
amino termini on Lys residues, resulting in isobaric precursor ions that fragment 
to differentiated reporter ions (9, 10).  Quantitation is based on ratios of reporter 
tag MS/MS signal intensities and has been demonstrated in multiplicities up to 8-
plex.  The major limitation to these approaches is variability among multiplex   
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Table 4. Immonium ion masses.   
 
 
Diagnostic immonium ions produced from internal fragmentation of each amino 
acid residue are listed.  Immonium ion masses shown in bold indicate production 
of a strong signal (1, 2).  Nitrotyrosine (in italics) was added since it is not one of 
the 20 naturally occurring amino acids.  It is expected to produce an immonium 
ion signal commensurate to that of Tyr. 
 
 
samples resulting in inaccurate quantitation and/or irreproducibility.  The 
inconsistency typically results from excessive sample processing prior to the 
post-digestion labeling and combining of samples.  Additionally, the mass range 
limitations for CID in an ion trap negate its utility for proteome-wide analysis 
using the low-mass reporter tags. 
  
Residue 3-Letter Code 1-Letter Code Immonium ion
Alanine Ala A 44
Arginine Arg R 129
Asparagine Asn N 87
Aspartic Acid Asp D 88
Cysteine Cys C 76
Glutamic Acid Glu E 102
Glutamine Gln Q 101
Glycine Gly G 30
Histidine His H 110
Isoleucine Ile I 86
Leucine Leu L 86
Lysine Lys K 101
Methionine Met M 104
Phenylalanine Phe F 120
Proline Pro P 70
Serine Ser S 60
Threonine Thr T 74
Tryptophan Trp W 159
Tyrosine Tyr Y 136
3-nitrotyrosine 3NT nY 181
Valine Val V 72
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Multiplex tandem mass spectrometry with stable isotope labeling 
 To overcome the aforementioned limitations of protein quantitation in 
linear ion trap MS, a novel approach to metabolic labeling using MS/MS 
quantitation of non-isobaric precursors (multiplex MS/MS) has been described 
(11).  In this approach, proteins were coded by supplementation with either 
normal or heavy [15N4] Arg and [13C6] Lys into Arg/Lys depleted media.  Thus, 
MS peptide pairs resulting from trypsin digestion were expected to deviate by 2 
or 3 Da (based on 2+ precursor charge). 
 To cover the mass range containing multiplex parent ions, the MS/MS 
precursor selection window was extended to 10 m/z.  Efficiencies for peptide and 
protein identifications from the extended isotope window were compared to data 
acquired using a conventional window of 2.5 m/z (11).  As expected, the 10 m/z 
window was more sensitive than the 2.5 m/z window, since its range ensured 
inclusion of both precursor isotope clusters.  However, specificity was diminished 
in the extended window, while background noise increased. 
 For automated quantitation of the complicated MS/MS spectra containing 
y and b ions with peptide pairs separated by 1 Da, it was necessary to develop a 
unique software program (MS2Ratio).  MS2Ratio was designed to apply stringent 
rules for ratio calculations between ≤ 2+ y-type product ions from ≥ 2+ charged 
precursors (11).  A second filter was integrated excluding y ions that overlapped 
with b and y ions with signal intensities ≤ 10% of the most abundant y ion pair 
(11).  This multiplex MS/MS approach compared favorably to conventional 
stable-isotope-labeling using integrated XICs for quantification (11) and appears 
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to be versatile enough for use in other applications requiring the sensitivity of a 
linear ion trap or where HR/AM instrumentation is unavailable. 
Nitrotyrosine-specific stable isotope labeling 
 Our isotope-labeling strategy was designed to capitalize on the 
advantages of the previously-described methods to develop a sensitive and 
quantifiable PTN-specific mass spectrometric method using a LTQ.  The method 
would be adaptable to an Orbitrap for HR/AM analyses.  Our plan was to exploit 
the unique 3NT immonium ion as a reporter for both PTN identification and as an 
agent for quantitation.  To develop and test the method, a 3NT-specific chemical 
label was applied to free Tyr, two peptide standards and a protein standard using 
isotope-coded peroxynitrite.  The long-term goal of this method was to apply 
PTN-specific stable isotope coding to a standard lysate representative of the 
experimental cell line for identification and quantitation of PTN resulting from 
oxidative/nitrative stress. 
Mass spectrometric analysis of isotope-coded nitrotyrosine immonium ions 
 We have developed a method that incorporates both CID and PQD 
activation in a linear ion trap to obtain sequence data and immonium reporter 
ions throughout the mass range of a LTQ.  Modified peptides can be identified by 
bioinformatic searches (e.g. Mascot) and/or de novo sequencing (13) of spectra 
found by manual screening of XICs reconstructed from ± 1 Da of the heavy-
labeled immonium ion (182 m/z).  Quantitation can be achieved using the ratios 
of the immonium ion peak pairs.  The relative contributions to immonium ions 
from endogenously-generated peroxynitrite (181.06 amu) and synthetic heavy-
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labeled peroxynitrite (m/z 182.06 amu) result in a ratio that is relevant to 
nitropeptide and, likewise, nitroprotein abundances.  Also, because quantitation 
is based on MS/MS peaks, background interference is expected to be minimal. 
 Future plans include use of an Orbitrap analyzer for HR/AM precursor 
ion scans with CID/PQD activation in the linear ion trap.  Also, application of HCD 
activation in an Orbitrap is in future plans to acquire HR/AM product ion spectra 
using shorter scan times than those required for high-resolution scans in a linear 
ion trap.  On- or offline fractionation with UV detection at 3NT’s unique 
absorbance λ of 356 nm can be employed to determine chromatographic 
fractions containing abundant 3NT.  Finally, a steep reversed-phase gradient 
coupled to MS acquisition with source fragmentation on a LTQ can also be used 
as a nitropeptide screen.  Signal for low abundance ions would be increased due 
to the steep gradient and sensitivity can be increased by implementation of a 
segmented MS method focusing on RTs where 3NT immonium ion signals were 
previously detected.  MSn target numbers can be increased during those 
segments.  The methods described in this chapter are expected to facilitate more 
abundant and more confident PTN identifications as well as a means for site-
specific nitration quantitation from complex protein sets. 
Materials and Methods 
Peroxynitrite synthesis 
 The following items were obtained to build a custom syringe pump-
driven chemical synthesis system for authentic and stable isotope-labeled 
peroxynitrite.  New Era Pump Systems (Farmingdale, NY, USA) supplied a NE-
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1600 Six Syringe Pump capable of syringe size-dependent infusion rates from 
0.452 µL× hr -1 to 1451 ml/hr.  Harvard Apparatus (Holliston, MA, USA) supplied 
the following: Monoject Plastic Syringes with Luer tips, Polypropylene Luer 
Connector Kit, 3.2 mm ID/4.8 mm OD Tygon R-3603 Tubing (For reagents and 
NaOH), and 2.4 mm ID/4.0 mm OD Tygon R-3603 Tubing (reaction tube). 
 Isotope-labeled and unlabeled peroxynitrite were synthesized from 
either “heavy” 15N sodium nitrite (Icon isotopes, Summit, NJ, USA) or “light” 14N 
sodium nitrite by reaction with acidified hydrogen peroxide (H2O2) using a 
modified version of a previously described method (14).  Briefly, NO2 or 15NO2 
and H2O2 were delivered to a “T”-junction at a static flow-rate using a six-syringe 
pump (New Era).  Volumes of reagents and reaction times were controlled by 
pump speed, syringe size, tube lengths and tubing inside diameters (IDs).
 Reactions were immediately quenched by downstream infusion of 1 M 
NaOH to a final concentration of 1 M (pH 13).  Products were collected on ice 
prior to spectrophotometric concentration assay at the absorbance maximum for 
peroxynitrite of 302 nm (14-16) on a NanoDrop 1000 (Thermo Scientific, USA).  
The stocks were distributed into one mL aliquots and assayed for ONOOˉ 
concentration or immediately stored at − 80°C to minimize degradation.  Assay 
results were followed by manipulations of reagent concentrations and the 
reaction tube length to optimize product yields as enumerated by Table 5.  
Syringe size (10 mL) was static and pump speed was maintained at the 
maximum flow-rate for 10 mL syringes of 415.9 mL × min-1. 
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Stable isotope labeling using synthetic peroxynitrite 
Free amino acid reactions 
 Products from the second synthesis (10 mM "light" and 8 mM "heavy") 
were used in reactions with 500 µM L-Tyr to test the nitration efficiency of 
dilutions from those starting concentrations.  Reactions using dilutions to final 
concentrations of 200 µM, 400 µM and 800 µM were performed in triplicate by 
addition of concentrated light or heavy ONOOˉ to microcentrifuge tubes 
containing 500 µM L-Tyr (~ 9 µg in 0.1 mL) followed by immediate vortex at room 
temperature (RT).  Reactions were incubated at RT for 1 h prior to quenching by 
addition of formic acid to 5%.  Reactions were combined and desalted with Zip-
Tip (EMD Millipore, Billerica, MA, USA) SPE columns, then suspended in 50:50 
water: acetonitrile in 0.1% formic acid prior to direct infusion on a Finnigan LTQ.  
Peak intensities for 50:50 mixtures of the two nitrated species were analyzed to 
evaluate the ability of a Finnigan LTQ to resolve a +1 Da mass shift in zoom-scan 
mode as well as to empirically determine an ionization efficiency correction 
factor. 
Peptide standard reactions 
 Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) obtained from Bachem 
(Torrance, CA, USA) was diluted to 0.5 mg × mL-1 (~ 478 µM) in 500 µL 
phosphate-buffered saline (PBS) pH 7.4 and reacted with 800 µM synthetic 
ONOOˉ (Table 5, synthesis #4) to test its nitration efficiency.  The pH was 
measured after ONOOˉ addition (in 1 M NaOH) with litmus paper which indicated 
a pH of ~10.  A second reaction was performed with 440 µM ONOOˉ, which 
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resulted in a final pH of ~8.  Both reactions were incubated for 1 h at 37°C.  
Reactions were quenched by addition to 5% formic acid followed by desalt in 
centrifugal C18/silica SPE columns (The Nest Group, Southborough, MA, USA).  
Peptides were eluted in 90:10 acetonitrile: water (0.1% formic acid) prior to 
concentration under vacuum at 50 °C until the volume was ~ 25 µL.  Samples 
were resuspended in 50:50 water: acetonitrile in 0.1% formic acid prior to direct 
infusion into an Orbitrap to qualify nitrated product evolution. 
Pentapeptide reactions 
 The pentapeptide GLYKG was selected for testing a 50:50 mixture of 
heavy and light (H&L) ONOOˉ due to its median nitration susceptibility 
demonstrated in Chapter Two.  An 800 µM stock was prepared by measuring 
683 µg into 1547 µL of PBS.  A 500 µM stock was prepared by diluting 625 µL of 
800 µM stock into 1 mL.  The 500 µM stock was aliquotted for 100 µL reactions 
and reacted with 800 µM ONOO.  Reactions were performed at RT, mixed on 
vortex immediately upon addition of ONOO and mixed again after 30 s, then 
incubated at 37 °C for 1 h. 
Protein standard reactions 
 Separate reactions of 800 nM BSA with 800 µM, 400 µM, and 200 µM 
ONOOˉ were performed at RT for one hour.  Reactions were trypsin digested by 
the in-solution method after alkylation in 6 M urea at RT in the dark.  Equal 
volumes of the reactions were combined prior to desalt and speed-vac 
concentration.  The combined samples were analyzed by HPLC-MS/MS on an 
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Orbitrap with HCD fragmentation to achieve high-resolution precursor masses 
and to exploit the extended mass range of the Orbitrap analyzer. 
 A second set of BSA reactions were performed in duplicate using 
equimolar amounts of H&L ONOOˉ.  Reaction mixtures were acid-quenched (5% 
formic acid) and combined in various ratios as outlined in Table 6.  After trypsin 
digestion, a synthetic nitropeptide standard (Gly-Glu-Tyr(nitro)-Leu-Gly) was spiked 
in as an IS prior to desalt.  Reaction mixtures were analyzed by HPLC-MS/MS on 
a LTQ to evaluate nitropeptide identification and immonium ion quantitation. 
 Five µg of BSA plus 11.65 ng IS (assuming 100% recovery from C18 SPE) 
were loaded on column for HPLC-MS/MS analysis by the following procedure.  
The IS (GEY(nitro)LG) was measured to 500 µM in 50 mM ABC, then diluted to 50 
µM in 50 mM ABC.  The IS was spiked-in using micropipette by adding 8 µL into 
1 mL of protein suspension to a final concentration of 0.4 µM.  Spiked BSA 
suspensions were desalted in centrifugal SPE columns and lyophilized.  The 
samples were resuspended to 1 mg × mL-1 in 100 µL of 0.1% formic acid.  The IS 
final concentration was 4 µM or 2.33 µg × mL-1.  Total mass on column was 5 µg 
BSA digest and 11.65 ng IS per 5 µL injection. 
Liquid chromatography and mass spectrometric analyses 
Direct infusions 
 Full-scans of light ONOOˉ-treated angiotensin II were set to analyze from 
400 – 1200 m/z.  Tandem MS was done on both the 546.26 m/z and 1091.52 m/z 
peaks using CID, PQD and HCD on a LTQ Orbitrap XL (Thermo).  CID and PQD 
energies were set to 35.  HCD scans ranged stepwise from 35 to 80.  H&L 
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ONOOˉ-labeled angiotensin II mixtures were analyzed with five µscans in ultra-
zoom mode in the range of 450 - 1200 m/z on a Finnigan LTQ. 
Tandem-mass spectrometric analyses 
 Five microliter injections of the H&L ONOOˉ BSA digests were separated 
by reversed-phase HPLC on an LC Packings Ultimate system (Thermo Fisher 
Scientific, USA).  Peptides were desalted on a capillary trap column (100 μm 
i.d.×2 cm C18) packed with 5 µm silica spheres with 300 Å pores (ProteoPep II) 
prior to elution from a ProteoPep II 75 μm i.d.×10 cm C18 analytical column.  The 
mobile phase flow-rate was 300 nL× min-1 and followed a linear gradient of 5% - 
40% B over 90 minutes (mobile phase A was 0.1% formic acid in water and B 
was 0.1% formic acid in acetonitrile). 
 Two tandem MS methods were utilized to optimize for immonium ion 
detection.  Tune parameters in the Finnigan LTQ for these analyses were as 
follows:  Spray voltage: 2.5 kV, Capillary temperature: 200 °C, Capillary voltage: 
40, Tube lens Voltage: 210, MSn target: 4 × 104, Scan time: 2 microscans with a 
maximum inject time of 200 ms. 
 A “triple-play” (MS-MS/MS-MS/MS/MS) method was used for H&L nitro-
BSA digests with MS acquisition in centroid mode, CID activation (MS2) on the 
top three most abundant ions, and PQD activation (MS3) on the top 3 product 
ions from the CID scan.  Dynamic Exclusion was set for 90 s after two repeats 
and early expiration after 3 counts with a signal to noise (S/N) threshold of 3.  
Finnigan LTQ settings were as follows: spray voltage: 2.0 kV; capillary 
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temperature: 160 °C; capillary voltage: 46.0; tube lens (V): 160; MSn target: 
4x104; 2 μscans; 200 ms.  The scan range for full MS was set to 400-1200 m/z. 
 A second data-dependent top 4 CID/PQD method was used to acquire 
complementary spectral data from the same precursors.  The method was set for 
data-dependent MS/MS on the top 4 ions using CID with a CE of 45, followed by 
top-4 MS/MS of the same precursors from the survey scan (MS) using PQD at 
CE of 45.  This method was intended to acquire MS2 spectra for the same 
precursors using both activation methods for comparison of immonium ion 
fragmentation efficiency. 
 The MS/MS spectra resulting from CID of tryptic peptides were isolated in 
a window of ± 2 Da.  This extended range was implemented to account for non-
isobaric parent ions coded by either +45 or +46 Da nitro-adducts.  In the 4 Da 
isolation window, precursor ions containing heavy, light or a combination of H&L 
3NT were activated simultaneously by CID or PQD.  The resulting MS/MS 
spectrum contained differential 3NT immonium ion peaks separated by 1 Da 
would be indicative of the relative amount of H or L nitropeptide and, thus, 
nitroprotein content. 
Results 
Isotope-labeled Spike-in Nitroprotein Standard (SNiPS) 
Overview 
 The methods described in this chapter are expected to facilitate 
identification and relative quantitation specific to PTN from complex protein 
mixtures.  Identification will be assisted by database searches specifying Tyr-
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nitration as a variable modification and screening of peptide spectra containing of 
H&L 3NT immonium reporter ions.  Quantitation will be calculated from the ratios 
of 3NT immonium ion peak pair intensities.  Immonium ion peak pairs will be the 
result of nitration imparted by either an isotope-labeled Spike-in NitroProtein 
Standard (SNiPS) or from endogenously-generated 3NT. 
 To initiate this process, stable isotope-labeled H&L ONOOˉ was 
synthesized using a syringe pump platform.  Synthesis and reactivity was 
validated by reactions with free L-Tyr, angiotensin II, and the pentapeptide 
GEYLG.  BSA was reacted with three concentrations of H&L ONOOˉ to test the 
feasibility of 3NT immonium ion screening for nitropeptides and quantitation 
using peak intensity ratios.  The long-term goal for this project was to perform 
similar in vitro reactions with a microglia control lysate for use as a SNiPS to 
screen for endogenously-generated (light) PTN and for quantification of PTN 
under a variety of oxidative/nitrative stress conditions.  Nitropeptides generated 
from a SNiPS are coded by a +46 Da mass increase resulting in 2+ charged MS 
peptide pairs separated by 0.5 Da where both H&L isotopes are present. 
 Since nitropeptide pairs would differentiate by ≤ 1 Da, an isotope window 
of 4 m/z (± 2 Da of monoisotopic m/z) was specified for MS/MS precursor mass 
selection, not the 10 m/z window described earlier for multiplex precursors with a 
Δm of +3 (11).  Nitrotyrosine-containing y or b ion series were expected to exhibit 
doublet peaks with a Δm of +1 Da, which could be quantified by a method similar 
to the one described by Zhang (2006) using ratios of MS2 fragment ions.  
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Preferably, our method will be quantifiable based exclusively on the ratio of peak 
intensities from the H&L 3NT immonium reporter ion pairs. 
 There are several advantages to using ratios of 3NT immonium ions for 
PTN quantitation.  First, since the nitroproteome should be modest in size, 
manual screening for 3NT immonium ion pairs is practicable.  Also, our focus is 
specific to a single isotope pair (181 & 182 m/z), negating the necessity for 
development of a complex search algorithm to pre-qualify peak pairs for 
quantitation.  Finally, the low-mass immonium reporter ions are specific to 3NT in 
that they neither overlap with any of the other twenty immonium ions, nor are 
they isobaric with any of the twenty common amino acid residue masses. 
Stable isotope-labeled peroxynitrite synthesis 
 Isotope-labeled ONOOˉ was a prerequisite to SNiPS development for 
immonium ion screening and quantitation described in the Introduction of this 
chapter.  Using a scaled-down version of a previously-described method (14), 30 
mL volumes of heavy or light isotope-labeled peroxynitrite were synthesized.  A 
syringe pump system was used to combine NaNO2 or Na15NO2 and acidified 
H2O2 to produce H or L ONOOˉ (Fig. 30).  Due to ONOOˉ instability at low pH, 
concentrated NaOH was added post-reaction from a separate syringe.  The 
product was collected on ice and either stored at − 80°C or assayed for 
concentration at 302 nm. 
 Because the syringe capacity used in this experiment was one-third the 
volume of the syringes used in the large-scale synthesis (14), optimization steps 
were necessary to maximize final product yields.  Table 5 details the adjustments   
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Figure 30.  Peroxynitrite synthesis.  A syringe pump method adapted from 
Robinson and Beckman (2005) was optimized using the general schema shown 
above with variations in tube lengths and reagent and storage buffer 
concentrations to synthesize both unlabeled and 15N-labeled peroxynitrite. 
  
ONOOˉ
NaNO2 HCl + HOOH
NaOH
Na15 2
O15NOO¯
Reaction tube
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Table 5.  Peroxynitrite synthesis optimization. 
 
 
Seven separate synthesis attempts resulted in the ONOOˉ yields above.  
Reagent concentrations and reaction tube lengths were manipulated based on 
visual observation of the intensity of the yellow color of the product that is 
characteristic of 3NT, assay results, and MS analyses indicating the reactivity of 
the product. 
 
 
made to reagent concentrations, tube lengths, and storage buffer concentrations 
for optimization of ONOOˉ yield (heavy ONOOˉ synthesis was discontinued 
temporarily to conserve isotope-labeled sodium nitrite).  The syringe pump was 
programmed for the maximum flow rate for all reactions. 
 The limiting factor for reaction yield was likely to have been syringe size 
as the maximum flow rate for 10 mL syringes is 415.9 mL× h-1 compared to 862.8 
mL × h-1 for 30 mL syringes and 2376 mL × h -1 for 140 mL syringes.  
Theoretically, the system described could produce ≥ 137 mM ONOOˉ using 140 
mL syringes at full-speed—much closer to the 180 – 190 mM yields reported by 
Robinson & Beckman (2005) using 30 mL syringes.  Nevertheless, the yield 
maxima for H&L ONOOˉ (24 mM and 22 mM for H&L ONOOˉ, respectively) were 
Synthesis # Peroxide Solution Nitrite
Reaction 
Tube Length
Storage 
Buffer 
concentration
Peroxynitrite 
Yield (mM)
HCl 
(M) H2O2 (M) NaNO2 (M) NaOH (M) Heavy Light
1 0.700 0.600 0.600 4.0 cm 1.00 8 9
2 0.700 0.600 0.600 3.0 cm 1.00 8 10
3 0.350 0.300 0.300 3.0 cm 1.00 12 14
4 0.350 0.300 0.900 2.4 cm 1.00 14 16
5 0.725 0.900 0.900 2.4 cm 1.00 NA 18
6 0.350 1.200 1.200 2.0 cm 0.30 NA 16
7 0.241 0.530 1.270 3.0 cm 0.30 24 22
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expected to be sufficient for our purposes.  The relatively low yields resulting 
from early synthesis reactions (Table 5, syntheses 1-3) required larger volumes 
than the commercially available ONOOˉ from Cayman (40 - 80 mM) used in the 
experiments described in Chapter Two.  The resulting reaction mixtures were 
read at pH above 8—possibly retarding efficient nitration at the standard ONOOˉ 
reaction concentrations of 200 µM, 400 µM and 800 µM. 
 Stock H&L ONOOˉ concentrates were reacted with free amino acid (L-
Tyr), a peptide standard (Angiotensin II), a pentapeptide (Gly-Leu-Tyr-Lys-Gly), 
and a protein standard (BSA) to test H&L ONOOˉ reactivity and optimize mass 
spectrometric parameters prior to heavy ONOOˉ use for labeling a SNiPS 
quantitative multiplex MS/MS analytical calibrant.  Reactions were performed by 
ONOOˉ addition to standards in PBS (pH 7.4) as described in Chapter Two and 
in Materials and Methods above.  To our knowledge, this study represents the 
first example of stable isotope-labeled peroxynitrite synthesis and use for 3NT-
specific isotope coding. 
Free amino acid testing 
 Peroxynitrite (Table 5, synthesis 2) reactions with free L-Tyr were 
analyzed by MS/MS using both CID and PQD activation on a LTQ to determine 
CE optima and to test feasibility for use of the immonium ion isotopes for semi-
quantitative analysis.  Immonium ion signals were expected to be strong, since a 
low-complexity mixture comprising three analytes (L-Tyr and H&L 3NT) was 
being analyzed.  Peptide-bound 3NT immonium ion signal intensities were 
expected to be significantly weaker than free amino acid as CID favors a single   
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Figure 31.  Isotope-labeled nitrotyrosine.  A) A representative MS spectrum 
showing precursor ion peaks for both the unlabeled (227 Da) and heavy-labeled 
(228 Da) nitrotyrosine from a LTQ analysis in zoom-scan mode.  B) Immonium 
ion peaks resulting from CID fragmentation of 227 Da (± 2 Da isolation window).  
C) Nitrotyrosine isotope cluster simulation showing the predicted intensity of the 
light immonium ion’s 2nd isotopic peak at 182.06 to be ~9%.  Green-dashed lines 
for A&B indicate the heavy 3NT peak intensities as follows: parent ion ~ 90%, 
immonium ion ~ 78% (average of 102 scans).  
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amide bond breakage.  Nevertheless, 3NT immonium ion signals were expected 
to be detectable and quantifiable. 
 The heavy 3NT precursor ion peak (228 Da) intensity was expected to 
be ~ 3% greater than the light-labeled peak (227 Da).  This calculation was 
based on two key factors.  First, the theoretical contribution from the second 
isotope peak of light 3NT (XCalibur isotope simulation, Fig. 31C) was estimated 
to overstate the heavy 3NT peak by ~ 9%.  Secondly, the stock purity of the 
15NO2 used for heavy ONOOˉ synthesis was 97%, which would result in a net 
6% reduction of the 228 m/z signal from a 3% contribution to the monoisotopic 
peak of light 3NT and 3% reduction in the heavy 3NTpeak.  Together, these 
factors would result in a net 3% increase on the heavy 3NT immonium ion 
isotope peak. 
 The experimental results showed the heavy labeled 3NT parent ion peak 
intensity to be closer to 90% of the light (Fig. 31A).  This variance could be due to 
inefficient reaction of heavy ONOOˉ with L-Tyr due to the low stock concentration 
or overstated purity of the Na15NO2.  Nevertheless, heavy 3NT labeling was 
considered successful based on the significant contribution to the 2nd parent ion 
isotope peak of light 3NT at 228 Da (Fig. 31A) and the heavy immonium ion peak 
at 182 m/z (Fig. 31B).  The ratio of L/H immonium ion intensities was ~ 1.25, 
correlating to the variance seen in the precursor intensities.  Considering the 
isotope-labeling of free L-Tyr was successful and that the ratios in a multiplex 
experiment would be normalized, these results were encouraging for the 
continued development of the method. 
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Angiotensin II Peptide standard testing 
 Light synthetic peroxynitrite (Table 5, synthesis 5) was reacted with 
Angiotensin II (~ 500 µM) to validate its reactivity when diluted from a stock 
concentration of 18 mM and to determine the signal strengths of reporter ions 
from a short peptide.  The 800 µM reaction mixture was measured to be pH 10, 
which may have stabilized the peroxynitrite anion, retarding its reactivity.  A 
second reaction performed by addition of half the ONOOˉ volume (440 µM) was 
measured to be pH 8. 
 Both reactions were analyzed by direct infusion on an Orbitrap.  
Angiotensin II nitration peaks expected at 546.2 m/z and 1091.5 m/z were not 
detectable from analysis of the 800 µM reactions; however, nitro-Angiotensin II 
parent ion signals were detected from infusion of the 440 µM reactions.  The 
nitropeptide precursor ion intensity was ~ 37%, relative to the unmodified peptide 
ion (Fig. 31).  These results confirmed our prediction that the 18 mM synthetic 
ONOOˉ stock concentration would require dilution below 800 µM to be reactive, 
which was not a major concern since PTN had previously been detected from 
reaction with ONOOˉ concentrations above 200 µM.  Another consideration was 
that the stock NaOH concentration could be lowered, reducing its impact on 
reaction mixture pH.  Subsequent syntheses were collected in 0.3 M NaOH—a 
three-fold decrease from the original storage buffer concentration. 
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 Figure 32.  Synthetic peroxynitrite reactivity test using Angiotensin II.  This 
mass spectrum represents nitration from reactions with 440 µM synthetic 
ONOOˉ.  The dashed green line indicates nitration peak intensity to be 37%.  
Due to pH increase from low concentration ONOO-, 800 µM reactions did not 
result in a detectable nitration peak. 
 
 
 Angiotensin II was also reacted with three concentrations (1 mM, 500 µM 
and 200 µM) of either H or L ONOOˉ (Table 5, synthesis 7) to quantify the 
relative contribution of each to the nitropeptide isotope cluster.  Equal amounts of 
the reaction mixtures were combined prior to desalt to give H/L ratios of 1:1, 2:1, 
4:1, 1:2, and 1:4.  The mixtures were desalted, speed-vac concentrated, and 
resuspended in 50:50 acetonitrile: water in 0.1% formic acid and analyzed by five 
µscans in Ultra Zoom mode on a Finnigan LTQ.   
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Figure 33.  H/L nitro-Angiotensin II MS signal ratios.  A-F)  Mass spectra 
representing the average of ten scans from A) the unmodified peptide, B) H/L 
nitropeptide mixture ratios of 1:1, C) 2:1, D) 4:1, E) 1:2, F) 1:4.  Dashed green 
lines indicate the relative abundances of (A) the 2nd isotopic peak of the 
unmodified peptide, (B) the 2nd peak of the nitropeptide with contributions from 
both H&L, (C&D) the monoisotopic peak of the light nitropeptide, (E&F) the 2nd 
peak of the H&L nitropeptide isotope cluster.  
 
 
 The monoisotopic peak for 2+ charged nitro-Angiotensin II was found at 
546.2 m/z and the heavy isotope at 546.7 m/z.  The average contribution from 
the second isotope from the light nitropeptide was estimated to be 55% based on 
the intensity of the second isotopic peak of the unmodified peptide (Fig. 33A) and 
XCalibur isotope cluster simulation (not shown).  The ratios of mass 
spectrometric peak intensities were 0.93, 1.07, 0.74, and 0.77 for the reaction 
mixtures of 1:1, 2:1, 1:2 and 1:4, respectively (Fig. 33G).  Ratios were not as 
expected considering the light nitropeptide second isotope contribution to the 
monoisotopic peak of the heavy nitropeptide (i.e. 546.7 m/z).  However, the 4:1 
mixture ratio (2.38) began to approach the expected ratio, indicating accurate 
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quantitation will require the heavy isotope to be present at greater than four-fold 
quantities.  This should not present an issue for our proposed method as the 
heavy amount is controlled by spike-in addition. 
 A limitation to this method is in quantitation by peak intensity.  Because 
a RP of 643,000 would be required to resolve the heavy monoisotopic peak from 
the second isotope peak of the light isotope, our calculations must take 
contributions from both into account.  These contributions can be inaccurately 
measured using the one-dimensional metric of peak height.  A more reliable 
measure of isotope contribution would be attained using AUCs as exemplified by 
the pentapeptide chromatograms in Chapter Two.  Currently, however, XCalibur 
software does not accommodate spectral peak integration. 
Pentapeptide standard testing 
 A pentapeptide (GLYKG) was reacted with 600 µM ONOOˉ (50:50 H&L) 
(Table 5, synthesis 4) to validate the reactivity of both H/L ONOOˉ and to validate 
the expected 3NT immonium reporter ion ratio.  Reaction mixtures were analyzed 
by direct infusion on a LTQ XL.  The isolation window for this experiment was 
opened to ± 6 Da to ensure capture of both parent masses.  Although the wide 
isolation window would not be expected to perturb data from a single analyte, it 
could significantly increase noise from a complex mixture.  Thus, our standard 
isolation width setting for SNiPS analyses will be ± 2 Da to attenuate background 
signals. 
 The H/L parent and immonium ion isotope ratios were ~ 1:1 as predicted 
(Fig. 33A&B).  Although this experiment was conducted using a linear ion trap set   
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 Figure 34.  Pentapeptide nitrotyrosine isotope labeling.  GLYKG peptide was 
reacted with equimolar concentrations of heavy and light synthetic peroxynitrite 
and analyzed via MS (A) to resolve H&L GLY(nitro)KG parent ions and MS/MS 
(B) to evaluate immonium ion peak intensities. 
 
 
to unit resolution at full-width half-maximum (FWHM), a high-resolution analysis 
using an Orbitrap can easily resolve the isotope overlap between 3NT-derived 
immonium ion isotopes.  Contributions to the 14N-containing 2nd and 3rd isotopes 
can be separated by instrument resolving power (RP) ≥ 52,000.  RP is 
determined by multiplying the mass resolution required between peaks by two.  
Mass resolution comes from application of the International Union of Pure and 
Applied Chemistry (IUPAC) definition—𝑅 = 𝑀
∆𝑀
 .  Since the second isotope peak 
from the 14N-labeled 3NT equals 182.065 and the monoisotopic peak from 15N-
labeled 3NT equals 182.058, the RP required for 3NT immonium ion isotope is 
calculated by: 2 (182.065 / (182.065 − 182.058)) ≅ 52,000.  The results of this   
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Table 6.  Analytical sample combinations of H&L peroxynitrite reactions 
with BSA.   
 
 
To evaluate the reactivity and immonium reporter ion ratios of H&L nitropeptides 
generated from synthetic peroxynitrite on a protein standard, the above mixtures 
were made prior to HPLC-MS/MS analysis. 
 
 
experiment bolstered the feasibility of synthetic ONOOˉ isotope-coding for 
SNiPS-assisted semi-quantitative nitration analysis of complex biological 
samples. 
Protein standard testing 
 A protein standard (800 nM BSA) was reacted with 200 µM, 400 µM, 
and 800 µM H or L ONOOˉ to test ONOOˉ reactivity with a protein standard and 
to analyze the ratio of immonium ions detected from differential combinations of 
H&L reactions as specified by Table 6.  The scheme for BSA treatment and 
analysis is identical to the intended approach for SNiPS production and 
application to cell culture lysates as outlined in Figure 35.  BSA peptides were 
separated by reversed-phase chromatography using a linear gradient over 90 
minutes to increase the probability of identification of the expected low-level 
nitropeptide ions.  Note: the gradient used in a complex biological sample may 
require further optimization.  Mass spectrometric analyses were performed using 
both a top-10 data-dependent method and a combined top-4 CID/PQD method.  
A custom tune method was incorporated to increase MS/MS precursor target by 
H/L 1:1              
(µM ONOOˉ)
H/L 2:1          
(µM ONOOˉ)
H/L 4:1         
(µM ONOOˉ)
H/L 1:2         
(µM ONOOˉ)
H/L 1:4         
(µM ONOOˉ)
800:800 800:400 800:200 400:800 200:800
400:400 400:200 200:400
200:200
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33% to 4 × 104 and injection time was doubled to 200 ms to enhance PQD 
spectral quality as previously described (7). 
 Raw data files were searched against the full UniProt/SwissProt non-
redundant database using Mascot with Tyr nitration specified as a variable 
modification to identify nitropeptides and PTN sites.  Concurrently, manual 
reconstruction of peaks containing 3NT immonium ions was used to determine 
CID or PQD spectral prospects for identification of potential low abundance 
nitropeptides.  Product ion masses from those spectra containing the expected 
ratios of H/L 3NT immonium ions were input directly into the Protein Prospector 
MS Fit program (http://prospector.ucsf.edu) and searched against the 
Swissprot.2012.12.3 database to mine for possible low-level nitropeptides not 
identified by Mascot searches. 
 Mascot searches identified a unique nitropeptide (Y(nitro)ICDNQDTISSK) 
from a unique spectrum found in four of nine analytical replicates.  Because the 
peptide was identified exclusively from CID spectra at an observed m/z of 744.2, 
immonium ion peaks were undetectable due to the one-third rule.  MS Fit 
analyses were unsuccessful in identifying BSA nitropeptides from the peak lists 
of spectra containing the expected ratios of H/L 3NT immonium ions.  Further 
experimentation will be necessary to determine the optimal ONOOˉ reaction 
concentration for SNiPS development. 
 This experiment was intended to evaluate quantitation among immonium 
ion intensities resulting from differential mixtures of protein reacted with three 
concentrations of H or L ONOOˉ.  The inability to detect BSA nitropeptides was   
145 
 
 Figure 35.  Schema for SNiPS production and application.  A protein 
standard (BSA) was selected to test the qualitative and quantitative MS data for 
optimization of the SNiPS method.  BSA was reacted with either H or L ONOOˉ 
at variant concentrations then pooled at known ratios prior to trypsin digestion.  
The digest was then analyzed by HPLC-MS/MS on a LTQ using both CID and 
PQD activation.  Alternatively, HPLC-MS/MS analysis can be done on an 
Orbitrap using the HCD cell for HR/AM spectra.  MS/MS spectra can be mined 
for H&L 3NT immonium ions for peptide/protein identification and PTN 
quantitation. 
 
 
likely due to one or more of the following factors: insufficient ONOOˉ molar 
excess, inadequate sensitivity of the MS method, or inadequate instrument 
sensitivity.  A targeted method had been intentionally omitted because 
endogenous nitration sites would remain largely unknown.  Thus, the use of the 
heavy 3NT immonium ion as a screening device to detect low-level PTN from a 
standard data-dependent MS/MS analysis was evaluated.  Assuming cell lysate 
reaction with bolus ONOOˉ would result in site-identifications from a SNiPS, a 
targeted method can be built to enhance nitropeptide detection from 
experimental protein sets as described in the following section.  
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Table 7.  Observed nitropeptides from reactions with isotope-labeled 
peroxynitrite.   
 
 
Nitropeptides identified from analysis of peroxynitrite-treated BSA.  Experimental 
data from this table was considered when building the targeted MS/MS method 
to improve sensitivity for BSA nitropeptides.  Predictions in Table 8 were used to 
determine complementary precursor ion targets. 
 
 
SNiPS-based targeted MS method development 
 Although SNiPS master mix production is intended for use as a spike-in 
screening and quantitation tool specific to PTN from cell culture, an ancillary 
application can be identification of putative nitration sites.  A SNiPS lysate can be 
analyzed by shotgun HPLC-MS/MS, followed by database searching with Tyr 
nitration as a constant modification.  From this, a list of protein targets and 
representative nitropeptides can be compiled.  An MS/MS targeted method can 
be developed from the list to increase sensitivity for likely nitration sites as 
discussed in Chapter Three.  
 Additionally, targeted MS method development for a SNiPS can be 
augmented by computational methods.  In silico digestion can be employed to 
identify all potential PTN sites from a given protein of interest (e.g. a nitration 
target identified from shotgun MS analysis of the SNiPS).  Programs such as the   
Observed m/z Charge Nitropeptide Sequence Modifications
806.87 2+ (-)DAFLGSFLYEySR(-) Nitro (+45)
762.26 2+ (-)ETyGDMADccEK(-) Nitro (+45), Carbamidomethyl (+57), Carbamidomethyl (+57)
967.46 2+ (-)HPYFYAPELLyYANK(-) Nitro (+45)
645.31 3+ (-)HPYFYAPELLyYANK(-) Nitro (+45)
762.89 2+ (-)LGEyGFQNALIVR(-) Nitro (+45)
590.61 3+ (-)MPcTEDyLSLILNR(-) Carbamidomethyl (+57), Nitro (+45)
885.41 2+ (-)MPcTEDyLSLILNR(-) Carbamidomethyl (+57), Nitro (+45)
893.41 2+ (-)mPcTEDyLSLILNR(-) Oxidation (+16), Carbamidomethyl (+57), Nitro (+45)
495.61 3+ (-)RHPEyAVSVLLR(-) Nitro (+45)
697.35 3+ (-)RHPYFYAPELLyYANK(-) Nitro (+45)
642.64 3+ (-)RPcFSALTPDETyVPK(-) Carbamidomethyl (+57), Nitro (+45)
963.46 2+ (-)RPcFSALTPDETyVPK(-) Carbamidomethyl (+57), Nitro (+45)
744.82 2+ (-)yIcDNQDTISSK(-) Nitro (+45), Carbamidomethyl (+57)
896.85 2+ (-)yNGVFQEccQAEDK(-) Nitro (+45), Carbamidomethyl (+57), Carbamidomethyl (+57)
1266.55 2+ (-)yNGVFQEccQAEDKGAcLLPK(-) Nitro (+45), Carbamidomethyl (+57), Carbamidomethyl (+57), Carbamidomethyl (+57)
844.70 3+ (-)yNGVFQEccQAEDKGAcLLPK(-) Nitro (+45), Carbamidomethyl (+57), Carbamidomethyl (+57), Carbamidomethyl (+57)
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Table 8.  Nitropeptide target list from empirical data and in silico digest 
predictions.   
 
 
Using the MS-Digest tool from Protein Prospector 
(http://prospector.ucsf.edu/prospector/mshome.htm), peptides with fixed 
modifications including Cys-alkylation, Met-oxidation, and Tyr-nitration were 
considered in calculating precursor m/z targets for increased sensitivity for the 
detection of nitropeptides modified with either H or L ONOOˉ. 
 
 
Protein Prospector (prospector.ucsf.edu) MS-Digest tool allow you to enter 
FASTA sequences or protein accession numbers to calculate proteolytic 
digestion products.  User input includes database selection, taxonomy, 
proteolytic enzyme (e.g. trypsin), constant modifications (e.g. 
carbamidomethylation to Cys), variable modifications (e.g. oxidation of Met), and 
the type of instrument to be used for analysis.  For PTN applications Tyr-nitration 
should be specified as a variable modification to acquire parent masses relevant 
to all possible modification states or as a constant modification for outputs limited 
to precursors with all Tyr residues in the nitro- modified state. 
 To demonstrate target identification for method development using 
complementary data from HPLC-MS/MS analysis of a SNiPS and an in silico 
digestion, Tables 7 and 8 were created using BSA as the target protein.  Table 7 
represents nitropeptides that were detected from ONOOˉ reacted BSA using a 
Predicted 2+ Tri-nitro Di-nitro Mono-nitro Previously Observed Average Nitropeptide Sequence
399.40 797.80 (K)NY(Nitro)QEAK(D)
509.54 487.04 1018.08 (K)Y(Nitro)LY(Nitro)EIAR(R)
665.25 495.61 1329.51 (R)HPEY(Nitro)AVSVLLR(L)
745.28 744.82 1489.57 (K)Y(Nitro)IC(Carbamidomethyl)DNQDTISSK(L)
762.81 762.26 1524.61 (R)ETY(Nitro)GDMADC(Carbamidomethyl)C(Carbamidomethyl)EK(Q)
763.36 762.89 1525.71 (K)LGEY(Nitro)GFQNALIVR(Y)
774.83 1548.65 (K)EY(Nitro)EATLEEC(Carbamidomethyl)C(Carbamidomethyl)AK(D)
800.84 1600.67 (K)DDPHAC(Carbamidomethyl)Y(Nitro)STVFDK(L)
829.87 807.37 806.87 1658.73 (K)DAFLGSFLY(Nitro)EY(Nitro)SR(R )
886.02 590.61 885.41 893.41 1771.03 (R)MPC(Carbamidomethyl)TEDY(Nitro)LSLILNR(L)
897.45 896.85 1266.55 844.70 1793.90
(K)Y(Nitro)NGVFQEC(Carbamidomethyl)C(Carbamidomethyl)QAEDK(G
)
964.08 642.64 963.46 1927.16 (R)RPC(Carbamidomethyl)FSALTPDETY(Nitro)VPK(A)
1025.20 2049.39 (K)WVTFISLLLLFSSAY(Nitro)SR(G)
1035.58 1013.08 990.58 968.08 967.46 645.31 697.35 2070.15 (R)HPY(Nitro)FY(Nitro)APELLY(Nitro)Y(Nitro)ANK(Y)
1269.95 2538.90 (K)GLVLIAFSQY(Nitro)LQQC(Carbamidomethyl)PFDEHVK(L)
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Top-5 data-dependent method on an Orbitrap.  Table 8 represents the 
consolidation of target masses from Table 7 and those calculated by in silico 
digestion.  The targeted MS method can be built using Table 8 data, resulting in 
increased sensitivity for nitropeptides detected by data-dependent methods as 
well as those that were not previously observed. 
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Chapter 5:  Conclusions and Future Directions 
 
Conclusions 
 The preceding chapters described methods exploiting the 
physicochemical attributes specific to protein-bound Tyr nitration that were 
developed and tested with the goal of elucidating the pathophysiological basis for 
PTN-related damage induced by oxidative/nitrative stress.  To that end, a 
proteomics-based workflow was developed to address PTN from both global and 
local perspectives.  Global nitration profiling emphasizes proteome-wide 
oxidative/nitrative stress effects, while identification of specific PTN targets and 
sites elucidates the metabolic pathways and molecular mechanisms affected by 
PTN. 
 Results of the described methods have successfully demonstrated 
increased mass spectrometric sensitivity for the identification of putative 
nitroproteins.  Progress has also been made linking nitration and energy 
metabolism through identification of site-specific nitration to ATPase-β.  
Optimized molecular methods combined with targeted mass spectrometry were 
shown to enhance analytical sensitivity for ATPase-β Tyr345. 
 Other putative PTN targets identified using the methods described herein 
had previously been affirmed to be nitration targets supporting our assertion that 
the mitochondrion is a nitration center.  The plenitude of protein targets involved 
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in energy metabolism and ROS disposition also indicates PTN’s potentially 
exacerbating effect on cellular injury.  PTN to core histones has even further-
reaching potential as it may modulate normal transcription of a variety of genes 
and may be involved in tumorigenesis (1). 
 Nitration targets such as myosin isoforms have been implicated in age-
related muscle atrophy and tissue damage due to dysfunctional energy 
metabolism.  PTN reported in skeletal muscle myosin isoforms have been shown 
to result in diminished interaction with actin (2), possibly contributing to age-
related muscle strength attenuation.  Nitrotyrosine IP experiments in this study 
identified abundant non-muscle myosin heavy chain IIa (myosin 9) as a novel 
putative PTN target.  Myosin 9 functions in mitochondrial DNA maintenance (3).  
Thus, myosin-9 nitration could promote mtDNA damage resulting in attenuated 
energy metabolism or apoptosis. 
 Also, a recurring trend of increased histone nitration was observed in 
activated microglia.  Histone nitration at sites normally occupied by other PTMs 
(e.g. acetylation, methylation, or phosphorylation) could alter chromatin 
remodeling and gene expression.  Identification of histone nitration sites and the 
associated genes can elucidate possible PTN-mediated regulation of gene 
expression. 
 Histones are essential for maintaining cell fitness through chromatin 
assembly and access to genes for transcription (4-7).  Normal gene expression is 
regulated by what is known as the histone code (4, 6-8).  The histone code refers 
to the specific patterns of histone posttranslational modifications regulating 
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normal transcriptional states (4, 6-8).  Many of these modifications are 
transmitted epigenetically (4, 6-8), which implies alterations to posttranslational 
states caused by stress may also be perpetuated. 
 Histone levels are also regulated through proteasomal degradation (4).  
Unbound histone accumulation within the nucleus is toxic as excess histones can 
non-specifically bind DNA due their inherent high-basicity, which can result in 
dysfunctional transcription (4).  Posttranslational modifications such as 
polyubiquitination on specific sites of excess histones are molecular markers for 
proteolysis (4).  Mutations or alternative modifications to those sites can result in 
histone accumulation and cell injury (4).  For example, histone H3 is regulated by 
polyubiquitination at Tyr99 under normal conditions.  Site-directed mutagenesis to 
Tyr99 has also been shown to result in genome instability (4). 
 The putative nitration site on Histone H3 Tyr41 identified in this study (Fig. 
28) is a phosphorylation site that is essential for cell viability (4, 9, 10).  However, 
hyper-phosphorylation to histone H3 Tyr41 by mutation-activated Janus kinase 2 
(JAK2) has been associated with leukemia (11).  JAK2 mediated phosphorylation 
to histone H3 Tyr41 inhibits the normal binding of heterochromatin protein 1α 
(HP1α) to the site, resulting in increased lmo2 expression and the leukemic 
phenotype (11).  Hyper-nitration to H3 Tyr41 could possibly mimic JAK2-mediated 
hyper-phosphorylation in an oxidative/nitrative stress-induced alternate pathway 
to leukemia.  It could also compete with normal phosphorylation related to 
viability. 
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 Our working hypothesis is that PTN modification to the regulatory sites on 
both chromatin-bound and unbound histones alters normal transcription and may 
be transmitted epigenetically due to the stability of the nitro- modification.  Future 
directions include experiments designed to identify PTN sites on histones and the 
genes affected by alternative Tyr modification.  Results of these experiments are 
expected to provide insight into gene regulation under oxidative/nitrative stress 
conditions.  Additionally, a complementary experiment is planned to determine 
Tyr41 site occupancy changes under nitrative stress conditions.  MRM analyses 
will be performed to assay both nitration and phosphorylation Tyr41 site 
occupancy. 
 Moreover, putative PTN targets discovered during this project represent 
strong prospects for further development of our immonium ion quantitative 
method using a Spike-in NitroProtein Standard (SNiPS).  Preliminary data are 
encouraging for quantification of greater than four-fold nitration variation.  
Sensitivity, however, is not limited to a four-fold variation between treatment and 
control since SNiPS addition is at the discretion of the investigator.  Quantitation 
will be determined by the ratio of SNiPS to endogenous nitration and is quantified 
among protein sets by the ratio of ratios.  SNiPS can also establish preliminary 
targeted MS methods as well as SRM/MRM methods specific to a biological 
model system.  These methods can be optimized by data inputs from analytical 
trials. 
 In conclusion, viable methods have been developed and tested that are 
specific for the nitrative stress-induced posttranslational modification, protein-
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tyrosine nitration.  Future development will continue the trend of novel 
approaches specific for the identification and quantitation of PTN targets and 
sites toward a more comprehensive understanding of the complex and diverse 
PTN roles in cellular processes. 
Future Directions 
Application of a mass spectrometric workflow for nitration site 
identification 
 The results described in Chapter Three were encouraging for future 
method development as the proteomics-based workflow discussed in Chapters 
One and Two can be applied to histone nitration—a posttranslational modification 
with potential to extend the scope of the current histone code (8).  In vitro ONOOˉ 
reactions can be performed with histone extracts at physiological pH to induce 
nitration in protein native conformations. 
 HPLC-MS/MS analysis of the reaction products and in silico analysis can 
assist in the identification of putative nitration targets for sensitive targeted MS 
method development.  Additional data-dependent scans will be possible with 
targeted scans limited to high-probability targets—facilitating more in-depth 
examination of the histone nitroproteome. 
Histone H3 peptide synthesis for nitration site validation 
 To validate histone H3 Tyr41 nitration, KPHRY(nitro)RPGTVALR and the 
unmodified and nitro-modified permutations of YRPGTVALR can be synthesized 
and analyzed by HPLC-MS/MS.  Assuming validation of RTs and spectral 
characteristics, an MRM method can be developed for quantitative analyses.  
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Additionally, the phosphorylated states of the peptide can be synthesized for 
MRM development specific to a well-characterized phosphorylation site that is 
potentially modulated by nitration. 
Nitrotyrosine immunoprecipitation of histone fractions 
 Since a robust histone isolation method has been established, further 
isolation of the nitroproteome can be acquired from those fractions.  Western 
blotting can be used to validate 3NT enrichment and nitration variation among 
differential treatment sets.  Parallel Coomassie detection can expedite accurate 
localization of cognate PTN-containing bands from the western blot, followed by 
application of the MS workflow described in Chapters One and Two as well as 
the histone nitroprotein targeted HPLC-MS/MS analysis described in Chapter 
Four. 
Histone purification using reversed-phase liquid chromatography 
 Acid extracted histones can be purified by a shallow reversed-phase 
HPLC method (12) to isolate histone H3, for example.  This method could be 
used to increase analytical sample while averting potential gel extraction pitfalls.  
Also, a chromatographic separation will allow for UV-Vis spectroscopy to identify 
fractions showing peaks at 356 nm—the unique 3NT absorbance wavelength at 
acidic pH.  Solution fractions can be digested and analyzed by targeted MS. 
 An alternate approach can be HPLC separation of the nuclear protein 
fraction acquired prior to histone acid extraction.  Because histone nitration 
remains undetected after acid extraction (e.g. by Western analysis), there is 
suspicion that chemical alteration may be occurring to the nitro- moiety.  
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Elimination of the acid extraction step will eradicate that particular variable.  
Western analysis of the nuclear fraction can also be performed to validate PTN 
retention. 
Colocalization analysis of inducible nitric oxide synthase, nitrotyrosine, 
and histones 
 Confocal microscopy is expected to improve resolution sufficiently over IF 
analysis to validate 3NT and histone colocalization.  In addition to LPS treatment, 
a cell-permeable iNOS-specific inhibitor such as N-(3-(Aminomethyl)benzyl) 
acetamidine (1400W) (13) can be applied to HAPI cultures to remove the iNOS 
background for localization experiment controls and to evaluate global changes 
to the nitroproteome in the absence of iNOS generated NO.  This approach can 
also be used to determine if iNOS localizes to the nucleus. 
Chromatin immunoprecipitation-sequencing to identify genes associated 
with histone nitration 
 To identify the genes associated with PTN induced by LPS-mediated 
microglial activation, a modified approach to chromatin immunoprecipitation with 
parallel DNA sequencing (ChIP-seq) can be performed.  Typical ChIP-seq 
experiments target specific proteins for immunoprecipitation with cross-linked 
DNA fragments.  An alternate approach would be to immunoprecipitate only 3NT-
containing proteins using either nitrotyrosine affinity sorbent (Cayman) or anti-
3NT bound to magnetic beads.  Upon liberation of DNA fragments from the 
associated nitroproteins, the DNA can be isolated and sequenced as is 
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customary.  DNA sequence results can be correlated to gene expression data to 
determine the functional impact of histone nitration. 
Spike-in nitroprotein standard-based workflow application to microglia 
 LPS has been shown to induce the classical activation phenotype in 
microglia (14, 15), which results in iNOS upregulation as well as increased 
ROS—conditions that favor increased PTN.  Our plan is to create a stable 
isotope-labeled microglial cell master lysate.  The heavy nitroprotein containing 
lysate can be used as a SNiPS to analyze nitration induced by direct (LPS-
stimulated) activation or by indirect activation resulting from neuronal secreted 
factor signaling after ethanol exposure. 
 HAPI cell lysate labeling can be performed by reaction with bolus heavy 
ONOOˉ to induce nitration of available residues representing prospective 
nitration targets/sites.  HPLC-MS/MS analysis of the standard with database 
searching can be used to identify putative nitration sites for targeted method 
development as well as a 3NT immonium ion quantitation optimization resource 
(Fig. 36A).  A SNiPS lysate can also be analyzed by SDS-PAGE with parallel 
Western blotting and in-gel digestion with HPLC-MS/MS analysis as described in 
Chapter Three.  Nitrotyrosine or protein- specific immunoprecipitation may be 
necessary to accumulate enough material for site identification from gel extracts.   
 Offline chromatography of SNiPS tryptic digests can pinpoint specific 
chromatographic fractions that are likely to contain 3NT by UV detection of its 
unique acidic absorbance λ of 356 nm.  Fractions showing strong absorbance at 
356 nm can be analyzed by data-dependent MS/MS to identify nitropeptide MS   
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Figure 36.  Application of SNiPS to activated microglia.  A) Nitration reactions 
are performed on a standard HAPI culture for putative PTN target identification.  
Prospective nitration sites are identified through Mascot database searches and 
Scaffold validation as well as manual reconstruction of XICs containing heavy 
3NT immonium ions.  LOD is determined for the identified nitropeptides to set the 
SNiPS spike-in amount.  B) SNiPS from (A) is applied to equal amounts of each 
protein set.  Protein sets are analyzed separately by targeted and data-
dependent MS/MS.  Nitropeptide sequences are identified and Log2 ratios are 
calculated for individual protein sets using the 3NT immonium ion pair relative 
intensities.  The H/L Log2 ratio of ratios is then calculated to determine relative 
nitration changes between treatment groups (Fig. 37). 
 
 
targets.  However, shotgun LC-MS analysis of SNiPS may be sufficient for PTN 
target/site identifications.  The shotgun approach will eliminate protein or peptide 
losses associated with gel extraction and 2D LC.  Nitropeptide identifications 
from SNiPS can be validated by manual spectral analyses and peptide synthesis 
for sites of particular interest.  
A. B. 
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 Figure 37.  SNiPS generated 3NT immonium ion pair quantitation.  In this 
scheme, both the control and LPS treatment groups inoculated with equal SNiPS 
content are analyzed separately.  A Log2 ratio of 3NT immonium ion pair 
intensities is determined individually for each protein set.  A Log2 ratio of ratios is 
then calculated between the two protein sets to determine change in nitration. 
 
 
SNiPS application for quantitative nitration analysis 
 Upon successful characterization of the microglial SNiPS, it can be 
applied as a SILAC control to a variety of microglial treatments.  For example, 
HAPI cells can be grown to near confluence and treated with 50 ng × mL-1 LPS or 
standard DMEM for 24 h.  After lysis and protein assay, SNiPS can be introduced 
in equal amounts to each protein group.  Trypsin digestion will provide duplicate 
peptide sets that can be analyzed by a combination of data-dependent and 
nitropeptide-targeted MS/MS acquisitions.  Database searches and manual 
mining for spectra containing heavy 3NT immonium ions can be conducted to 
identify nitration sites and quantify PTN from classical microglia activation based 
on ratios of 3NT immonium ion pair intensities (Fig. 36B). 
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 The Log2 ratios of immonium ion pairs can be calculated for all validated 
nitropeptide spectra (Fig. 37) and normalized for the contribution of any 
previously-identified endogenously-generated 3NT.  The Log2 ratio of ratios 
between protein groups and the SNiPS can then be calculated for improved 
correlation and to determine variation between experimental protein sets (Fig. 
37).  This process can be performed for entire proteomes as well to determine 
variant expression profiles between microglia expressing differential activation 
stages (e.g. resting stage versus classical activation) (15).  Successful SNiPS 
development is a novel approach that is expected to become a powerful tool for 
the elucidation of the contribution of PTN to the cellular injury associated with 
oxidative/nitrative stress. 
Nitration and phosphorylation analyses using a triple quadrupole mass 
spectrometer 
 Another MS method that can exploit the generation of 3NT immonium ions 
to identify PTN is precursor ion scanning (PIS) in a triple quadrupole MS.  
Precursor ions enter Q1 from the source and are scanned, transmitting narrow 
mass ranges into the collision cell (Q2) where they are fragmented by CID.  Q3 
would be set to transmit product ions of 181 or 182 m/z.  A mass spectrum would 
then be generated for all parent ion m/z that produced an immonium ion (Fig. 
38A).   
 A subsequent SRM (selected reaction monitoring) analysis can be 
developed using the precursor ion masses identified from PIS spectra with 
product ion selection of 181 and 182 m/z.  This method will provide sequence   
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 Figure 38.  Triple quadrupole scans for PTN characterization.  A) A precursor 
ion scan (PIS) scans the entire instrument mass range in Q1.  The collision cell 
(Q2) fragments the Q1 masses individually and Q3 selects for H&L 3NT 
immonium ion masses.  Spectra result exclusively for m/z scanned in Q1 that 
produced 3NT immonium ions upon CID.  B) Precursor ions identified from (A) 
that resulted in 3NT immonium ion products from PIS are selected in Q1, 
fragmented by CID in Q2 and scanned in Q3 to produce MS2 spectra for 
sequence identification and immonium ion quantitation.  C) PTN target 
sequences identified from (B) can be input into Pinpoint or Skyline programs to 
calculate all permutations of Tyr nitration to create a comprehensive SRM or 
MRM method as described in Chapters One and Two.  Quantitation is based on 
the AUCs of the SRM/MRM peaks. 
 
 
information for nitropeptide identification as well as the potential for quantitation 
of AUCs for each SRM containing either the heavy or light 3NT isotope (Fig. 
38B). 
 To augment SRM scanning, Pinpoint (Thermo) or Skyline (16) programs 
can be employed to calculate SRM or MRM transitions for specific target 
proteins.  Table S2 demonstrates a Skyline output from input of FASTA 
sequences of the four histone isoforms from both mouse and rat.  Nitration was 
specified as a variable modification, trypsin was specified as the proteolytic 
Scanning
Q1 Q2 Q3
Fragmentation Selection
181
182
Selection Fragmentation Scanning
Q1 masses
Skyline 
181
182
Q1 masses
Q3 masses
Quant
Quant
Selection Collision Cell Selection
A.
B.
C.
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enzyme and MRM transitions were limited to three.  The MRM method can be 
input into the TSQ method builder, resulting in quantifiable nitropeptide-specific 
MRM peaks (Fig. 38C) similar to those described for the pentapeptides in 
Chapter Two. 
 A major advantage to TSQ analysis is the range of CE available in the 
collision cell.  A TSQ collision cell uses argon as the collision gas, which 
facilitates energy-dependent fragmentation similar to HCD in an Orbitrap—
allowing for optimization of 3NT immonium ion signal by CE optimization.  SRM 
and MRM specificity is extremely reliable, since peak detection is dependent 
upon precursor mass transitioning to specific product ion masses.  Sensitivity 
and specificity can be further enhanced by modification of the method based on 
experimental RTs.  The analytes of interest can be isolated in truncated time 
windows (segments)—resulting in more data points across quantifiable peaks. 
 Histone phosphorylation MRM assays can be set up in a similar manner to 
the PTN method.  To determine the impact of nitration on a known 
phosphorylation site (e.g. histone H3 Tyr41) precursor mass entries will reflect 
YRPGTVALR with both +45 Da for nitration and +80 Da for phosphorylation.  Site 
occupancy for both modifications will be calculated by dividing the signal for the 
each modification by the sum of the modified and unmodified peptide signals. 
Expected outcomes and significance 
 Together, these experiments are expected to improve the characterization 
of PTN from complex biological matrices.  The identification and quantitation of 
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PTN targets and sites are expected to provide insight into its impact on protein 
function, metabolic pathways, transcription, and intracellular signaling. 
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Appendix C: Supplemental Figure Legends 
 
Supplemental Figure 1.  Nitration efficiencies of pentapeptides.  Percent 
nitration for pentapeptides (500 µM) is shown for three peroxynitrite 
concentrations reacted for 1 h.  A general trend was observed where nitration 
efficiency is influenced by both hydrophobicity and net peptide charge.  Error 
bars represent standard deviation for 5 replicate reactions (2 injections each).   
 
Supplemental Figure 2.  Circular dichroism spectrum of 0.1 mg/mL 
synthetic DAFLGSFLYEYSR.  This spectrum proved to be inconclusive with 
regard to the secondary structure of the peptide in the reaction buffer.   
 
Supplemental Figure 3.  Validation of spectra from nitrotyrosine BSA 
standard with synthetic AQUA™ peptides.  AQUA™ peptides were analyzed 
via HPLC-MS/MS in LTQ Orbitrap XL to validate sequence and nitration site-
specificity. A) Comparison of spectra from unmodified DAFLGSFLYEYSR (top) 
and AQUA peptide analogue (bottom).   B)  Comparison of DAFLGSFLYEY [3-nitro] 
SR (top) with AQUA peptide analogue (bottom).   
 
Supplemental Figure 4.  Alternate nitropeptides identified from 
peroxynitrite-treated BSA standard.  These spectra (A-F) represent additional 
nitration sites identified from the Cayman nitrotyrosine BSA standard.   These 
peptides meet all identification criteria outlined in 2.2 of the manuscript.   
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Supplemental Table 1.  MRM method parameters.   
Analyte 
Parent 
Ion 
m/z 
Charge 
State 
Transition 
1  
Transition 
2  
Transition 
3  
Spray 
Voltage 
(V) 
Capillary 
Temperature 
(°C)  
Sheath 
Gas 
(Arb) 
Aux 
Gas 
(Arb) 
L-tyrosine 182 1 91 123 136 4200 270 30 10 
13C L-tyrosine 
191 1 98 130 144 4200 270 30 10 
3-nitrotyrosine 227 1 117 181   4200 270 30 10 
DAFLGSFLYEYSR 785 2 554 717 1121 4200 270 30 10 
DAFLGSFLYEY*SR 807 2 599 762 1166 4200 270 30 10 
DAFLGSFLY*EYSR 807 2 599 762 1188 4200 270 30 10 
GEY[Nitro]KG 599 1 204 412 542 4200 270 30 10 
GKY[Nitro]EG 599 1 205 413 542 4200 270 30 10 
GKY[Nitro]KG 598 1 204 412 541 4200 270 30 10 
GKY[Nitro]LG 583 1 189 397 526 4200 270 30 10 
GKY[Nitro]SG 557 1 163 371 500 4200 270 30 10 
GLY[Nitro]KG 583 1 204 412 526 4200 270 30 10 
GSY[Nitro]KG 557 1 204 412 500 4200 270 30 10 
GSYSG 236 2 163     4200 270 30 10 
GSYSG 236 2 326     4200 270 30 10 
GSYSG 236 2 413     4200 270 30 10 
GSYSG 470 1 163     4200 270 30 10 
GSYSG 470 1 326     4200 270 30 10 
GSYSG 470 1 413     4200 270 30 10 
GSY[Nitration]SG 258 2 163     4200 270 30 10 
GSY[Nitration]SG 258 2 371     4200 270 30 10 
GSY[Nitration]SG 258 2 458     4200 270 30 10 
GSY[Nitration]SG 515 1 163     4200 270 30 10 
GSY[Nitration]SG 515 1 371     4200 270 30 10 
GSY[Nitration]SG 515 1 458     4200 270 30 10 
GSYLG 249 2 189     4200 270 30 10 
GSYLG 249 2 352     4200 270 30 10 
GSYLG 249 2 439     4200 270 30 10 
GSYLG 496 1 189     4200 270 30 10 
GSYLG 496 1 352     4200 270 30 10 
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GSY[Nitration]LG 271 2 189     4200 270 30 10 
GSY[Nitration]LG 271 2 397     4200 270 30 10 
GSY[Nitration]LG 271 2 484     4200 270 30 10 
GSY[Nitration]LG 541 1 189     4200 270 30 10 
GSY[Nitration]LG 541 1 397     4200 270 30 10 
GSY[Nitration]LG 541 1 484     4200 270 30 10 
GSYEG 257 2 205     4200 270 30 10 
GSYEG 257 2 368     4200 270 30 10 
GSYEG 257 2 455     4200 270 30 10 
GSYEG 512 1 205     4200 270 30 10 
GSYEG 512 1 368     4200 270 30 10 
GSYEG 512 1 455     4200 270 30 10 
GSY[Nitration]EG 279 2 205     4200 270 30 10 
GSY[Nitration]EG 279 2 413     4200 270 30 10 
GSY[Nitration]EG 279 2 500     4200 270 30 10 
GSY[Nitration]EG 557 1 205     4200 270 30 10 
GSY[Nitration]EG 557 1 413     4200 270 30 10 
GSY[Nitration]EG 557 1 500     4200 270 30 10 
GLYLG 262 2 189     4200 270 30 10 
GLYLG 262 2 352     4200 270 30 10 
GLYLG 262 2 465     4200 270 30 10 
GLYLG 522 1 189     4200 270 30 10 
GLYLG 522 1 352     4200 270 30 10 
GLYLG 522 1 465     4200 270 30 10 
GLY[Nitration]LG 284 2 189     4200 270 30 10 
GLY[Nitration]LG 284 2 397     4200 270 30 10 
GLY[Nitration]LG 284 2 510     4200 270 30 10 
GLY[Nitration]LG 567 1 189     4200 270 30 10 
GLY[Nitration]LG 567 1 397     4200 270 30 10 
GLY[Nitration]LG 567 1 510     4200 270 30 10 
GLYSG 249 2 163     4200 270 30 10 
GLYSG 249 2 326     4200 270 30 10 
GLYSG 249 2 439     4200 270 30 10 
GLYSG 496 1 163     4200 270 30 10 
GLYSG 496 1 326     4200 270 30 10 
GLYSG 496 1 439     4200 270 30 10 
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GLY[Nitration]SG 271 2 163     4200 270 30 10 
GLY[Nitration]SG 271 2 371     4200 270 30 10 
GLY[Nitration]SG 271 2 484     4200 270 30 10 
GLY[Nitration]SG 541 1 163     4200 270 30 10 
GLY[Nitration]SG 541 1 371     4200 270 30 10 
GLY[Nitration]SG 541 1 484     4200 270 30 10 
GLYEG 270 2 205     4200 270 30 10 
GLYEG 270 2 368     4200 270 30 10 
GLYEG 270 2 481     4200 270 30 10 
GLYEG 538 1 205     4200 270 30 10 
GLYEG 538 1 368     4200 270 30 10 
GLYEG 538 1 481     4200 270 30 10 
GLY[Nitration]EG 292 2 205     4200 270 30 10 
GLY[Nitration]EG 292 2 413     4200 270 30 10 
GLY[Nitration]EG 292 2 526     4200 270 30 10 
GLY[Nitration]EG 583 1 205     4200 270 30 10 
GLY[Nitration]EG 583 1 413     4200 270 30 10 
GLY[Nitration]EG 583 1 526     4200 270 30 10 
GEYEG 278 2 205     4200 270 30 10 
GEYEG 278 2 368     4200 270 30 10 
GEYEG 278 2 497     4200 270 30 10 
GEYEG 554 1 205     4200 270 30 10 
GEYEG 554 1 368     4200 270 30 10 
GEYEG 554 1 497     4200 270 30 10 
GEY[Nitration]EG 300 2 205     4200 270 30 10 
GEY[Nitration]EG 300 2 413     4200 270 30 10 
GEY[Nitration]EG 300 2 542     4200 270 30 10 
GEY[Nitration]EG 599 1 205     4200 270 30 10 
GEY[Nitration]EG 599 1 413     4200 270 30 10 
GEY[Nitration]EG 599 1 542     4200 270 30 10 
GEYSG 257 2 163     4200 270 30 10 
GEYSG 257 2 326     4200 270 30 10 
GEYSG 257 2 455     4200 270 30 10 
GEYSG 512 1 163     4200 270 30 10 
GEYSG 512 1 326     4200 270 30 10 
GEYSG 512 1 455     4200 270 30 10 
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GEY[Nitration]SG 279 2 163     4200 270 30 10 
GEY[Nitration]SG 279 2 371     4200 270 30 10 
GEY[Nitration]SG 279 2 500     4200 270 30 10 
GEY[Nitration]SG 557 1 163     4200 270 30 10 
GEY[Nitration]SG 557 1 371     4200 270 30 10 
GEY[Nitration]SG 557 1 500     4200 270 30 10 
GEYLG 270 2 189     4200 270 30 10 
GEYLG 270 2 352     4200 270 30 10 
GEYLG 270 2 481     4200 270 30 10 
GEYLG 538 1 189     4200 270 30 10 
GEYLG 538 1 352     4200 270 30 10 
GEYLG 538 1 481     4200 270 30 10 
GEY[Nitration]LG 292 2 189     4200 270 30 10 
GEY[Nitration]LG 292 2 397     4200 270 30 10 
GEY[Nitration]LG 292 2 526     4200 270 30 10 
GEY[Nitration]LG 583 1 189     4200 270 30 10 
GEY[Nitration]LG 583 1 397     4200 270 30 10 
GEY[Nitration]LG 583 1 526     4200 270 30 10 
 
Isobaric precursor masses were differentiated by 0.002 Da (not shown in table). 
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Appendix F: Table S2 Predicted MRM transitions for mouse and rat  
histone nitropeptides 
 
Peptide 
Sequence 
Modified Sequence Precursor 
Charge 
Precursor 
m/z 
Product 
m/z 
Product 
Charge 
Fragment 
Ion 
ALAAAGYDVEK ALAAAGYDVEK 2 554.29 781.37 1 y7 
ALAAAGYDVEK ALAAAGYDVEK 2 554.29 710.34 1 y6 
ALAAAGYDVEK ALAAAGYDVEK 2 554.29 653.31 1 y5 
ALAAAGYDVEK ALAAAGYDVEK 2 554.29 618.32 1 b7 
ALAAAGYDVEK ALAAAGYDVEK 2 554.29 733.35 1 b8 
ALAAAGYDVEK ALAAAGYDVEK 2 554.29 832.42 1 b9 
ALAAAGYDVEK ALAAAGY[+45]DVEK 2 576.78 826.36 1 y7 
ALAAAGYDVEK ALAAAGY[+45]DVEK 2 576.78 755.32 1 y6 
ALAAAGYDVEK ALAAAGY[+45]DVEK 2 576.78 698.30 1 y5 
ALAAAGYDVEK ALAAAGY[+45]DVEK 2 576.78 663.31 1 b7 
ALAAAGYDVEK ALAAAGY[+45]DVEK 2 576.78 778.34 1 b8 
ALAAAGYDVEK ALAAAGY[+45]DVEK 2 576.78 877.41 1 b9 
YSDMIVAAIQAEK YSDMIVAAIQAEK 2 719.87 942.56 1 y9 
YSDMIVAAIQAEK YSDMIVAAIQAEK 2 719.87 829.48 1 y8 
YSDMIVAAIQAEK YSDMIVAAIQAEK 2 719.87 730.41 1 y7 
YSDMIVAAIQAEK YSDMIVAAIQAEK 2 719.87 780.36 1 b7 
YSDMIVAAIQAEK YSDMIVAAIQAEK 2 719.87 851.40 1 b8 
YSDMIVAAIQAEK YSDMIVAAIQAEK 2 719.87 964.48 1 b9 
YSDMIVAAIQAEK Y[+45]SDMIVAAIQAEK 2 742.36 1073.60 1 y10 
YSDMIVAAIQAEK Y[+45]SDMIVAAIQAEK 2 742.36 942.56 1 y9 
YSDMIVAAIQAEK Y[+45]SDMIVAAIQAEK 2 742.36 829.48 1 y8 
YSDMIVAAIQAEK Y[+45]SDMIVAAIQAEK 2 742.36 754.31 1 b6 
YSDMIVAAIQAEK Y[+45]SDMIVAAIQAEK 2 742.36 825.34 1 b7 
YSDMIVAAIQAEK Y[+45]SDMIVAAIQAEK 2 742.36 896.38 1 b8 
GNYSER GNYSER 2 363.16 668.30 1 y5 
GNYSER GNYSER 2 363.16 554.26 1 y4 
GNYSER GNYSER 2 363.16 391.19 1 y3 
GNYSER GNYSER 2 363.16 422.17 1 b4 
GNYSER GNYSER 2 363.16 551.21 1 b5 
GNYSER GNY[+45]SER 2 385.66 713.28 1 y5 
GNYSER GNY[+45]SER 2 385.66 599.24 1 y4 
GNYSER GNY[+45]SER 2 385.66 391.19 1 y3 
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GNYSER GNY[+45]SER 2 385.66 467.15 1 b4 
GNYSER GNY[+45]SER 2 385.66 596.19 1 b5 
GNYAER GNYAER 2 355.17 652.30 1 y5 
GNYAER GNYAER 2 355.17 538.26 1 y4 
GNYAER GNYAER 2 355.17 375.20 1 y3 
GNYAER GNYAER 2 355.17 406.17 1 b4 
GNYAER GNYAER 2 355.17 535.21 1 b5 
GNYAER GNY[+45]AER 2 377.66 697.29 1 y5 
GNYAER GNY[+45]AER 2 377.66 583.25 1 y4 
GNYAER GNY[+45]AER 2 377.66 380.12 1 b3 
GNYAER GNY[+45]AER 2 377.66 451.16 1 b4 
GNYAER GNY[+45]AER 2 377.66 580.20 1 b5 
EESYSIYIYK EESYSIYIYK 2 647.81 949.50 1 y7 
EESYSIYIYK EESYSIYIYK 2 647.81 786.44 1 y6 
EESYSIYIYK EESYSIYIYK 2 647.81 699.41 1 y5 
EESYSIYIYK EESYSIYIYK 2 647.81 709.30 1 b6 
EESYSIYIYK EESYSIYIYK 2 647.81 872.37 1 b7 
EESYSIYIYK EESYSIYIYK 2 647.81 985.45 1 b8 
EESYSIYIYK EESY[+45]SIYIYK 2 670.31 994.49 1 y7 
EESYSIYIYK EESY[+45]SIYIYK 2 670.31 786.44 1 y6 
EESYSIYIYK EESY[+45]SIYIYK 2 670.31 699.41 1 y5 
EESYSIYIYK EESY[+45]SIYIYK 2 670.31 754.29 1 b6 
EESYSIYIYK EESY[+45]SIYIYK 2 670.31 917.35 1 b7 
EESYSIYIYK EESY[+45]SIYIYK 2 670.31 1030.44 1 b8 
EESYSIYIYK EESYSIY[+45]IYK 2 670.31 994.49 1 y7 
EESYSIYIYK EESYSIY[+45]IYK 2 670.31 831.42 1 y6 
EESYSIYIYK EESYSIY[+45]IYK 2 670.31 744.39 1 y5 
EESYSIYIYK EESYSIY[+45]IYK 2 670.31 709.30 1 b6 
EESYSIYIYK EESYSIY[+45]IYK 2 670.31 917.35 1 b7 
EESYSIYIYK EESYSIY[+45]IYK 2 670.31 1030.44 1 b8 
EESYSIYIYK EESYSIYIY[+45]K 2 670.31 994.49 1 y7 
EESYSIYIYK EESYSIYIY[+45]K 2 670.31 831.42 1 y6 
EESYSIYIYK EESYSIYIY[+45]K 2 670.31 744.39 1 y5 
EESYSIYIYK EESYSIYIY[+45]K 2 670.31 709.30 1 b6 
EESYSIYIYK EESYSIYIY[+45]K 2 670.31 872.37 1 b7 
EESYSIYIYK EESYSIYIY[+45]K 2 670.31 985.45 1 b8 
EESYSIYIYK EESY[+45]SIY[+45]IYK 2 692.80 1039.47 1 y7 
EESYSIYIYK EESY[+45]SIY[+45]IYK 2 692.80 831.42 1 y6 
EESYSIYIYK EESY[+45]SIY[+45]IYK 2 692.80 744.39 1 y5 
EESYSIYIYK EESY[+45]SIY[+45]IYK 2 692.80 754.29 1 b6 
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EESYSIYIYK EESY[+45]SIY[+45]IYK 2 692.80 962.34 1 b7 
EESYSIYIYK EESY[+45]SIY[+45]IYK 2 692.80 1075.42 1 b8 
EESYSIYIYK EESY[+45]SIYIY[+45]K 2 692.80 1039.47 1 y7 
EESYSIYIYK EESY[+45]SIYIY[+45]K 2 692.80 831.42 1 y6 
EESYSIYIYK EESY[+45]SIYIY[+45]K 2 692.80 744.39 1 y5 
EESYSIYIYK EESY[+45]SIYIY[+45]K 2 692.80 754.29 1 b6 
EESYSIYIYK EESY[+45]SIYIY[+45]K 2 692.80 917.35 1 b7 
EESYSIYIYK EESY[+45]SIYIY[+45]K 2 692.80 1030.44 1 b8 
EESYSIYIYK EESYSIY[+45]IY[+45]K 2 692.80 1039.47 1 y7 
EESYSIYIYK EESYSIY[+45]IY[+45]K 2 692.80 876.41 1 y6 
EESYSIYIYK EESYSIY[+45]IY[+45]K 2 692.80 789.38 1 y5 
EESYSIYIYK EESYSIY[+45]IY[+45]K 2 692.80 709.30 1 b6 
EESYSIYIYK EESYSIY[+45]IY[+45]K 2 692.80 917.35 1 b7 
EESYSIYIYK EESYSIY[+45]IY[+45]K 2 692.80 1030.44 1 b8 
EESYSIYIYK EESY[+45]SIY[+45]IY[+45]K 2 715.29 1084.46 1 y7 
EESYSIYIYK EESY[+45]SIY[+45]IY[+45]K 2 715.29 876.41 1 y6 
EESYSIYIYK EESY[+45]SIY[+45]IY[+45]K 2 715.29 789.38 1 y5 
EESYSIYIYK EESY[+45]SIY[+45]IY[+45]K 2 715.29 754.29 1 b6 
EESYSIYIYK EESY[+45]SIY[+45]IY[+45]K 2 715.29 962.34 1 b7 
EESYSIYIYK EESY[+45]SIY[+45]IY[+45]K 2 715.29 1075.42 1 b8 
ESYSIYIYK ESYSIYIYK 2 583.29 786.44 1 y6 
ESYSIYIYK ESYSIYIYK 2 583.29 699.41 1 y5 
ESYSIYIYK ESYSIYIYK 2 583.29 586.32 1 y4 
ESYSIYIYK ESYSIYIYK 2 583.29 743.32 1 b6 
ESYSIYIYK ESYSIYIYK 2 583.29 856.41 1 b7 
ESYSIYIYK ESYSIYIYK 2 583.29 1019.47 1 b8 
ESYSIYIYK ESY[+45]SIYIYK 2 605.78 994.49 1 y7 
ESYSIYIYK ESY[+45]SIYIYK 2 605.78 786.44 1 y6 
ESYSIYIYK ESY[+45]SIYIYK 2 605.78 699.41 1 y5 
ESYSIYIYK ESY[+45]SIYIYK 2 605.78 625.25 1 b5 
ESYSIYIYK ESY[+45]SIYIYK 2 605.78 788.31 1 b6 
ESYSIYIYK ESY[+45]SIYIYK 2 605.78 901.39 1 b7 
ESYSIYIYK ESYSIY[+45]IYK 2 605.78 831.42 1 y6 
ESYSIYIYK ESYSIY[+45]IYK 2 605.78 744.39 1 y5 
ESYSIYIYK ESYSIY[+45]IYK 2 605.78 631.31 1 y4 
ESYSIYIYK ESYSIY[+45]IYK 2 605.78 788.31 1 b6 
ESYSIYIYK ESYSIY[+45]IYK 2 605.78 901.39 1 b7 
ESYSIYIYK ESYSIY[+45]IYK 2 605.78 1064.46 1 b8 
ESYSIYIYK ESYSIYIY[+45]K 2 605.78 831.42 1 y6 
ESYSIYIYK ESYSIYIY[+45]K 2 605.78 744.39 1 y5 
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ESYSIYIYK ESYSIYIY[+45]K 2 605.78 631.31 1 y4 
ESYSIYIYK ESYSIYIY[+45]K 2 605.78 743.32 1 b6 
ESYSIYIYK ESYSIYIY[+45]K 2 605.78 856.41 1 b7 
ESYSIYIYK ESYSIYIY[+45]K 2 605.78 1064.46 1 b8 
ESYSIYIYK ESY[+45]SIY[+45]IYK 2 628.28 831.42 1 y6 
ESYSIYIYK ESY[+45]SIY[+45]IYK 2 628.28 744.39 1 y5 
ESYSIYIYK ESY[+45]SIY[+45]IYK 2 628.28 631.31 1 y4 
ESYSIYIYK ESY[+45]SIY[+45]IYK 2 628.28 833.29 1 b6 
ESYSIYIYK ESY[+45]SIY[+45]IYK 2 628.28 946.38 1 b7 
ESYSIYIYK ESY[+45]SIY[+45]IYK 2 628.28 1109.44 1 b8 
ESYSIYIYK ESY[+45]SIYIY[+45]K 2 628.28 831.42 1 y6 
ESYSIYIYK ESY[+45]SIYIY[+45]K 2 628.28 744.39 1 y5 
ESYSIYIYK ESY[+45]SIYIY[+45]K 2 628.28 631.31 1 y4 
ESYSIYIYK ESY[+45]SIYIY[+45]K 2 628.28 788.31 1 b6 
ESYSIYIYK ESY[+45]SIYIY[+45]K 2 628.28 901.39 1 b7 
ESYSIYIYK ESY[+45]SIYIY[+45]K 2 628.28 1109.44 1 b8 
ESYSIYIYK ESYSIY[+45]IY[+45]K 2 628.28 876.41 1 y6 
ESYSIYIYK ESYSIY[+45]IY[+45]K 2 628.28 789.38 1 y5 
ESYSIYIYK ESYSIY[+45]IY[+45]K 2 628.28 676.29 1 y4 
ESYSIYIYK ESYSIY[+45]IY[+45]K 2 628.28 788.31 1 b6 
ESYSIYIYK ESYSIY[+45]IY[+45]K 2 628.28 901.39 1 b7 
ESYSIYIYK ESYSIY[+45]IY[+45]K 2 628.28 1109.44 1 b8 
ESYSIYIYK ESY[+45]SIY[+45]IY[+45]K 2 650.77 876.41 1 y6 
ESYSIYIYK ESY[+45]SIY[+45]IY[+45]K 2 650.77 789.38 1 y5 
ESYSIYIYK ESY[+45]SIY[+45]IY[+45]K 2 650.77 676.29 1 y4 
ESYSIYIYK ESY[+45]SIY[+45]IY[+45]K 2 650.77 833.29 1 b6 
ESYSIYIYK ESY[+45]SIY[+45]IY[+45]K 2 650.77 946.38 1 b7 
ESYSIYIYK ESY[+45]SIY[+45]IY[+45]K 2 650.77 1154.43 1 b8 
LAHYNK LAHYNK 2 373.20 632.32 1 y5 
LAHYNK LAHYNK 2 373.20 561.28 1 y4 
LAHYNK LAHYNK 2 373.20 424.22 1 y3 
LAHYNK LAHYNK 2 373.20 485.25 1 b4 
LAHYNK LAHYNK 2 373.20 599.29 1 b5 
LAHYNK LAHY[+45]NK 2 395.70 677.30 1 y5 
LAHYNK LAHY[+45]NK 2 395.70 606.26 1 y4 
LAHYNK LAHY[+45]NK 2 395.70 469.20 1 y3 
LAHYNK LAHY[+45]NK 2 395.70 530.24 1 b4 
LAHYNK LAHY[+45]NK 2 395.70 644.28 1 b5 
YTSSK YTSSK 2 293.15 422.22 1 y4 
YTSSK YTSSK 2 293.15 321.18 1 y3 
201 
 
Appendix F continued 
 
YTSSK YTSSK 2 293.15 352.15 1 b3 
YTSSK YTSSK 2 293.15 439.18 1 b4 
YTSSK Y[+45]TSSK 2 315.64 422.22 1 y4 
YTSSK Y[+45]TSSK 2 315.64 321.18 1 y3 
YTSSK Y[+45]TSSK 2 315.64 397.14 1 b3 
YTSSK Y[+45]TSSK 2 315.64 484.17 1 b4 
ISGLIYEETR ISGLIYEETR 2 590.81 923.48 1 y7 
ISGLIYEETR ISGLIYEETR 2 590.81 810.40 1 y6 
ISGLIYEETR ISGLIYEETR 2 590.81 697.32 1 y5 
ISGLIYEETR ISGLIYEETR 2 590.81 647.38 1 b6 
ISGLIYEETR ISGLIYEETR 2 590.81 776.42 1 b7 
ISGLIYEETR ISGLIYEETR 2 590.81 905.46 1 b8 
ISGLIYEETR ISGLIY[+45]EETR 2 613.31 968.47 1 y7 
ISGLIYEETR ISGLIY[+45]EETR 2 613.31 855.38 1 y6 
ISGLIYEETR ISGLIY[+45]EETR 2 613.31 742.30 1 y5 
ISGLIYEETR ISGLIY[+45]EETR 2 613.31 692.36 1 b6 
ISGLIYEETR ISGLIY[+45]EETR 2 613.31 821.40 1 b7 
ISGLIYEETR ISGLIY[+45]EETR 2 613.31 950.45 1 b8 
DAVTYTEHAK DAVTYTEHAK 2 567.77 849.41 1 y7 
DAVTYTEHAK DAVTYTEHAK 2 567.77 748.36 1 y6 
DAVTYTEHAK DAVTYTEHAK 2 567.77 585.30 1 y5 
DAVTYTEHAK DAVTYTEHAK 2 567.77 651.30 1 b6 
DAVTYTEHAK DAVTYTEHAK 2 567.77 780.34 1 b7 
DAVTYTEHAK DAVTYTEHAK 2 567.77 917.40 1 b8 
DAVTYTEHAK DAVTY[+45]TEHAK 2 590.27 993.46 1 y8 
DAVTYTEHAK DAVTY[+45]TEHAK 2 590.27 894.40 1 y7 
DAVTYTEHAK DAVTY[+45]TEHAK 2 590.27 793.35 1 y6 
DAVTYTEHAK DAVTY[+45]TEHAK 2 590.27 595.24 1 b5 
DAVTYTEHAK DAVTY[+45]TEHAK 2 590.27 696.28 1 b6 
DAVTYTEHAK DAVTY[+45]TEHAK 2 590.27 825.33 1 b7 
TVTAMDVVYALK TVTAMDVVYALK 2 655.85 938.50 1 y8 
TVTAMDVVYALK TVTAMDVVYALK 2 655.85 807.46 1 y7 
TVTAMDVVYALK TVTAMDVVYALK 2 655.85 692.43 1 y6 
TVTAMDVVYALK TVTAMDVVYALK 2 655.85 718.34 1 b7 
TVTAMDVVYALK TVTAMDVVYALK 2 655.85 817.41 1 b8 
TVTAMDVVYALK TVTAMDVVYALK 2 655.85 980.48 1 b9 
TVTAMDVVYALK TVTAMDVVY[+45]ALK 2 678.35 983.49 1 y8 
TVTAMDVVYALK TVTAMDVVY[+45]ALK 2 678.35 852.45 1 y7 
TVTAMDVVYALK TVTAMDVVY[+45]ALK 2 678.35 737.42 1 y6 
TVTAMDVVYALK TVTAMDVVY[+45]ALK 2 678.35 718.34 1 b7 
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TVTAMDVVYALK TVTAMDVVY[+45]ALK 2 678.35 817.41 1 b8 
TVTAMDVVYALK TVTAMDVVY[+45]ALK 2 678.35 1025.46 1 b9 
TLYGFGG TLYGFGG 2 357.68 613.30 1 y6 
TLYGFGG TLYGFGG 2 357.68 500.21 1 y5 
TLYGFGG TLYGFGG 2 357.68 378.20 1 b3 
TLYGFGG TLYGFGG 2 357.68 435.22 1 b4 
TLYGFGG TLYGFGG 2 357.68 582.29 1 b5 
TLYGFGG TLY[+45]GFGG 2 380.17 658.28 1 y6 
TLYGFGG TLY[+45]GFGG 2 380.17 545.20 1 y5 
TLYGFGG TLY[+45]GFGG 2 380.17 423.19 1 b3 
TLYGFGG TLY[+45]GFGG 2 380.17 480.21 1 b4 
TLYGFGG TLY[+45]GFGG 2 380.17 627.28 1 b5 
 
Data acquired using Skyline Targeted Proteomics Environment (v1.1) (18).  
These data can be entered into method software on a TSQ Ultra for pilot 
quantitative measurements.  The actual RTs and spectral intensities can be 
entered into the skyline platform to optimize the method before uploading back to 
TSQ. 
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